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ABSTRACT 
Salmonella Typhimurium definitive type 104 CST DTI04) isolates resistant to antibiotics have 
been an issue since the multi-resistant clone was identified in 1985. In order to advance 
understanding of ST DTI04 infections in Scotland, 2,796 human and 2,439 animal isolates 
with their corresponding antibiotic resistance patterns submitted from 1988 to 2004 were used 
to conduct descriptive, hierarchical, and geographical cluster studies and to construct a time 
series model. The analyses showed that using the 13 antibiotics used by the Scottish 
Salmonella Reference Laboratory, isolates could be allocated into two distinct groups. The 
first group containing the ApCISpStSuTe R-type with its associated resistance patterns, 
mainly the ApCISpStSuTeTm and the ApCISpStSuTeNa R-types, dominated the trend 
throughout the study period. The second group, mainly composed of fully sensitive isolates, 
formed a low proportion except during the period from 1988 to 1990. Descriptive and 
temporal studies evidenced many similarities between the isolates of human and animal origin. 
The temporal analyses showed that there was an epidemic from 1993 to 1998 in human ST 
DTI04 and from 1992 to 1999 in animals. The hierarchical cluster analysis also identified 
many similarities between the isolates from animals and humans although there was a higher 
proportion of multi-resistance and lower proportion of fully sensitive isolates sourced from 
animals when compared with humans. Spatial analysis identified the southern part of Scotland 
as the higher relative risk area for both human and animal infections caused by multi-resistant 
ST DTI04 strains In contrast, the central belt of Scotland was mainly the relative risk lower 
spatial cluster for the multi-resistant ST DTI04 R-types. Of note in the spatio-temporal 
analysis was the stability and persistence of the chromosomally mediated multiple resistance 
compared to the more sporadic plasmid mediated resistance types of the second group. Time 
series analyses were hindered by the quality of the data relating to the animal isolates but 
there was a suggestion that there may be some underlying fundamental differences in the 
drivers for patterns from the human and the animal data. When considering the emergence of 
resistance to individual antimicrobials, although there were many similarities between the 
infections in humans and animals, there was no consistent temporal association between the 
emergence of clones in humans compared with animals suggesting that the ecological and 
epidemiological direction of the relationships is complex. Data quality and uniformity of 
surveillance systems were identified as important issues for future studies. 
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CHAPTER I 
INTRODUCTION AND REVIEW OF THE LITERATURE 
In this chapter, the relevant information about Salmonellae will be described in three sections. 
The first section contains general information on Salmonella and its serotype Salmonella 
Typhimurium definitive type 104 (ST DT104). The second section describes the history of 
antibiotics and resistance mechanisms found in ST DT104. The third section contains 
epidemiological information from the UK and other European countries. The definitions used 
in this thesis are the same as those used by the Veterinary Laboratories Agency (VLA), the 
Department for Environment Food & Rural Affair (Defra; http://www.defra.gov.uk) and 
Health Protection Scotland (HPS) (http://www.show.scot.nhs.uk/scieh/). 
1.1 INTRODUCTION TO SALMONELLA 
1.1.1 History of Salmonella 
Salmonellosis has been causing disease in people and animals for over 100 years. It was first 
reported by Dr. Daniel Elmer Salmon in 1884 and Theobald Smith isolated the organism two 
years later. They described an infection caused by hog cholera bacillus which caused "swine 
plague" and named it as Baciterium suipestifer. This organism finally became the typical 
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species of Salmonella, S. Choleraesuis as suggested by Dr. Lingier in 1900 out of respect for 
Dr. Salmon (Georgala et al. 1999). 
In 1888 a German, Dr. Gaeter, isolated Bacterium enteritidis during an epidemic. He isolated 
the micro-organism from both the meat of an emergency-slaughtered cow and the organs of a 
patient (Bell and Kyriakides 2002). In this epidemic, there were 58 patients who consumed 
the meat and developed salmonellosis. This was probably the first laboratory confirmed 
outbreak of salmonellosis (Georgala et al. 1999). 
In the following years, some other important species of Salmonella, including typhosum (later 
Typhi), paratyphosum A and B (Paratyphi A and B), Gallinarum and Typhimurium were 
characterised. These organisms result in a significant range of illnesses including food 
poisoning (gastroenteritis), typhoid (enteric fever), paratyphoid, bacteraemia and septicaemia 
in humans and animals. Today, the species of Salmonella are very important food-borne and 
water-borne pathogens and play an important role in public health. To date, more than 2,463 
serotypes of Salmonella have been identified (Brenner et al. 2000) and they are the most 
common form of food-borne illness. 
Serotypes of Salmonella can be grouped into three categories: 1) highly adapted to human 
hosts, 2) adapted to non-human hosts, and 3) unadapted to specific hosts (Brenner et al. 2000). 
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The first group includes S. Typhi and S. Paratyphi A, B (S. schottmuelleri), and C (S. 
hirschfeldii), which are pathogenic only in humans and commonly cause enteric fever. The 
second group causes diseases almost exclusively in animals, although two strains within this 
group, S. Dublin and S. Choleraesuis, also cause diseases in humans. The third group, 
designated S. enteritidis, includes 2,000 serotypes that cause gastro-enteritis and account for 
85% of all Salmonella infections in the USA (Brenner et al. 2000). Usually, when people are 
talking about Salmonellae, they mean Salmonella enteritidis. 
The epidemiology of the non-typhoidal salmonellosis is similar to, but more complicated than, 
that of typhoid fever. The main reason is that disease can be spread by direct and indirect 
contact with infected species of animals, the products derived from these animals, and these 
animals' excreta. All salmonellae are considered as pathogens and can cause various degrees 
of salmonella gastro-enteritis (Georgala et al. 1999) 
1.1.2 Characteristics of Salmonellae 
Salmonella is a Gram-negative, facultatively anaerobic, straight, small (0.7-1.5 * 2.0-50 uM), 
and non-endospore-forming rod. They can move using peritrichous flagellae. Their normal 
habitat is in the intestinal tracts of animals, especially poultry and cattle. Contamination of 
food material can occur under insanitary conditions (GeOl'gala et al. 1999). The biochemical 
characteristics of Salmonella are: Catalase (+); Oxidase (-); Acid produced from lactose (-); 
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Gas produced from glucose (+) - except Typhi; Indole (-); Urease produced (-); Hydrogen 
sulphide produced from triple-sugar iron agar (+); Citrate utilised as sole carbon source (+), 
except Typhi; Methyl red (+); Voges-Proskauer (-); Lysin decarboxylase (+); and Ornithine 
decarboxylase (+) (Georgala et al. 1999). 
The genome is about 4.5 Mbp in size. The similarity of the Salmonella at the DNA level is 
between 95% to 99%. Escherichia coli is the closest genus to Salmonella with between 60% 
and 70% similarity (Georgala et al. 1999). 
Different serotypes of Salmonellae can be distinguished by specific antibodies using a system 
known as the Kauffmann-White scheme (Brenner et al. 2000; Georgala et al. 1999). This 
system names an organism by numbers and letters that correspond to specific antigens on the 
organism's capsule (K), cell wall (0; somatic), and flagella (H). Serotype names designated 
by antigenic formulae include the following: (i) subspecies designation (subspecies I through 
VI), (ii) 0 (somatic) antigens followed by a colon, (iii) H (flagellar) antigens (phase 1) 
followed by a colon, and (iv) H antigens (phase 2, if present) (e.g. S. serotype IV 45:g,z51:-). 
Many newly discovered Salmonella serotypes are named only by their antigenic formulae. 
Serovars can be further differentiated by special biochemical or physiological properties into 
biovars, or biotypes (Brenner et al. 2000). 
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1.1.3 The nomenclature system of Salmonella 
The traditional nomenclature system names bacteria by family, genus and then serotype. 
However, there are too many similar serotypes and there is a high likelihood that this number 
will continue to increase. In addition and for example, the majority (59%) of the 2,463 
Salmonella serotypes belong to S. enterica subsp. I (S enterica subsp. enterica). Consequently, 
the Judicial Commission of the International Committee for Systematic of Prokaryotes has 
decided to adopt the suggestions from Le Minor and Popoff in 1987 to divide the bacterial 
species Salmonella enterica into six subspecies: enterica, salamae, arizonae, diarizonae, 
houtenae and indica (Judicial Commission of the International Committee on Systematics of 
Prokaryotes 2005). 
The naming system of serovars of subspecies enterica differs from the other five subspecies, 
in which the familiar serovar names are still assigned to subspecies enterica. However, the 
other subspecies are designated by antigenic structure only as described in 1.2.2. In this thesis, 
S. Typhimurium DTI04 (ST DTI04) refers to S enterica subspecies enterica serovar 
Typhimurium definitive type 104. 
1.1.4 Salmonella as an aetiological agent 
From the 1980s onwards, the second most common cause of food poisoning by Salmonella 
species was due to S. Typhimurium (ST). As its name suggests, it causes a typhoid-like 
CHAPTER I 7 
disease in mice. In humans, ST does not cause as severe disease as S. Enteritidis, and is not 
normally fatal (Leegaard et al. 2000). 
The main route of transmission for all salmonellosis is oral-faecal route, especially Via 
contaminated water or foods. Human multi-resistant (MR) ST DT104 infection has been 
associated with the consumption of raw meats and their products and/or with contact with 
infected cattle (Threlfall 2000). The bacteria colonises and then multiplies on the intestinal 
mucosa. It may pass through the intestinal mucosa to enter the lymphatic and cardiovascular 
systems and then spread and affect other organs. The infection is more common during the 
summer and is more associated with some human activities than others (Killalea et al. 1996). 
The symptoms of salmonellosis in humans usually begin 12 to 72 hours following ingestion. 
The symptoms and signs of salmonellosis include gastro-enteritis, enteric fever, focal 
manifestations, and occasionally bacteraemia. The duration of signs is generally up to 7 days. 
Patients feel a moderate fever accompanied by nausea, abdominal pain and cramps, and 
diarrhoea. The patient can shed a billion Salmonellae per gram in faeces during the acute 
phase of the illness and shedding may continue for up to 6 months (Georgala et al. 1999). 
Persistent shedding of Salmonella in faeces longer than 1 year occurs rarely - in only 0.2 to 
0.6% of patients with nontyphoidal Salmonella infections (Georgala et al. 1999). Even though 
bacteraemia is rare, some serotypes of Salmonella, e.g. S. Typhi, S. Paratyphi, S. Choleraesuis, 
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S. Typhimurium, S. Dublin, and S. Heidelberg, are invasive (Stephen et al. 2003). 
The mortality rate is usually lower than 1 %. However, the death rate may be higher in infants, 
in immunocompromised patients, and among the elderly. The main cause of fatality is 
bacteraemia. The crude mortality associated with bacteriemia may be above 25% due to 
hospital specific variables (Pessoa-Silva et al. 2001; Pittet and Wenzel 1995). Salmonella 
infection is responsible for 70 to 100 deaths in England and Wales each year, either directly or 
indirectly (Humphrey et al. 2000). 
The reported mortality and morbidity in animals varies because severe diarrhoea and anorexia 
in production animals will often be treated without specific diagnosis. The infection is 
generally asymptomatic and may become chronic. Usually, infection in animals is limited to 
diarrhoea, a common occurrence which generally does not demand extensive medical 
intervention. The bacteria can be carried in animals for weeks or months, and shedding may 
continue long after the animal has visibly recovered. Many animals will never show signs, but 
will serve as reservoirs and passive carriers of the disease (Smith et al. 2007). 
1.1.5 Factors affecting growth and survival of Salmonella 
Temperature is an important factor of direct influence in the growth of Salmonella in different 
seasons although the precise role of temperature has been an issue for over 100 years. The 
CHAPTER I 9 
normal range of survival temperature for Salmonella is between 5.2°C to 46°C but the 
growth rate is greatly reduced at temperatures below 15°C (Bell and Kyriakides 2002). 
Salmonella Enteritidis and Typhimurium can survive at 27°C in ice cream for 7 years. (Bell 
and Kyriakides 2002). It is well documented that the survival in environmental conditions 
(including heat) rely on the mechanisms regulated by rpo genes (Bell and Kyriakides 2002). 
Few Salmonella serotypes will grow at temperatures below 7°C (Bell and Kyriakides 2002). 
The minimum reported temperature for the growth of S. Typhimurium is 6.2°C (Anon 1992). 
The resistance to low temperature can vary given other environmental conditions; for example, 
dry conditions increase heat resistance and low pH reduces heat resistance (Bell and 
Kyriakides 2002). Examples of the effect of environment on the ability of ST DTI04 to 
survive is presented in Table 1.1 showing varying temperatures and times required for death 
of the bacteria. The fat content in beef provides protection from heat, thus ST DTI04 can 
survive for longer in mince with a higher content of fat (Juneja and Eblen 2000). The sucrose 
content of a substrate also affects the ability of Salmonella to survive for longer at 65°C 
rather than glucose, sorbitol or fructose (Bell and Kyriakides 2002). The effect of the 
changing rate of temperature from low temperature to a lethal high temperature can make 
Salmonella produce heat shock proteins (Bell and Kyriakides 2002). 
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Table 1.1 Death (D) values in minutes for Salmonella in some food substrates at given 
temperatures (Bell and Kyriakides 2002) 
Food substrate/condition Salmonella serotype Temperature-°c D value 
Liquid whole egg, pH 8.0 ST 60 0.55 min 
Liquid whole egg, pH 5.5 ST 60 2.2 mins 
Liquid whole egg STDT104 55 6.05 mins 
Liquid whole egg ST (except DT104) 55 8.04 mins 
Ground beef ST 63 0.36 mins 
Milk Chocolate ST 71 6.6 hours 
Liquid whole egg + 10% salt ST DT 104 55 4.21 mins 
Liquid whole egg + 10% salt ST (except DT104) 55 4.73 mins 
Liquid egg yolk STDT104 55 9.40 mins 
Liquid egg yolk ST (except DT104) 55 8.03 mins 
Liquid egg yolk + 10% salt ST DT104 55 9.06 mins 
Liquid egg yolk + 10% salt ST (except DT1 04) 55 10.85 mins 
1.1.6 Identification methods 
Methods for detecting the presence of Salmonella in samples have been well established for 
many decades. Currently, most national and international microbiological standard methods 
for the detection of Salmonella, and food industry recommended methods, are based on the 
recommendations of different bodies (Tortora et al. 2001), e.g., European Standard 12824; 
Association of Official Analytic Chemists; UK Public Health Laboratory Service; Campden 
and Chorleywood Food Research Association. 
1.1.6.1 Bacterial isolation 
Bacterial isolation is the first step in identifying the bacteria. The procedures stati with 
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pre-enrichment in media followed by sub-culture into selective enrichment broths and finally 
selective plating. Once the bacteria have been isolated, identification using a number of 
biochemical tests and serotyping can be undertaken. The time taken to identify the bacteria 
ranges from 24 to 72 hours (Bell and Kyriakides 2002). 
There are many different methods of isolation that have been developed. The most commonly 
adopted method of isolation uses buffered peptone water as a pre-enrichment medium with 
selective enrichment broth Selenite-Cystine (SC) broth (1 +9) or Rappaport-Vassiliadis (RV) 
broth (1 + 100) and Brilliant Green Agar or Hektoen Enteric Agar, and XLD Agar as the 
selective agar (Bell and Kyriakides 2002). Once the bacteria has been isolated and identified 
as Salmonella these isolates can be stored for further analysis at a later date. 
1.1.6.2 Alternative methods 
In order to reduce the identification time, faster and more sensitive methods are continually 
being developed. Some techniques are based on antibody-antigen response, some are based on 
the modified biochemical identification, and others are based on the molecular biological 
processes. Due to concerns about false positives in new techniques, the traditional bacterial 
culture is still carried out for confirmation (Tortora et al. 2001). 
The biochemical identification kits are based on the traditional biochemical reactions (Bell 
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and Kyriakides 2002). These reactions are prepared in pre-formed chambers and supplied in a 
disposable unit. After inoculation and incubation of the test chambers, reaction results are read. 
Usually, the readers just need to describe positive/negative and value the score by specific 
colour changes in the media. Finally, a profile of the organism is obtained and usually the 
result is analysed by software. 
Enzyme-linked immuno-sorbent assay (ELISA), immuno-chromatography, 
chemi-Iuminescent immuno-assays, antibody-coated dipsticks or beads, latex agglutination 
and other technologies such as electrical conductance methods belong to this field (Tortora et 
al. 2001). Some kits use prepared Salmonella specific antibodies that attach to Salmonella 
antigens providing a rapid and useful method of identification, but false positives can occur. 
The polymerase chain reaction (PCR) is a very powerful and fast method, which use primers 
to amplify the number of copies of a pre-selected region of DNA to a sufficient level to test 
for identification (Georgala et al. 1999). There are many new methods based on PCR, e.g. 
16S-23S ribotyping; rep-PCR-(ERIC, REP AND BOX elements)-targets multiple copies of 
conserved repetitive DNA sequences; RAPD, AP-PCR -targets multiple random chromosomal 
locations; AFLP-multiple genomic restriction fragments amplified; IS fingerprinting - targets 
insertion sequences; VNTR, SSR - targets sequence repeats in coding and non-coding 
sequences; SLST, MLST-sequencing of hyper-variable genes, Pyro-sequencing; and DNA 
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micro arrays (Georgala et al. 1999). 
The plasmid profile method presents the plasmid profile on agarose gel after serial procedures 
including extraction and separation of the target extra-chromosomal circular DNA. Due to the 
transferable nature of plasmids amongst organisms, and even different species, plasmid 
profiling is very useful for tracing these epidemiological markers. The method is routinely 
used in the Salmonella Scottish Reference Laboratory (SSRL) and the results are usually 
published in HPS (formerly SCIEH) Weekly Reports. (Browning et al. 2005). 
Typing of an organism by Pulsed-field gel electrophoresis (PFGE) is also a useful 
epidemiological tool and is also used in SSRL. It involves the cutting of chromosomal DNA 
into large fragments by specific enzymes. The chosen enzyme for cutting the DNA of 
Salmonella is XbaI. The separation of these fragments by electrophoresis provides a 
'fingerprint'. The comparison of fingerprints from different isolates can provide some 
information such as where the related isolates occurred (Browning et al. 2005). This 
information helps to find related outbreaks and to trace the source of the infection. Even 
though the discriminatory power of the PFGE method has been challenged in several repOlis 
that show the difficulty of typing DTI04 isolates with PFGE (Lindstedt et al. 2003; Liebana et 
al. 2002), it is still a well-developed and suitable method for epidemiologic analysis. Ridley 
and Threlfall have reported that sensitive and multidrug-resistant strains of ST DTI 04 can be 
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separated by PFGE with ADaI, generating a fragment of approximately 10kb which hybridized 
to the integrons (Baggesen et al. 2000; Ridley and Threlfall 1998). Combining two or more 
epidemiological methods to trace Salmonella is useful in practice to trace the source of an 
outbreak. A variety of sources exist which may be used for guidance in appropriate method 
selection. National and International Standard methods published, for example, by the British 
Standards Institution, the European Committee for Standardisation (CEN), International 
Organisation for Standardisation (ISO), and the International Dairy Federation (IDF) are 
available. In addition, methods have been reviewed, practiced and validated by reputable 
bodies such as the Public Health Laboratory Service (UK), the Association of Official 
Analytical Chemists (USA) and Campden & Chorleywood Food Research Association (UK). 
1.1.7 Sources of salmonellosis 
Poultry eggs, and egg products are considered high risk foods due to their likelihood to be 
contaminated by Salmonella (Tortora et al. 2001). Most salmonellosis can be traced back to 
dairy, poultry and meat products, but Salmonellae can grow on many food substrates 
(Takkinen et al. 2005). Vegetables, such as lettuce, can be a source for spreading 
salmonellosis (Takkinen et al. 2005). The intestinal tracts of animals are a potential source of 
the bacteria for the contamination of meat during processing. Anothersource of Salmonella is 
the faeces of pets, especially those with diarrhoea. Wild birds have been shown to be a vector 
in the spread of salmonellosis (Hudson et al. 2000), 
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ST DT104 has been isolated from cattle, pigs, sheep, horses, chicken, pigeons, rabbits, cats, 
dogs and wild animals (Threlfall 2000). Pets can carry ST DT104 (Carlson and Ferris 2000) 
and their carrier rate can be as high as 90% (Tortora et al. 2001). One famous epidemic in the 
1970s was caused by direct contact with small turtles and, in response, the USA government 
banned the sale of small turtles (Anon 1986). Wild animals also playa role in dissemination 
of ST infection among livestock (Hollinger et al. 1998; Liebana et al. 2002). Humans are 
also a potential source of infection with person to person transmission by the faecal-oral route, 
principally via contaminated water or food (Parry 2003). In the UK, the main reservoir for ST 
DT104 and MR ST DT1 04 is cattle, although they have been isolated in other farm animals 
(Defra 2003; Browning et al. 2004; Browning et al. 2001a; Browning et al. 2001b; Browning 
et al. 2005; Browning et al. 1999; Browning et al. 2003). 
The are several points throughout the meat production chain, from farm to meat product, 
which have been associated with the contamination (Nielsen et al. 2001). Chronic infected 
animals are more likely to shed bacteria during stressful situations, such as transportation, 
unloading and mixing in the lairage. The slaughterhouse environment can be a source of 
direct and indirect transmission through contaminated equipment or people (Nielsen et al. 
2001). One infected animal could introduce bacteria to the slaughterhouse environment, 
providing a source of possible contamination for meat being processed. 
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1.1.8 Control and prevention 
The economic cost is huge regardless of whether the infection occurs in humans or animals. 
The economic impact of dealing with Salmonella infection on a farm is very hard to predict 
and much of the cost depends on management, control and prevention programmes. The total 
cost of mortality of pigs and increased feed consumption during a Salmonella outbreak was 
£9,608 in a 400 sow farm (Anon 2007d). The costs in industry in theoretical studies 
conducted by Reading University were estimated as £6 m per year in the poultry industry and 
between £0.5 m and £2.2 m in the cattle industry (Anon 2007c). For the human infection, the 
British government estimates costs in excess of £1. 7 million (Anon 2007b). 
Numerous efforts to reduce the risks and costs of salmonellosis and ST DTI 04 infections have 
been made. The implementation of control and prevention methods have been made to cover 
all aspects of the meat production chain 'from farm to fork'. Two basic standard control 
protocols are: 1) Herd Biosecurity, which is used at farm level (Anon 2007b), and 2) Hazard 
Analysis Critical Control Points (Food Standards Agency 2007), which is used to manage the 
risk of contamination occurring during processing of raw food to prepared food. 
Herd Biosecurity recommends that every farm needs to use suitable disinfection against 
pathogens. Unsuitable disinfection procedures and improper disinfection programmes may 
CHAPTER I 17 
result in competitive pathogens growing and may produce resistant bacteria. "Biosecurity: 
Publicity campaign at markets 2005" was an initiative launched by Defra (Anon 2007b). 
In addition to biosecurity, there are a number of other important methods to prevent 
salmonellosis spreading within a farm or between farms. Normally, quarantine, buying 
disease free animals, vaccination, and hygiene are useful and routine activities for farmers. In 
instances where an infected animal is unlikely to recover, slaughter is the best way to remove 
the animal and prevent further spread of disease within the farm. Suitable diagnostic methods, 
appropriate treatments correctly administered, and disease control programs are also 
important in maintaining disease status on a farm. 
The HACCP system is an internationally accepted procedure to manage and prevent food 
contamination following seven principles. It provides a suitable way to identify and control 
risks by setting alarm systems at suitable points, thus the food safety hazards can be managed 
and reduced to an acceptable level. Meat (HACCP) Regulations 200 was replaced by EU 
Regulation 852/2004 (Article 5). The new regulation requires food business operators in the 
supply chain to implement and maintain hygiene procedures, which are based on HACCP 
principles 
The implementation of good hygiene is important to prevent human to human spread of 
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foodborne pathogens. Food and or the environment may be polluted by carriers, especially by 
those who forget to wash their hands with soap after using the bathroom. Chicken meat is 
believed to be a factor for widespread dissemination in the kitchen of Campylobaeter and 
Salmonella (Humphrey et al. 2000). The contaminated food or environment then becomes a 
possible reservoir of infection for others. Cross-contamination of foods should be avoided 
during cooking preparation. It is recognised as an important contributory factor in 
approximately 30% of domestic outbreaks of Salmonella infection (Humphrey et al. 2000). 
Uncooked meats should be kept separate from produce, cooked foods, and ready-to-eat foods. 
Hands, cutting boards, counters, knives, and other utensils should be washed thoroughly after 
handling uncooked foods. People who have salmonellosis should not prepare food or pour 
water for others until they have been shown to no longer be carrying the Salmonella 
bacterium. Hands should be washed before handling any food, and between handling different 
food items. 
Pets, especially those with diarrhoea are also a potential reservoir of infection for their owners. 
Reptiles, dogs and cats have been proved as reservoirs of Salmonella (Balotescu et al. 2003). 
People can become infected if they do not wash their hands after contact with pets' faeces. In 
2007, NHS Greater Glasgow and Clyde launched a campaign advocating hands washing 
(Anon 2007a). 
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Vaccines are not usually suggested for human adults; however, for children, there are three 
kinds of vaccine suitable. The traditional vaccine protects efficiently for 4 to 7 year olds and 
can approach protection rates between 51 % to 76%. The live oral recombinant Salmonella 
vaccine is more efficient, but is only suitable for children over 6 years of age. The 
polyglycotide vaccine is suitable for children over 2 years of age and its protection efficiency 
can reach between 64% to 72% (Bell and Kyriakides 2002). 
In conclusion, the best way of preventing salmonellosis is good food hygiene and correct 
cooking. There is a greater risk of infection in the consumption of raw or unpasteurised milk 
or other diary products. Produce should be thoroughly washed before consuming. 
1.1.9 The mechanisms of antimicrobial resistance genes and other resistance mechanisms 
in ST DTI04 
1.1.9.1 The emergence of multi-resistant Salmonella serotypes 
There is long standing contention that multi-resistant strains spread from animals to humans. 
In the 1980s, it was asserted that antibiotic resistant bacteria were being transfened from 
animals to humans directly in meat and milk (Wall et al. 1994). In 1985, An 
antibiotic-resistant strain of S. Typhimurium infected 16,000 people in seven US states and 
the source of origin was one Illinois dairy farm (Ryan et al. 1987). As a consequence the 
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emergence ofMR ST DTI04 strain in animals has been linked by some researchers to the use 
of antimicrobial agents in some food animals (Angulo et al. 2000) 
An increase in resistance of ST to antimicrobial agents has been reported in several countries 
during the last 10 years (Threlfall 2000). The main reason for this increase is the emergence 
of a ST DT104 clone, which is resistant to five or more antibiotics: ampicillin (A); 
chloramphenicol (C); streptomycin (S) (or with spectinomycin); sulphonamides (Su) and 
tetracycline (T) (Threlfa112000). This clone is typically known as R-type ACSSuT ST DT104. 
The clone is famous because these resistance mechanisms are operated by 
chromosomal-integrated genes. Trimethoprim and ciprofloxacin resistances have recently 
been observed in ST DT1 04 isolates (Leegaard et al. 2000). It is suggested that the emergence 
of the additional trimethoprim resistant strains is caused by use of the drug to treat the ST 
DTI04 ACSSuT R-type infections (Threlfall 2000). It is also suggested that the additional 
nalidixic acid resistance is related to the licensing of flouroquinolones in veterinary use 
(Threlfall 2000). 
Molecular typing analysis has indicated that ST DT104 isolates from different hosts and 
geographical origins can be very similar (Malorny et al. 2001; Prager et al. 1999). Conversely, 
diversity of MR ST DT104 has been demonstrated (Threlfall et al. 2005; Yang et al. 2002). 
For example, isolates resistant against ApClSpStSuTe and ApClSpStSuTeTm identified in 
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2000 had different RFLP profiles from previous clones (Threlfall et al. 2005). 
1.1.9.2 Where and how does ST DT104 get antimicrobial resistance genes? 
Darwin's theory, survival of the fittest, suggests that suitable species can survive under 
selection pressure. The evolution of antimicrobial resistance bacteria might be considered as a 
good example of adaptive evolution (Levin et al. 2000). The organisms with resistance genes 
would be expected to survive and proliferate when the fitness cost associated with resistance 
is low relative to non-resistant organisms (Dick 2003). 
1.1. 9. 2.1 Mutation: stimulation-response reaction 
Mutation may occur in the process of cell proliferation. The mutation can occur through 
environmental changes that then activate certain genes. The spontaneous rate of mutation in a 
bacterial population for any particular gene is usually very low - about 1 per 106 to 108 (Rang 
and Ritter 1971). However, this is high enough for antibiotic resistance to develop. The 
surviving bacteria may then have, under pressure, a better chance of continued survival and 
the potential to propagate the necessary gene to the next generation. Mutation can occur in 
two phases - the stationary phase and the logarithmic growth phase. The mutation in the 
former phase has a better chance of leading to adaptive mutation (Loewe et al. 2003 ;Carlson 
and Ferris 2000). 
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The mutation rate is controlled by many mechanisms in Salmonella spp .. The mutS gene, 
which is responsible for DNA mis-match repair, can function under stress caused by an 
environment rich in ampicillin-derivatives (Carlson and Ferris 2000). Presence of bile salts 
and chloramphenicol can induce the over-expression of mar A gene, which translate 
multi-functional efflux pump protein (George and Levy 1983). In addition, the numbers of 
active efflux pumps on the cell membrane or the numbers of plasmids will be high when 
ciprofloxacin is present as an inducer (Chu et al. 2005). Environmental response genes, such 
as the rpo gene could be induced and a high mutant rate would be expected (Jorgensen et al. 
2000). 
1.1.9.2.2 Plasm ids, transposons, integron or gene cassette 
Transposons can jump out of or into any DNA segment, e.g., plasmid DNA or chromosome 
DNA. They can also "hitch-hike" on a plasmid to a new species (Hall and Collis 1995). 
However, transposons cannot replicate themselves but can replicate during transfer. Plasmids 
can be transferred to another bacteria via conjugation. The conjugation process can occur 
either in the same species or in different species. This occurs more readily in the gut because 
there are many gene fragments in the gut contents (Hall and Collis 1995). The antimicrobial 
resistance genes in plasmids are called r genes 
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Integrons also playa role in the resistance gene transmission and are usually located in a 
transposon. An integron may contain many different resistance genes. This system -
transposonlintegronlmulti-resistance cassette array - allows particularly rapid and efficient 
transfer of resistance genes between plasmids, between chromosomes and between plasmids 
and chromosomes (Hudson et al. 2000). 
There are 9 classes of integrons. (Hochhut et al. 2001; Nield et al. 2001). Over 60 distinct 
antibiotic resistance gene cassettes have been found in a single integron (Naas et al. 2001; 
Fluit and Schmitz 1999). Many plasmids encoding multi-resistance in the Enterobacteriaceae 
carry a transposon of the Tn21 family, which contains a class 1 integron (Goldstein et al. 2001; 
Grinsted et al. 1990). In one study, 60% of Escherichia coli isolates from poultry possessed a 
Tn21-like transposon carrying the aadAl streptomycin-spectinomycin resistance gene 
cassette (Bass et al. 1999). 
Class 1 integrons are widely distributed in nature (Hudson et al. 2000). All class 1 integrons 
possess the following key components: an integrase gene (in tIl ), a recombination site (attll), 
and a promoter (Pc) for the transcription of cassette-associated genes. These components 
encompass the basic functions needed for the acquisition and expression of a second type of 
mobile genetic element known as a gene cassette (Hall and Collis 1995; Stokes and Hall 
1989). As a result of multiple insertion and excision events, class 1 integrons can compile and 
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shuffle arrays of gene cassettes (Hall and Collis 1995; Stokes and Hall 1989). When an 
integron has hitch hiked into bacterial genome, the bacteria propagate the resistance genes 
into the next generation. The antibiotic resistance gene cassette, which is called Salmonella 
genomic island 1 (SGIl), is located on a ST DT104 chromosome and is class I integron (Boyd 
et al. 2001; Boyd et al. 2000). The structure of SGI is shown in Figure 1.1 (Cloeckaert and 
Schwarz 2001). 
1.1.9.3 The structure of SGI 1 in MR ST DTI 04 
It is now believed that SGIl the original gene cassette of antimicrobial resistance genes inside 
the ST DT104 chromosome could come from three sources: the bacterial pathogen of fish 
(Doublet et al. 2003), Pseudomonas spp., and from within the Enterobacteriae group 
(Cloeckaert and Schwarz 2001). 
Integron Integron 
aadAl j10R t.atfi. tetU bla.P:SE-l sull 
_.........,...,~  l ¢=l r===> ,. ~
tnpR Int1 SuiL:l1 
o 2000 4000 6000 
01:/1 orj2 
8000 
groBL 
IntI 
10000 
qacBL:ll 
'12000 13077 
Figure 1.1 Gene organization of SGIl of ST DT104 according to Cloeckaert and Schwarz 
(Cloeckaert and Schwarz 2001). 
Two different integrons were identified in the ACSSuT R-type ST DT104 clone in 1998 
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(Ridley and Threlfall 1998;Sandvang et al. 1998). The first integron carries aadA2 gene, 
which confers resistance to streptomycin-spectinomycin and sulfl1 genes, which is a 
non-functional gene. The second integron contained the ~-lactmase gene blapSE-l (Cloeckaert 
and Schwarz 2001) and sull gene, which confers resistance to sulphonamide and disinfectant 
resistance gene qacEl. In 1999, several research groups identified the remaining resistance 
genes conferring resistance to chloramphenicol and tetracyclines, which are located between 
the two integrons. As a consequence, all antibiotic resistance genes cluster on a chromosomal 
locus of about 12.5 kb (Cloeckaert et al. 2000). The gene conferring resistance to 
chloramphenicol also confers resistance to its fluorinated analogue, florfenicol, and has been 
named emlA-like, floR or floSt (Cloeckaert and Schwarz 2001). According to the deduced 
amino acid sequence homologies and the topology of the assumed protein, this gene encodes 
an efflux pump, which belongs to the 12-transmembrane segment (TMS) family export 
proteins of the major facilitator superfamily (MFS) (Paulsen et al. 1996). Downstream of the 
floR gene are the tetracycline resistance genes tetR and tetA. 
This chromosomal antibiotic resistance gene cluster is a part of SGIl, which is about 43 kb 
(Boyd et al. 2001; Boyd et al. 2000). SGIl is located in the genome between the thdfgene and 
a prophage CP-4-like integrase gene (int2). It is flanked by an imperfect 18-bp direct repeat 
(Boyd et al. 2000). A 1.9 kb retron sequence was located in the downstream of SGIl between 
genes int2 and yidY. This retron sequence may be unique to ST because it has not been 
CHAPTER I 26 
detected in other S. enterica serovars (Boyd et al. 2000). 
Although it is popularly believed that the distribution of ST DTI04 is caused by the use of 
antimicrobial agents in agriculture, some genes in the cluster, such as aadA2, blapSE-l, or sulI, 
are widely distributed among Enterobacteriaceae. The remaining two genes, floR and tetA, 
are most probably not of enterobacterial origin (Cloeckaert and Schwarz 2001). A floR 
homologue was first identified on a plasmid in a fish pathogen, Photobacterium damselae 
(Cloeckaert and Schwarz 2001). The tetG gene has also been detected on plasmids of 
Photobacterium damselae. In addition, the cluster containing tetG gene and the floR gene in 
ST DT104 antibiotic resistance strain was also first identified in a fish pathogen, Vibrio 
anguillarum. They have a similar G+C content (58%) and could be thought to have the same 
origin. Angulo and Griffin concluded that the resistance determinants of MR ST DTI04 
emerged among bacteria in aquaculture and then horizontally transferred to ST DT104 
(Augulo and Griffin 2000)). Fish have also been identified as the main reservoir of SGIl 
(Doublet et al. 2003). The use of antimicrobial agents in animals would then favour the 
dissemination of the MR ST DT1 04. 
However, another hypothesis by Davis et al. states that the cassette's origin is most likely 
from Pseudomonas spp., which occurs in hospitals (Cloeckaert and Schwarz 2001). Thus, the 
dissemination of MR ST DT104 could be associated with nosocomial infection and also 
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associated with usage of antibiotics. The main support for this argument is that tetG occurs in 
bacteria of this genus, and similarly, floR is closely related to the P aeruginosa 
chloramphenicol-resistance gene emlA. Moreover, the blapSE-1 gene is a common feature of 
hospital P aeruginosa isolates (Cloeckaert and Schwarz 2001). 
Nevertheless, identifying the origin of MR ST DTI04 only represents the visible part of an 
iceberg. The fact is that antibiotic resistance genes are chromosomally encoded. The spread of 
MR ST DTI04 might occur even without the selective pressure imposed by the use of 
antibiotics (Cloeckaert and Schwarz 2001). In 1994, Threlfall said, "Since the resistance now 
has been shown to be integrated chromosomally, withdrawal of antibiotics is unlikely to have 
a significant effect" (Threlfall et al. 1994). 
Recently, the mobile ST DTI04-like antibiotic resistance gene cluster has been found in 
Salmonella Agona. It has been shown that the resistance genes of ST DTI 04 can be efficiently 
transduced by P22-like phage ES 18 and by phage PDT 17, which is released by all DT 1 04 
isolates analysed so far (Cloeckaert et al. 2000). 
1.1.9.4 The relevant antimicrobial resistance genes and their mechanisms 
Antibiotic resistance genes can translate functional proteins to reduce the effect of antibiotics 
or destroy antimicrobial agents. Usually, the resistance mechanisms are operated by 1) change 
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in impermeability, 2) enzyme inactivation, 3) enzyme addition, 4) enzyme transfer, 5) active 
efflux pumps, 6) using an alternative way to synthesize necessary enzymes, and 7) use of an 
alternative target to bind. There have been more than 100 resistance genes recognised (Dick, 
2003). In this section, the resistance genes against the antibiotics used in Scottish Salmonella 
Reference Laboratory (SSRL) will be introduced. 
1.1. 9. 4.11mpermeability 
Because the cell wall in Gram-negative bacteria is double-layered, antimicrobial agents are a 
little harder to efflux into Gram-negative bacteria, such as Salmonella; this process is called 
"impermeability" (Gillespie and Bamford 2003). For example, Gram-negative bacteria are 
impermeable to some beta-Iactam antibiotics. Gram-negative bacteria are usually more 
resistant to antimicrobial agents compared with Gram-positive bacteria. 
1.1.9.4.2 Enzyme inactivation -for beta-lactam antibiotics 
This is the most common resistance mechanism, especially for Gram-negative organisms 
(Gillespie and Bamford 2003). It occurs when the bacterium produces beta-Iactamase that can 
break open the beta-lactam ring of penicillins and cephalosporins rendering these agents 
inactive. The gene blapSE-l is the main functional gene in antibiotic resistant ST DTI04 
(Cloeckaert and Schwarz 2001). 
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1.1.9.4.3 Enzyme addition 
Bacteria may express enzymes that add a chemical group to the antibiotic and the antibiotic 
function is then reduced or prevented (Gillespie and Bamford 2003). The process of 
inactivation of aminoglycosides may be via phosphorylation, adenylation or acetylation. The 
resistance genes are carried on plasmids and several are found on transposons. The aadA2 
gene can be found in some strains of MR ST DT104 (Cloeckaert and Schwarz 2001). 
Additionally, aaaC(3)IV gene can be found in some R-plasmids (Davies and O'Connor 1978). 
1.1.9.4.4 Enzyme transfer 
The enzyme acetyltransferase can be produced by gram-positive and gram-negative 
orgamsms and it is plasmid-borne (Sands and Shaw 1973). Acetyl-transferase is very 
important in the inactivation of chloramphenicol. In gram negative bacteria, this enzyme is 
produced constitutively and consequently the level of resistance in gram-negative bacteria is 
fivefold higher than that in gram-positive bacteria, in which the enzyme is inducible (Rang 
and Ritter 1971). The chloramphenicol acetyltransferase (CAT) gene encodes an enzyme 
which catalyses O-acetylation of chloramphenicol by acetyl-coenzyme A (CoA) (Sands and 
Shaw 1973). 
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1.1.9.4.5 Active efflux pumps 
The ability to be resistant against chloramphenicol in the antibiotic chromosomal integrated 
ST DT1 04 strain is operated by the floR gene (Threlfall et al. 1997). Such DT1 04 strains show 
an eight-fold increase in resistance levels to chloramphenicol and florfenicol when compared 
to a quinolone-susceptible DT104 strain (Cloeckaert and Schwarz 2001). Another important 
mechanism is active efflux due to overproduction of the AcrAB efflux pump, which is an 
oxygen response gene (Rychlik and Barrow 2005). It also plays an important role in resistance 
to bile salts and detergents and in intestinal colonization (Lacroix et al. 1996). 
1.1.9.4.6 Using alternative synthesis pathways 
Bacteria can avoid attack by enzyme blocks or competitive antibiotics by developing 
alternative pathways to synthesize necessary enzymes or structural proteins. The merA gene 
has been found in the hybrid virulence resistance plasmid pUO-StVR2 in some Salmonella 
Typhimurium (Herrero et al. 2006). The merA gene confers resistance to methicillin. It codes 
an alternative penicillin-binding protein (PBP2 ') which is not inhibited by methicillin. 
Although the composition of the cell wall is altered, the organism is still able to multiply 
(Rang and Ritter 1971). 
1.1.9.4.7 Alter the target site or reduce the affinity 
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When the target site is altered to decrease the affinity to the antibiotic the effectiveness of the 
antibiotic is reduced. The mechanism of decreased susceptibility to fluoroquinolones in ST 
DT104 isolates involves point mutations in the quinolone resistance determining region of the 
target gene gyrA (Cloeckaert and Schwarz 2001). The point mutations in gyrA genes also 
results in low-level ciprofloxacin resistance. 
1.1.9.4.8 Environment resistance genes 
Many environment resistance genes can cope with environmental challenge and are also 
involved in the expression of virulence. The virulence factors of Salmonella are stress 
resistance and invasive ability. It is believed that the antibiotic resistant chromosomal 
integrated ST DT104 has a better environmental resistance ability (Loewen and 
Hengge-Aronis 1994). The rpoS-encodes the deltas subunit of RNA polymerase and is an 
important regulator of the general stress response. The rpoS gene is also required for virulence 
in S. Typhimurium in orally infected mice (Loewen and Hengge-Aronis 1994). The QacEL11 
gene is located between 28,953 and 29,300 bp in SGIl DNA fragment and can transcribe a 
quaternary ammonium compound and a disinfectant resistant partial protein. The presence of 
this gene could be one reason for improved environmental survival ability over other 
Salmonella Typhimurium. 
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1.1. 9. 4. 9 Change in virulence 
Host adaptation is influenced by the distribution of fimbrial and non-fimbrial adhesins among 
Salmonellae (Baumler et al. 1997). Some scientists believe that ST DT104 is not a 
hyper-virulent strain (Cloeckaert and Schwarz 2001). Some resistant DT104 isolates appear 
less invasive than non-resistant strains and in a mouse model of infection, MR ST DT104 
strains did not reveal evidence of enhanced nor reduced virulence when compared with ATCC 
S. Typhimurium strain 14028s (Cloeckaert and Schwarz 2001). 
Conversely, other case control studies have suggested that MR ST DT104 is possibly a 
hypervirulent strain (Boyd et al. 2001). However, the argument is that the virulence does not 
appear to be related to a hyperinvasive phenotype as shown in tissue culture assays and the 
resistant ST DT104 is no more invasive than susceptible Salmonella Typhimurium strains 
with or without exposure to antibiotics (Boyd et al. 2001). 
There is evidence to show that ST DT104 containing the SGIl gene may be more virulent 
than susceptible strains lacking SGIl gene in an experimental poultry model (Cloeckaert and 
Schwarz 2001). The result suggests a potential role for SGIl in virulence. 
1.2 THE HISTORY OF ANTIBIOTIC AGENTS AND THE MECHANISMS OF ACTION OF ANTIBIOTICS 
The discovery of penicillin initiated the discovery of numerous antibiotics from fungi. 
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Antibiotics either kill bacteria or reduce the growth rate of bacteria by different mechanisms. 
The mechanisms can be classified into twelve groups: 1) beta-Iactam antimicrobial agents 
(penicillins and cephalosporins); 2) amino-glycosides; 3) glycoproteins; 4) quinolones; 5) 
macrolides; 6) streptogramins; 7) oxazoladinones; 8) metronidazole; 9) tetracyclines; 10) 
sulphonamides and 11) trimethoprims; 12) chloramphenicols. There is only scope in this 
thesis to introduce eight categories as discussed below. 
1.2.1 Beta-Iactam antimicrobial agents - ampicillin and cefotaxime 
Ampicillin is the original oral form of penicillins. Cefotaxime is the third generation of 
cephalosporins. The two groups belong to beta-Iactam antimicrobial agents. These agents 
inhibit peptidoglycan linking with cell wall. The resulting dys-functional cell wall is fatal for 
the bacteria (Rossi et al. 1995). Gram-negative bacteria are less likely to be affected by these 
antimicrobials due the differences in structure in the cell wall and hence the target site for the 
antimicrobial is not present. Some bacteria have the ability to protect themselves against these 
agents. blapSE-l gene can encode carpencillinase protein, a beta-Iactamase (Boyd et al. 2001), 
which can denature the beta-Iactame ring. Many Salmonella strains have the gene in 
R-plasmid or in genome (Rossi et al. 1995). 
Cephalosporins are antimicrobials with both gram-positive and gram-negative activity 
(Gillespie and Bamford 2003). Because of safety and broad spectrum of activity, they are 
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frequently chosen for treatment of infection caused by gram-negative bacilli and 
gram-positive cocci. Compared with penicillins, cephalosporins only have an advantage 
against gram-negative bacilli. 
In the development of cephalosporins there have been five generations (Gillespie and 
Bamford 2003). The third-generation cephalosporins have much better activity against 
Enterobacteriaceae compared with the first generation. It is believed that the resistant strain 
of S. Typhimurium for cephalosporins in the UK emerged between 1993 to 1995 (Threlfall et 
al. 1996). 
1.2.2 Chloramphenicol 
Chloramphenicol belongs to the group of miscellaneous antibiotics. It is primarily a 
bacteriostatic. It binds to the 50S sub-unit of the ribosome and inhibits the synthesis of 
bacterial protein. It has a good activity against gram-positive and gram-negative cocci and 
bacilli. Chloramphenicol is selectively used to treat only serious Salmonella infections. 
Chloramphenicol was restricted for use in veterinary practice in Europe from 1994. 
Florfenicol was introduced and has been used for treatment in veterinary practice since 
January 1995. However, the chloramphenicol resistant strains still can be seen almost 
everywhere (Arcangioli et al. 1999). The resistance mechanism can be operated by 
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chloramphenicol acetyl transferases (CAT), or by non-enzyme mechanism like efflux, 
impermeability, and ribosomal modification (Arcangioli et al. 1999). 
FloR gene, which exists in some Salmonella, can transcribe chloramphenicol and florfenicol 
resistance protein (Boyd et al. 2001). It can be located in R-plasmids or in ST DT104 
chromosome (Cloeckaert and Schwarz 2001). From sequence analysis, jloR gene belongs to 
the 12-TMS (trans-membrane segments) multidrug efflux pumps family (Arcangioli et al. 
1999). It is established that resistance to chloramphenicol in S. Typhimurium isolates is a 
highly specific marker for ST DT104 (Anon 1997). 
1.2.3 Aminoglycosides - gentamicin; kanamycin; streptomycin 
The aminoglycosides are bactericidal antibiotics (Gillespie and Bamford 2003). They bind to 
30S ribosome and inhibit bacterial protein synthesis. Its target site is inside the nucleus. 
Aminoglycosides inhibit the function of mRNA restricting the translation of proteins and thus 
causing bacterial death. The group is only used against aerobic gram-negative bacilli and 
staphylococci. The disadvantage of aminoglycosides is the toxic effect on the kidney and the 
eighth cranial nerve. Gentamicin and kanamycin have been widely used in human beings and 
animals. However, kanamycin has a limited usage because it is more toxic than the other 
aminoglycosides. 
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Resistance to gentamicin and kanamycin in S. Typhimurium has primarily been identified in 
phage type 204C (DT204c) (Wray and Davies 1996). Gemtamicin resistance was first 
reported in S. Typhimurium in 1982 (Sojka et al. 1982). The resistance was shown to be 
transferable and the plasmids responsible for this resistance specified the enzyme 
3-N-aminoglycoside acetyl-transferase (AAAC(3)IV) (Davies and O'Connor 1978). The 
enzyme can use antibiotics with 2-deoxystreptamine rings as acceptors for its 
acetyl-transferase activity. Aminoglycoside-resistance plasmids have been identified in E. coli 
and some Salmonella serotypes including Typhimurium (Threlfall et al. 1983; Threlfall et al. 
1985; Wray and Davies 1996; Chaslus-Dancla et al. 1986). The resistance to kanamycin can 
also be operated by aphA gene, which encodes amino glycoside 3' -phosphotranferase. In 
ACSSuT R-type ST DT104, the resistance gene, AadA2, encodes 
aminoglycoside-(3")(9)-adenylyltransferase, which confers resistance to 
streptomycinispectinomycin (Boyd et al. 2001). The gene enhances the activity of the enzyme 
by one or more point mutations in the gene in Integron C (InC) cassette (Nesvera et al. 1998). 
The plasmids containing the resistance gene belong to incompatibility group I (InC I) 
(Threlfall et al. 1985; Threlfall et al. 1986). 
1.2.4 Sulphonamide 
The sulphonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most 
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gram-positive and many gram-negative organisms. Sulphonamides inhibit multiplication of 
bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid 
metabolism cycle. They inhibit bacterial synthesis of tetrahydrofolate. Bacterial sensitivity is 
the same for different sulphonamides, because they have the same structure. 
The first use of a sulphonamide compound was in 1932. After the introduction of 
trimethoprim in 1962 in England, they were usually used as a combination after 1968 
(Huovinen et al. 1995). They were heavily used in 1980s and 1970s. With awareness of drug 
resistance growing, the use of sulphonamides declined (Enne et al. 2001). However, the 
resistance in bacteria remains. The sull gene encodes the enzyme hydopteroate synthase 
(Daly and Fanning 2004), which can process an alternative pathway for folic acid metabolism. 
1.2.5 Tetracyclines 
The tetracyclines interfere with bacterial protein synthesis by locking tRNA to the specific site 
of mRNA. Tetracyclines are active against many gram-positive and some gram-negative 
pathogens and are widely used. Because of this widespread use in human and veterinary 
practice, there are more than 30 different kinds of tetracycline resistance determinants 
(Furushita et al. 2003). Resistance genes are of two different types; one is operated by a 
proton-dependent efflux of tetracycline and the other using cytoplasmic ribosomal protecting 
proteins (Furushita et al. 2003). Class G tetracycline resistance determinant (TetG) has been 
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found in Vibrio spp., Pseudomonas spp., and Salmonella spp. (Furushita et al. 2003). It has 
two open reading frames in SGIl: TetR (210 amino acids) and TetA (393 amino acids) in 
Salmonella. TetA encodes proton-dependent tetracycline efflux proteins (Furushita et al. 2003). 
Based on the analysis of amino acid sequences, the similarity of proteins of tet A(G) and tet 
R(G) is about 60% homology with those ofRPlITn1721 (class A) and pSC101/pBR322 (class 
C), and the homology with Tn10 (class B) is about 50% (Zhao and Aoki 1992). The tetR gene 
can transcribe the tetracycline resistance regulator; a repressor protein (Boyd et al. 2001). 
1.2.6 Quinolones - nalidixic acid; ciprofloxacin 
Quinolones inhibit the function of bacterial DNA gyrase, resulting in DNA synthesis being 
blocked and rendering the bacteria unable to multiply (Gillespie and Bamford 2003). 
Nalidixic acid is the original type of quinolone. The fluoro- group was added in order to 
enhance affinity and efficacy: ciprofloxacin is one of these fluoroquinolones. Quinolones, 
especially fluoroquinolones, are very efficacious against gram-negative bacteria, including 
Pseudomonas and Chlamydia. 
The emergence of fluoroquinolone resistance may be related to agricultural use (Threlfall et al. 
1996;Chiu et al. 2002). Enrofloxacin was licensed for veterinary use in the UK in 1993 and it 
has been widely used in cattle and poultry (Threlfall et al. 2000). There was an observed 
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increased in resistance of human isolates of DT104 to fluoroquinolone following the 
introduction (Threlfall et al. 1996). The percentage of DT1 04 isolates that were additionally 
resistant to quinolones increased from 0.5% in 1994 to 13% in 1997 (Threlfall et al. 1997). 
This trend was also seen in Finland during the same period, especially in patients who 
acquired infection abroad (Hakanen et al. 1999). In contrast, the trend was dissimilar in the 
United States (Herikstad et al. 1997). In the USA in 1998, an outbreak of a fluoroquinolone 
resistant DT104, occurring in a hospital, resulted in the death of two people (Carnevale et al. 
2000). 
The quinolone resistance mechanism is associated with the mutation(s) in gyrA and with the 
mutation in gyrB to get full resistance to fluroquinolone (Aarestrup et al. 2003). The 
resistance also can be acquired from the spontaneous gene mutation in R-plasmids 
(Martinez-Martinez et al. 1998). Travellers provide the perfect vehicle to aid the spread of 
such a clone from one area to another (Hakanen et al. 2001). The first documented outbreak 
of fluoroquinolone-resistant salmonellosis occurred in New York in 2001 (Olsen et al. 2001). 
The index patient is believed to have contracted the disease from the Philippines in 1997 
(Olsen et al. 2001). 
In 1995, the Food and Drug Administration of the USA agreed that the fluoroquinolone, 
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sarafloxacin, could be used in the poultry industry for the treatment of Escherichia coli 
infections (Anon 1997). The resistant ST DT104 strain was detected in the USA in 1997 
(Anon 1997). Recently, the FDA in USA has proposed the withdrawal of enrofloxacin for 
use in poultry, but the FDA still allows fluoroquinilones to be used in cattle (Centre for 
Veterinary Medicine 2003). The development of fluoroquinolone resistance in bacteria may 
have serious public health implications (Centre for Veterinary Medicine 2003) . 
1.2.7 Trimethoprim 
Trimethoprim (Tm) has a dihydrofolate reductase that bacteria need to use for folic acid 
synthesis (Amyes et al. 1989). Tm prevents the reduction of dihydrofolate to tetrahydrofolate 
in the folic acid metabolism cycle. The resistance mechanism arises when bacteria reduce the 
dependence on dihydrofolate reductase. The commercial product, 
trimethoprim-sulfamethoxazole, is a bacteriostat and is a fixed combination of the two 
antimicrobials which is much more active as a combination of the two than either agent is 
alone. In the UK, acquisition of trimethoprim resistance may have resulted from use of this 
agent to treat DT1 04 R-type ACSSuT infections in cattle (Threlfall et al. 1996). 
1.2.8 Nitrofuran - furazolidone 
Furazolidone (N-[ 5-nitro-2-furfurylidene ]-3-amino-2-oxazolidone) IS a synthetic 
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antimicrobial drug, which belongs to the nitrofuran family (De Angelis et al. 1999), has good 
ability against gastrointestinal infections and has been widely used in medical and 
veterinary practice (De Angelis et al. 1999). The antibacterial ability is activated after the 
agent is modified to the metabolic form by nitroreductase (Kumar and Jayaraman 1991). The 
nitrofurans appear to block the initiation of translation and inhibit many microbial enzyme 
systems (Anon 2006). The resistance mechanism against furazolidone still needs to be 
clarified but it would be related to either mutations in genome which result in the loss of 
nitro-reductase activity (Brown et al. 1991; Kumar and Jayaraman 1991) or the development 
of a permeability barrier (van Duijkeren et al. 2003). 
1.3 EPIDEMIOLOGY OF ST DTI04 
Antibiotic-susceptible isolates of ST DT104 have been obtained from cases of human 
infection in England and Wales since the early 1960s (Threlfall 2000). In the early 1980s, MR 
ST DT104 ACSSuT R-type was identified, with the first isolations from cattle and human in 
the UK (Threlfall 2000). In the following years, MR ST DT104 strains have been isolated 
from a wide range of animals, and has become the second most common human salmonellosis 
after S. Enteritidis PT4 in the UK and Germany (Baggesen et al. 2000). Outbreaks of MR ST 
DT104 from origins of poultry, beef, cheese, and swine have also been reported in numerous 
countries (Boyd et al. 2001). Due to many people not presenting with significant symptoms, it 
is believed that only one-third of cases were reported in the UK (Wheeler et al. 1999). 
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The MR ST DT104 strains were initially characterised as having chromosomally located 
genes for five antibiotics, but in recent years strains with additional resistance susceptibility to 
gentamicin, trimethoprim, and fluoroquinolones have been observed in many countries 
(Threlfall et al. 1994; Threlfall et al. 1996; Low et al. 1997). Although some variants have 
been identified, the majority of MR ST DT104 strains have a distinctive XbaI generated 
macro-restriction fingerprint when studied by PFGE. The ST DT104 strain may be a single 
clone spreading worldwide, although it shows five different variants by PFGE (Leegaard et al. 
2000). The same clone has been isolated in many countries, such as Germany (Almuth et al. 
1997), the United States (Besser et al. 1997), Canada (Poppe et al. 1996), Italy (Rubino et al. 
1998), Belgium (Imberechts et al. 1998), Israel (Metzer et al. 1998), Irish Republic (Threlfall 
2000), Austria (Threlfall 2000), France (Threlfall 2000), the Czech Republic (Threlfall 2000), 
and Denmark (Baggesen and Aarestrup 1998). Infections in humans have also been 
recognised in Trinidad, South Africa, The Netherlands, Northern Ireland, the United Arab 
Emirates, the Philippines and in Israel (Threlfall 2000). In 1996 infections with the MR ST 
DT104 strain were recognised in cattle and humans in Canada and the USA (Threlfall 2000). 
In the USA a considerable number of outbreaks have been associated with the consumption of 
cheese made from raw milk (Threlfa1l2000). 
It is believed that the spread of ST DT104 strains worldwide is due to international travellers 
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(Baggesen and Aarestrup 1998; Rodrigue et al. 1990; Rowe et al. 1979; Threlfall et al. 1978). 
People can travel the breadth of the globe within 24 hours. Thus, the index case of an 
infection may occur far from the source of contamination. Free movement of people and 
goods between countries is therefore an effective way of distributing pathogens 
internationally (Kill ale a et al. 1996). The MR ST DTI04 strain could be considered as an 
pandemic pathogen. Due to the threat of the MR ST DTI04, the SENTRY Antimicrobial 
Surveillance Program has been established, monitoring the susceptibilities and resistance 
patterns of key bacterial and fungal pathogens from nosocomial and community-acquired 
infection, through over 85 sentinel hospitals and laboratories around the world (Pfaller et al. 
1998). 
1.3.1 Enter-net and Salm-net in Europe 
The European Enter-net network is an international surveillance system for human 
gastrointestinal infections in Europe (Fisher 1999). The network monitors salmonellosis and 
Verocytotoxin producing Escherichia coli (VTEC) 0157, including their antimicrobial 
resistance patterns (Van Pelt 1999; Fisher 1999). When the network began, it involved all 15 
countries of the European Union, Switzerland and Norway. The network is funded by the 
European Commission (EC) and represents a continuation of the Salm-Net surveillance 
network (1994-97). Salm-Net successfully established a frequently updated international 
Salmonella database and concentrated on harmonisation of Salmonella phage typing. 
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Salm-Net showed, through the recognition of outbreaks and investigation, that the timely 
exchange of information between experts in 17 countries in Europe could lead to effective 
public health action (Fisher 1999; Van Pelt 1999). This network functions to aid experts in 
achieving excellent public health action in Europe. 
1.3.2 United Kingdom 
MR ST DTI04, with the penta-resistant pattern, became a major cause of salmonellosis in 
humans in the UK in the late 1980s, and then appeared in several countries during the 1990s 
(Threlfall et al. 1994). In Scotland, England, Wales, and Northern Ireland, a passive 
surveillance system set up by the Veterinary Laboratories Agency is now part of Enter-net 
(Liebana et al. 2002). With the exception of a small outbreak in Scotland in the mid-1980s, 
there were no isolates of MR ST DT104 from humans until 1989, by which time the strain 
had begun to be isolated from cattle and became epidemic. In a study done in England and 
Wales, the incidence of infection with ST DT104 strains alone rose from 259 cases in 1990 to 
4006 cases in 1996 (Smith et al. 2007). 
In contrast to previous epidemic multiresistant phage types of S. Typhimurium, such as DTs 
29, 204, 193, and 204c, which were mainly restricted to cattle, MR ST DT104 has also 
become a dominant strain in many hosts, such as turkeys, pigs and sheep (Threlfall 2000; 
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Low et al. 1997; Threlfall et al. 1994; Threlfall et al. 1996). In Scotland in 1993 it was the 
major phage type of S. Typhimurium isolated from humans, cattle, pigs, and sheep (Anon 
1994). 
Twenty-five per cents of pigs were infected with Salmonella at slaughter in (Davies, 2000). 
The predominant serotype of Salmonella infecting pigs in the UK was S. Typhimurium, which 
accounted for 68% of those reported (Defra 1999). The Center for Disease Research reported 
that in 1998, 95% of isolates in human cases were ST DT104; in addition, these isolates also 
showed resistance to most of the drugs traditionally used to treat salmonellosis, such as 
aminoglycosides, trimethoprim and nalidixic acid (Smith et al. 2007), 
In England and Wales, the incidence of ciprofloxacin resistance in ST DT104 strains 
increased from 0.6% in 1994 to 13% in 1997 (Threlfall et al. 1999). From 1993 to 1995, 
trimethoprim-resistant ST DT1 04 (R-type ACSSuTTm) increased from 1 % to 27% of isolates, 
and ciprofloxacin-resistant ST DT1 04 (R-type ACSSuTCp) increased from 0 to 6% of isolates 
(Threlfall et al. 1996). It was believed that only one major clone spread within the UK, but 
from 2000 onwards, new PFGE profiles of the ACSSuT and the ACSSuTm R-types were 
identified (Threlfall et al. 2005). 
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1.3.3 Other European countries 
The strains of S. Typhimurium in the UK and France are believed to be the same (Baggesen et 
al. 2000). In France, 69.8% of ST strains of bovine origin have compatible PFGE profiles 
with the multidrug-resistant strains of ST DT1 04 in the UK (Baggesen et al. 2000). 
In Germany, the rate of fully susceptible ST DT104 strains isolated decreased from 73% in 
1987 to 48% in 1996 (Gross et al. 1998). It has been estimated that in Germany 20% of 
human cases of salmonellosis in 1996-1997 were attributed to Salmonella originating in pigs 
(Steinbach and Hartung 1999). In Spain, ampicillin resistance in S. Typhimurium from 
humans rose from 10 to 15% in 1986-8 to above 50% in 1989-91 (Ramos et al. 1996). In Italy, 
a 2002 report mentioned that 52% of S. Typhimurium isolated between 1998 and 2000 and 
37.7% of other strains of Salmonella from animals were multi-resistant (Mammina et al. 
2002). 
Isolates of S. Typhimurium from the Czech Republic have been phage-typed since 1991 
(Karpiskova et al. 1999). The first ST DT104 ACSSuT R-type isolates were identified from 
animals in 1994. The first two human ST DT104 isolates were detected in summer 1996 
(Karpiskova et al. 1999). The first outbreak caused by ST DT104 (ACSSuT R-type) was 
identified in June 1998 (Karpiskova et al. 1999). 
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In 1998 23% of the human isolates domestically acquired were multi-resistant, and a majority 
were S. Typhimurium DTI04. In 2003, S. Typhimurium was the only serovar of Salmonella 
that was endemic in Norway (Alvseike et al. 1997; Leegaard et al. 2000; Lindstedt et al. 2003). 
It is believed the ST DT104 strains have been transmitted within the country, and the trend of 
multi-resistant S. Typhimurium DT1 04 is going up; however, the majority of the resistant and 
multi-resistant isolates are imported (Leegaard et al. 2000). 
MR ST DTI04 might have been present in Denmark for a long time but spread of infection 
appears to be limited (Baggesen et al. 2000). The identification of MR ST DT104 in Danish 
food production animals in 1996 resulted in an agreement that the contamination of foodstuffs 
of Danish origin with MR ST DT104 should be considered unacceptable (Baggesen and 
Aarestrup 1998). The aim of the Danish Salmonella surveillance system is to eradicate MR 
ST DT104 from food production animals (Baggesen et al. 2000). 
1.4 CONCLUSION 
The epidemiology of Salmonella Typhimurium DT104 is complex and that of its many 
resistance manifestations more so. What is clear is that it is a widespread problem that 
changes over time. The implication of animals and veterinary drug usage in human 
salmonellosis remains unproven and it is only by careful examination of the appearance of 
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resistance in space and time that this question will be answered, even in part. 
The aims of this thesis are 1) to describe the trends and current situation of antimicrobial 
resistant Salmonella Typhimurium DTI04 in human and animals in Scotland; and 2) to 
describe and explore relationships in time and space of the different antimicrobial resistant ST 
DTI04 in human and animals in Scotland. 
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CHAPTER II 
MATERIALS AND METHODS 
2.1 INTRODUCTION 
In Chapter 1, the epidemiology of Salmonella and its serotype S. Typhimurium was 
discussed. There are two organisations in Scotland which are responsible for the 
identification and recording of salmonellosis. The Scottish Salmonella Reference 
Laboratory (SSRL), located within Stobhill Hospital, provides information, advice, and a 
full complement of techniques, including serotyping, phage typing and a range of 
biochemical and molecular methods, for identification and typing of Salmonella 
(http://www.show.scot.nhs.uklssrl/index.htm). The records of salmonellosis are stored in 
Health Protection Scotland (HPS; http://www.hps.scot.nhs.ukL). For the purposes of this 
thesis, the complete datasets were kindly provided by the two above organizations. 
A thorough understanding of the biology and epidemiology of S. Typhimurium DTI04 (ST 
DTI04) should enable appropriate control and prevention policies to be established. In 
this chapter, the methods used at SSRL for isolation and identification of ST DTI04, the 
means of information storage at HPS and statistical methods employed in this thesis will 
be discussed. 
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2.2 LABORATORY METHODS USED IN SSRL 
Samples tested in SSRL are from human sources, e.g. faecal samples submitted by general 
practices or hospitals and from veterinary sources, e.g. routine faecal sample collections, 
faecal samples from clinically unwell animals, foodstuffs or environment. Samples are 
tested for the presence of Salmonella using one of a number of different techniques. 
2.2.1 Serotyping method 
In SSRL, Salmonella isolated from humans, animals or feed is biochemically confirmed 
and serotyped by an agglutination test which was mentioned in Chapter 1. Each culture is 
tested for the presence of somatic and flagella antigens by mixing with specific Salmonella 
antiserum. Serovars are derived by reference to the Kauffmann White Scheme (Defra 
2003). 
2.2.2 Phage typing method 
Salmonella Typhimurium, is phage typed according to the Health Protection Agency phage 
typing schemes (Ward et al. 1987). Different necessary phages are seeded onto LB agar 
plates covered by the testing strain. After 24 to 48 hours incubation, the degree and pattern 
of lysis are read and then, according to the Phage Type Scheme for Salmonella, a definite 
type given (Ward et al. 1987). Some phage types are related variants although they are still 
reported as distinct types, e.g. DT104b of S. Typhimurium. Those which cannot be typed 
are recorded as "untyped". 
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2.2.3 Antimicrobial susceptibility testing method 
The antimicrobial susceptibility testing method was introduced in 2005 (Murray et al. 
2005). The most common antimicrobial susceptibility testing method is the Kirby Bauer 
Disk Diffusion and it is used as the standard method in SSRL. It evaluates the Minimum 
Inhibitory Concentration (MIC) in a solid agar plate, which is Mueller-Hinton II agar 
(Becton Dickinson Microbiology Systems) supplemented with 5% bovine blood and 
contains a predetermined concentration of antimicrobial agents as described in Table 2.1. 
Table 2.1 The pre-determined concentration of antibiotics in the MIC test (Murray et al. 
2005;Defra 2003) and the years which were introduced. 
Antibiotic MIC*(llg/ml) Code Date 
............ _ ... _-_ .. _-_ .... 
Ampicillin 10 Ap 1988 
Cefotaxime 30 Cf 1999 
Chloramphenicol 12.5 - 25 CI 1989 
Ciprofloxacin 0.5 Cp 1990 
Furazolidone 15 Fu 1990 
Gentamicin 10 Gm 1988 
Kanamycin 30 Ka 1988 
Nalidixic acid 40 Na 1989 
Netilmicin 12.5 Ne 1989 
Spectinomycin 100 Sp 1989 
Streptomycin 12.5 - 25 St 1988 
Sulphonamide 300 Su 1988 
Tetracycline 10-30 Te 1988 
Trimethoprim 5 Tm 1988 
Low level Ciprofloxacin 0.125 Lc 1999 
Fourteen antimicrobial agents and fifteen treatments were chosen by SSRL to test the 
resistance of Salmonella spp. The test for the resistance to ciprofloxacin is carried out at 
two different concentrations to evaluate the trend of resistance to ciprofloxacin (Murray et 
al. 2005). The low concentration of ciprofloxacin is used to compare the resistance with 
that for nalidixic acid. In practice, the susceptibility of a bacterial strain to an antibiotic is 
determined by observing "resistant" or "sensitive" after 24 hours inoculation in a cutting 
CHAPTER II 53 
zone SIze equal to 13mm. Sometimes, the colony will be categorised "intermediate"; 
however, for the purposes of this thesis, "intermediate" was considered as "sensitive". 
2.2.4 Other methods used in SSRL 
There are many other methods used in SSRL, such as polymerase chain reaction and pulse 
field gel electrophoresis for different purposes. However, the information collected using 
those methods will not be presented in this thesis. 
2.3 COMPILATION OF DATABASES 
2.3.1 Data from human sources 
The database from human sources was derived from routine collection by the Health 
Public Scotland (HPS). It is based on reports of isolates from single patients to HPS from 
the Scottish Salmonella Reference Laboratory (SSRL). The flowchart of the sample 
transferring system is shown in Figure 2.1. When people become unwell, they can choose 
to stay at home, they may go to see a general practitioner (OP) or they may present 
themselves at a hospital. Doctors take a detailed history, examine patients and decide 
whether antibiotics may be prescribed directly or whether a specimen should be collected 
and sent to contract laboratories for testing. If the laboratories conclude that there is a 
Salmonella infection, samples are then sent to SSRL for confirmation. The details of the 
case are recorded at the local hospital and all necessary information is forwarded to SSRL, 
although no personal identification is logged. SSRL identifies the phage type and antibiotic 
resistance pattern. If necessary, molecular biological testing is undertaken. The SSRL then 
forwards a report to HPS. 
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Figure 2.1 Flowchart detailing infonnation transfer among patients, practices and 
laboratories in cases where infection with Salmonella is suspected. 
The information system described is a part of Enter-net, which means that the stored data 
may be shared with other ED countries. The experts in HPS or similar organisations in 
other countries can use the infonnation to set an alarm or develop suitable policies in 
advance. SSRL also reports the result back to clients (laboratories) and shares important 
infonnation with the Health Board where the case occurred. HPS also will send a report to 
Department for Environment, Food and Rural Affairs (Defra). The corresponding Health 
Board may formally visit the patient(s). If a visit has been made responses, a formal 
questionnaire is recorded and all details are be shared among SSRL, HPS and Defra. 
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2.3.2 Collection of data from veterinary sources 
The dataset of samples derived from veterinary sources is maintained by the Veterinary 
Laboratories Agency (VLA). The Zoonoses Order (1989) of the Animal Health Act (1981) 
requires that isolation of organisms of the genus Salmonella in food-producing animals and 
birds be reported to a Veterinary Officer of the Department for Environment, Food and 
Rural Affairs (Defra). Generally, after veterinarians collect samples from owners, or 
business managers send routinely collected samples, the specimen is sent to any veterinary 
laboratory, which may be privately owned or inside a veterinary school. The data are 
recorded on the "Salmonella Supplementary Form - General" or "Salmonella 
Supplementary Form -Avian", depending on the source of the sample. In the form, the 
responsible veterinarian is required to complete Section I with where samples came from 
and who sent them. In Section 2 (risk assessment) symptoms and environment and 
business behaviour of the farm are recorded. In Section 3, the veterinary laboratory is 
required to record what will be done or what situation they have found. For the form 
relating to avian samples, more details about where the animals are kept are required. After 
confirmation of identity by the veterinary laboratory, and when the results are known of 
tests and antibiotic resistance patterns for all Salmonella, the forms are distributed to the 
Scottish Agriculture College (SAC) and SSRL and then to Defra. Defra may arrange a 
formal visit if necessary. 
In contrast to the human data, these statutory animal notifications are based on "incidents"; 
a term is defined by Defra as "An incident comprises the first isolation and all subsequent 
isolations of the same serovar or serovar and phage/definitive type combination of a 
particular Salmonella from an animal, group of animals or their environment on a single 
premises, within a defined time period (usually 30 days)" (Defra 2003). The purpose of 
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using "incident" is to assess more accurately data in the number of live-stock units. Finally, 
Defra arranges a visit in order to progress an order if necessary. 
2.4 THE STRUCTURE OF DATASETS RECEIVED IN THIS STUDY 
The surveillance of Salmonella infection in Scotland is based on cooperation between 
SSRL and HPS. Veterinary laboratories are involved in collecting the data from veterinary 
sources. 
2.4.1 The structure of datasets derived from human sources 
Two datasets were kindly supplied by HPS and SSRL: 1) Weekly recordings of all 
Salmonella cases between 1988 and 2002, 2) A different presentation of the data, recording 
the received dates ofST DT104 only, from 1988 to 2004. 
Cases received from different National Health Service (NHS) boards were coded as "report 
board". In Scotland, there are fifteen Health Boards: Ayrshire & Arran (AA); Argyll & 
Clyde (AC); Borders (BR); Dumfries & Galloway (DG); Fife (FF); Forth Valley (FV); 
Greater Glasgow (GG); Grampian (GR); Highland (HG); Lanarkshire (LN); Lothian (LO); 
Orkney (OR); Shetland (SH); Tayside (TY); and Western Isles (WI) (Figure 1.1). AC has 
recently been integrated into GG. 
The datasets supplied included both Home Cases and Imported Cases, that is, cases in 
which the patient declared that salmonellosis had been contracted overseas. The 
subsequent study deals only with Home Cases. The datasets were supplied in excel 
spreadsheet format, with columns detailing sample identification and further information, 
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such as phage type, gender of patient and other potentially useful epidemiological details 
as outlined in Table 2-2. 
Table 2.2 The description of variables used in the human databases. 
Variables Dataset 1 Dataset2 Description 
Pathogen Yes Yes Serotype of an isolate 
Type Yes Yes Phage type of an isolate 
Year Yes Yes The year of collection 
Gender Yes Yes Gender of a patient 
Age Yes Yes Age of a patient 
Report board Yes Yes Where the cases are from 
Imported Yes Yes Developed originally in the UK or 
not 
Isolated site Yes Yes Sampling sites of an isolate 
Resistance Yes Yes 15 different antibiotic resistances 
Received date No Yes The date the case was received 
Month Yes No The month the case was received 
Week Yes No The week the case was received 
'Yes' means the dataset has the variable and 'No' means that the dataset does not have the variable. 
2.4.2 The structure of dataset derived from veterinary sources 
In the veterinary dataset, samples originated from a wide variety sources - including from 
animals, foodstuffs and environment. According to the description from a DEFRA 
publication, since 1993, Salmonella reports from livestock have been separated into 
"isolations" and "incidents" (Defra 2003). By definition, "Isolations comprise individual 
reports of Salmonella made from samples and reported to Officers of the Minister" (Defra 
2003). Repeat and duplicate samples were removed (Browning et al. 2001a; Defra 2003) 
Then, incidents and isolations from veterinary sources between July 1990 and December 
2004 were added to the national dataset in BPS. 
Poultry samples offer a further source of veterinary samples. A poultry monitoring system 
is operated in the poultry industry and therefore samples from poultry may contain many 
non-clinical diagnostic samples. 
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All records were kindly provided by HPS. The datasets were supplied in excel spreadsheet 
format, with column headings detailed in Table 2.3. 
Table 2.3 Details of case information contained within the datasets provided by veterinary 
laboratories where Salmonella infection had been determined. 
Variables 
Pathogen 
Type 
Year 
NO 
Source 
True source 
Lab source 
Resistance pattern 
Week 
Pathogen2 
Description 
Serotype of Salmonella 
Phage types of Salmonella Enteriditis and 
Typhimurium 
The year of collection 
The collection number - contains the reported week 
Which animal the case is from 
The categories of animal 
The veterinary laboratory of isolation 
The 15 antibiotic resistance patterns 
The week the case was reported to laboratory 
S. Typhimurium, S. Enteritidis, and Others 
2.5 CLEANING THE DATASETS 
All data were checked by EXCEL 2000. The two datasets were compared and then the 
errors were corrected. A unique number was given to each record to trace the original data 
when necessary. In the human database, the postal district for each record was added using 
the electronic map enquiry system on the website: http://streetmap.co.uk. The records, 
which did not have address information, were marked as 'missing'. 
In the animal database, the original dataset did not contain the date received. Instead of that, 
a reference number including the information on the year and week was used. A new 
variable, week, was generated from the reference numbers. The week ranged from 1 to 53 
and the week number was used as the minimum time interval. Thus, a year was divided 
into 13 four-weekly months. The 53rd week was assigned to the 13th four-weekly month. 
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Text categories were encoded as nominal variables and "Yes" or "No" answers were 
changed to binary format. Similarly, antibiotic resistant patterns were re-coded to binary 
format - 1 referred to resistant and 0 referred to sensitive. "Intermediate" was recoded as 
"0" - only three cases had intermediate resistance to tetracycline, trimethoprim, kanamycin, 
respectively. Cases for which there was missing information were considered individually, 
depending on the analysis being undertaken. Missing data were usually coded as '9'. No 
information in a variable was coded as '99'. Date format, such as 0110112005, was 
reclassified into two separate fields - "month" and "year". 
2.6 EPIDEMIOLOGICAL ANALYSIS METHODS 
Descriptive, cluster, spatial and time series modelling were used to conduct different 
analysis, some details of which will be presented in later chapters. Where appropriate, 
statistical significance was set at a p-value <0.05; all tests were two-tailed. 
2.6.1 Descriptive statistics 
Descriptive statistics help to summarise data and identify trends or patterns which can then 
be further explored using more sophisticated statistical techniques. Functions within the 
Microsoft Office software package, Excel version 2000, namely pivot table and pivot chart, 
were used to generate summary tables and charts. To further enhance the readability of 
figures, PowerPoint version 2000 was employed. The population statistics in the 2001 
Census were used to calculate the cumulative incidence in an area or used as the base for 
other statistical analysis (General Register Office for Scotland 2002) (Table 2.4). 
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2.6.2 Cluster analysis 
The purpose of cluster analysis is to understand the relationships amongst cases and 
variables, in this situation, the relationship between Salmonellae and antibiotics 
(SPSS Inc 2006). The clustered groups can be further assessed using more advanced 
statistical methods, such as temporal, spatial or spatio-temporal analyses. There are 
now a large number of database, spreadsheet and statistical analysis software 
packages available, and in this study, SPSS, Excel 2000, SatScan and MapInfo 5.5 
were used where appropriate for analysis and presentation purposes. Excel 2000 
spreadsheets were used for cleaning the datasets and to generate SPSS compatible 
files. In SPSS, hierarchical cluster analyses, K-means cluster analyses, McNemar and 
chi-square tests were undertaken. The results were exported to Excel 2000 and 
modified to fit the Mapinfo 5.5 format to present clusters or other information in the 
electronic map files, which were all kindly supplied by Dr. Dominic Mellor. 
2.6.2.1 The test of independence 
The McNemar sign test was used to determine the independence of antibiotic 
resistances. It is usually used for testing prior and post dichotomous results in the 
same sample. However, it can be used to test the response for a related pair of 
variables, e.g. antibiotic resistance patterns. If the null hypothesis is true, it is 
expected that the frequency table for 'yes, no' and 'no, yes' will be equal. If the p-
value is less than 0.05, it means the pair show significantly different responses (SPSS 
Inc. 2006; Dohoo et al. 2003). 
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2.6.2.2 Hierarchical cluster analysis 
In hierarchical cluster analysis, clusters are not formed in one simple step. It is a long 
procedure involving many calculations. The results are derived and presented 
according to the linkage and measure methods chosen by the researcher. Square 
Euclidean Distance (SED) is the most common means of measuring the distance 
between a pair of observations. Euclidean distance (ED) and simple matching are both 
used for calculating the distance between data in binary format (SPSS Inc. 2006). The 
difference among the measure methods lies in the description of the positions of 
outliers. Outliers are those results very dissimilar to the major patterns. In the 
clustering study, SED was chosen as the standard measure method. Simple matching 
and ED were also used in order to check the positions of outliers. 
There are 7 different linkage methods supported by SPSS (SPSS Inc. 2006). However, 
for binary data, e.g., antibiotic resistant patterns, "between-group-linkage" is a more 
suitable method. The methods differ in the selection of the first observation (target) in 
the algorithm. Normally, if the dataset is big enough, different distance measurement 
or linkage methods will usually generate the same or very similar results. The 
"between-group-linkage" calculates the distance according to the average of distances 
between all pairs of objects (isolates). In the "between-group-linkage", D(r,s) is 
computed as 
D(r,s) = Trs / ( Nr * Ns) 
Where Trs is the sum of all pairwise distances between cluster r and cluster s. Nr and 
Ns are the sizes of the clusters rand s respectively 
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At each stage of hierarchical clustering, the clusters rand s, for which D(r,s) is the 
minimum, are merged. 
The first step in the algorithm is to separate all cases into different clusters containing 
one case only. Then, the two closest observations are joined. In the next step, a third 
observation can either join the cluster to form one group or joins another observation 
to create two different clusters. Each step results in one less cluster than in the 
previous step. This calculation continues until all cases are combined in one cluster. In 
this algorithm, missing values are not allowed, and so missing data were removed for 
the purposes of this particular analysis. 
The final results of clustering are usually shown as a dendrogram. The decision maker 
needs to determine what degree (level) can be thought of as a group. This is known as 
'cutting the dendrogram'. This answer can be got from checking the dendrogram or 
the score in the calculation. The pattern of how these scores change with the 
clustering steps can help the user to find the final grouping. 
The main disadvantage of this type of analysis is that there are no exact rules about 
which distance measures and linkage methods to use. A sensible approach is to try 
different linkage methods and use different distance measures to assess the robustness 
of output; "K-means" analysis can be undertaken to validate conclusions. 
2.6.2.3 K-means cluster analysis 
Data can be classified by a method with no pre-assumptions, such as hierarchical 
clustering analysis, or classified by a pre-determined clustering method, such as K-
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means clustering. K-means clustering analysis is another classifying package 
available in SPSS (SPSS Inc. 2006). This method can assist decision-makers III 
choosing the most appropriate cutting line in hierarchical clustering analysis. 
In simple terms, K-means clustering analysis is an algorithm which may be used to 
classify or to group observations based on a given K number of groups, where K is a 
positive integer number. The result is given by minimizing the sum of squares of 
distances between data and the corresponding cluster centroid. The advantages of this 
method are that it helps users identify homogeneous groups of cases; it can handle 
large numbers of cases; the centres can be assigned a priori, if they are known; and 
users can select a method for classifying cases. In this method, analysis of variance F 
statistics will be generated. The weakness of this method is it is not robust with 
respect to outliers. The centroid may be influenced away from the true centre when 
some cases are very far from the centroid. 
2.6.3 Spatial analysis methods 
Spatial analysis is a method used for understanding relationships in a certain time 
and/or certain zone. It is a powerful, meaningful and useful tool in understanding and 
predicting the relationships between cases and space. There are many software 
packages with capabilities in this field, such as MapInfo and SaTScan. In this thesis, 
MapInfo was used for presenting the clusters on the electronic map. In the thesis, the 
cumulative incidence in NBS board level and post district level were shown in the 
thematic map format. 
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The main analyses were implemented in SaTScan. SaTScan was developed by 
Kulldorff and colleagues (Kulldorff, 1997). It is able to detect clusters of cases in time, 
space, and time-space using a random circling scanning method. In the Poisson-based 
model, the criterion is that the data must follow a Poisson distribution. The model can 
help users to detect clusters of any size anywhere in the study region. SaTScan uses 
the random circling method to identify the highest possible cluster(s) in time, space or 
time-space. The alternative hypothesis is that there is an increased risk of disease in 
the focused area; the null hypothesis is that the risk is not increased. For each random 
circle, a likelihood ratio is calculated until the system finds the most likely cluster, 
which has the largest likelihood ratio. The other possible clusters are listed and the p-
value shown under each possible cluster. All random circle finding is obtained by 
Monte Carlo simulation. 
In the Poisson model, census population data over time are necessary. In the thesis, 
the 2001 Scottish census population data were used. The census data in 1981, 1991, 
and 2001, did not show a dramatic changes and it was assumed that the population did 
not change dramatically over the study years. In the animal dataset, this underlying 
assumption could not be upheld and so the Poisson model was not used. 
The second model used in the thesis was a Bernoulli model. It is suitable for binary 
data and is used as a case-control study model. The null hypothesis is the risk in the 
case group is the same as that in the control group. This model was more suitable for 
the animal data. The positions of laboratories were used as specific coordinative 
position and the assumption was that the proportion of cases at each laboratory was 
the same under a Poisson distribution. 
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SaTScan also supports three additional models but they were not used: 1) a space-time 
permutation model; 2) an ordinal model; or 3) an exponential model. 
2.6.4 Time series method 
Time series study is a technique used to identify the nature of the phenomenon in a 
series of observations in a fixed time interval. It was first developed by Yule and 
Slutsky in the 1920s and used to develop a comprehensive model called 
autoregressive integrated moving average model (ARIMA) by Box and Jenkins in the 
1970s (Box and Jenkins 1976). It has four main purposes: modelling, forecasting, 
characterisation and classification (Borovkova 1998). The aim of modelling is to build 
a model which can describe historic data. Then, the generated model can be used for 
forecasting, providing basic estimates about the future. The fundamental characters of 
a model can be identified and models can be classified into groups according to the 
level of similarities (Borovkova 1998). It can focus on the series itself as a uni-variate 
time series study or take into account other factors as a multivariate study. There are 
linear and non-linear time series approaches. For example, the ARIMA model is a 
linear model and the self-threshold auto-regressive model is a nonlinear model 
(Watier 1995). 
The most basic time series model is the simple additive regression form: 
Zt= b + St + Tt+ Et 
Where b is the constant. Et is the white noise, which explains the background 
information, St is the seasonal component and Tt is the trend (level) component. 
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There is another multiplicative form (Zt=b+Et*St*Tt} which, for disease researchers, 
is attractive given epidemic increases from one time point to the next. The trend 
package in SPSS 14 supports two models: the exponential smoothing model and the 
ARIMA model. The ARIMA model is a group of different forms. It contains: auto-
regressive (AR), moving average (MA), auto-regressive and moving average (ARMA) 
and auto-regressive integrated moving average (ARIMA) models. 
The AR model needs a time series in stationary form. In contrast, the MA model can 
deal with infinite time series. The ARIMA model combines the advantages of both 
processes and minimises the disadvantages. The general programmatic form is 
ARIMA(p,d,q), where p is the AR parameters, d is the differencing passes and q is the 
MA parameters. This thesis focuses on the ARIMA model because it also addresses 
some of the issues of exponential smoothing models. The ARIMA model is also 
advantageous because it has a low cost of development and maintenance and finally, 
it can generate lower root-mean-square-error (RMSE) compared with other models. 
This means that it has a better descriptive ability and in turn provides a good 
predictive ability (Abeku et al. 2002; Smelser and Baltes 2001). These issues are 
discussed further in later chapters. 
I 
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2.3.2 Collection of data from veterinary sources 
The dataset of samples derived from veterinary sources is maintained by the Veterinary 
Laboratories Agency (VLA). The Zoonoses Order (1989) ofthe Animal Health Act (1981) 
requires that isolation of organisms of the genus Salmonella in food-producing animals and 
birds be reported to a Veterinary Officer of the Department for Environment, Food and 
Rural Affairs (Defra). Generally, after veterinarians collect samples from owners, or 
business managers send routinely collected samples, the specimen is sent to any veterinary 
laboratory, which may be privately owned or inside a veterinary school. The data are 
recorded on the "Salmonella Supplementary Form - General" or "Salmonella 
Supplementary Form -Avian", depending on the source of the sample. In the form, the 
responsible veterinarian is required to complete Section I with where samples came from 
and who sent them. In Section 2 (risk assessment) symptoms and environment and 
business behaviour of the farm are recorded. In Section 3, the veterinary laboratory is 
required to record what will be done or what situation they have found. For the form 
relating to avian samples, more details about where the animals are kept are required. After 
confirmation of identity by the veterinary laboratory, and when the results are known of 
tests and antibiotic resistance patterns for all Salmonella, the forms are distributed to the 
Scottish Agriculture College (SAC) and SSRL and then to Defra. Defra may arrange a 
formal visit if necessary. 
In contrast to the human data, these statutory animal notifications are based on "incidents"; 
a term is defined by Defra as "An incident comprises the first isolation and all subsequent 
isolations of the same serovar or serovar and phage/definitive type combination of a 
particular Salmonella from an animal, group of animals or their environment on a single 
premises, within a defined time period (usually 30 days)" (Defra 2003). The purpose of 
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using "incident" is to assess more accurately data in the number of live-stock units. Finally, 
Defra arranges a visit in order to progress an order if necessary. 
2.4 THE STRUCTURE OF DATASETS RECEIVED IN THIS STUDY 
The surveillance of Salmonella infection in Scotland is based on cooperation between 
SSRL and HPS. Veterinary laboratories are involved in collecting the data from veterinary 
sources. 
2.4.1 The structure of datasets derived from human sources 
Two datasets were kindly supplied by HPS and SSRL: 1) Weekly recordings of all 
Salmonella cases between 1988 and 2002, 2) A different presentation of the data, recording 
the received dates of ST DT1 04 only, from 1988 to 2004. 
Cases received from different National Health Service (NHS) boards were coded as "report 
board". In Scotland, there are fifteen Health Boards: Ayrshire & Arran (AA); Argyll & 
Clyde (AC); Borders (BR); Dumfries & Galloway (DG); Fife (FF); Forth Valley (FV); 
Greater Glasgow (GG); Grampian (GR); Highland (HG); Lanarkshire (LN); Lothian (LO); 
Orkney (OR); Shetland (SH); Tayside (TY); and Western Isles (WI) (Figure 1.1). AC has 
recently been integrated into GG. 
The datasets supplied included both Home Cases and Imported Cases, that is, cases in 
which the patient declared that salmonellosis had been contracted overseas. The 
subsequent study deals only with Home Cases. The datasets were supplied in excel 
spreadsheet format, with columns detailing sample identification and further information, 
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such as phage type, gender of patient and other potentially useful epidemiological details 
as outlined in Table 2-2. 
Table 2.2 The description of variables used in the human databases. 
Variables Dataset 1 Dataset2 Description 
Pathogen Yes Yes Serotype of an isolate 
Type Yes Yes Phage type of an isolate 
Year Yes Yes The year of collection 
Gender Yes Yes Gender of a patient 
Age Yes Yes Age of a patient 
Report board Yes Yes Where the cases are from 
Imported Yes Yes Developed originally in the UK or 
not 
Isolated site Yes Yes Sampling sites of an isolate 
Resistance Yes Yes 15 different antibiotic resistances 
Received date No Yes The date the case was received 
Month Yes No The month the case was received 
Week Yes No The week the case was received 
'Yes' means the dataset has the variable and 'No' means that the dataset does not have the variable. 
2.4.2 The structure of dataset derived from veterinary sources 
In the veterinary dataset, samples originated from a wide variety sources - including from 
animals, foodstuffs and environment. According to the description from a DEFRA 
publication, since 1993, Salmonella reports from livestock have been separated into 
"isolations" and "incidents" (Defra 2003). By definition, "Isolations comprise individual 
reports of Salmonella made from samples and reported to Officers of the Minister" (Defra 
2003). Repeat and duplicate samples were removed (Browning et al. 2001a; Defra 2003) 
Then, incidents and isolations from veterinary sources between July 1990 and December 
2004 were added to the national dataset in HPS. 
Poultry samples offer a further source of veterinary samples. A poultry monitoring system 
is operated in the poultry industry and therefore samples from poultry may contain many 
non-clinical diagnostic samples. 
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All records were kindly provided by HPS. The datasets were supplied in excel spreadsheet 
format, with column headings detailed in Table 2.3. 
Table 2.3 Details of case information contained within the datasets provided by veterinary 
laboratories where Salmonella infection had been determined. 
Variables 
Pathogen 
Type 
Year 
NO 
Source 
True source 
Lab source 
Resistance pattern 
Week 
Pathogen2 
Description 
Serotype of Salmonella 
Phage types of Salmonella Enteriditis and 
Typhimurium 
The year of collection 
The collection number - contains the reported week 
Which animal the case is from 
The categories of animal 
The veterinary laboratory of isolation 
The 15 antibiotic resistance patterns 
The week the case was reported to laboratory 
S. Typhimurium, S. Enteritidis, and Others 
2.5 CLEANING THE DATA SETS 
All data were checked by EXCEL 2000. The two datasets were compared and then the 
errors were corrected. A unique number was given to each record to trace the original data 
when necessary. In the human database, the postal district for each record was added using 
the electronic map enquiry system on the website: http://streetmap.co.uk. The records, 
which did not have address information, were marked as 'missing'. 
In the animal database, the original dataset did not contain the date received. Instead of that, 
a reference number including the information on the year and week was used. A new 
variable, week, was generated from the reference numbers. The week ranged from 1 to 53 
and the week number was used as the minimum time interval. Thus, a year was divided 
into 13 four-weekly months. The 53rd week was assigned to the 13th four-weekly month. 
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Text categories were encoded as nominal variables and "Yes" or "No" answers were 
changed to binary format. Similarly, antibiotic resistant patterns were re-coded to binary 
format - 1 referred to resistant and 0 referred to sensitive. "Intermediate" was recoded as 
"0" - only three cases had intermediate resistance to tetracycline, trimethoprim, kanamycin, 
respectively. Cases for which there was missing information were considered individually, 
depending on the analysis being undertaken. Missing data were usually coded as '9'. No 
information in a variable was coded as '99'. Date format, such as 01101/2005, was 
reclassified into two separate fields - "month" and "year". 
2.6 EPIDEMIOLOGICAL ANALYSIS METHODS 
Descriptive, cluster, spatial and time series modelling were used to conduct different 
analysis, some details of which will be presented in later chapters. Where appropriate, 
statistical significance was set at a p-value <0.05; all tests were two-tailed. 
2.6.1 Descriptive statistics 
Descriptive statistics help to summarise data and identify trends or patterns which can then 
be further explored using more sophisticated statistical techniques. Functions within the 
Microsoft Office software package, Excel version 2000, namely pivot table and pivot chart, 
were used to generate summary tables and charts. To further enhance the readability of 
figures, PowerPoint version 2000 was employed. The population statistics in the 2001 
Census were used to calculate the cumulative incidence in an area or used as the base for 
other statistical analysis (General Register Office for Scotland 2002) (Table 2.4). 
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2.6.2 Cluster analysis 
The purpose of cluster analysis is to understand the relationships amongst cases and 
variables, in this situation, the relationship between Salmonellae and antibiotics 
(SPSS Inc 2006). The clustered groups can be further assessed using more advanced 
statistical methods, such as temporal, spatial or spatio-temporal analyses. There are 
now a large number of database, spreadsheet and statistical analysis software 
packages available, and in this study, SPSS, Excel 2000, SatScan and MapInfo 5.5 
were used where appropriate for analysis and presentation purposes. Excel 2000 
spreadsheets were used for cleaning the datasets and to generate SPSS compatible 
files. In SPSS, hierarchical cluster analyses, K-means cluster analyses, McNemar and 
chi-square tests were undertaken. The results were exported to Excel 2000 and 
modified to fit the Mapinfo 5.5 format to present clusters or other information in the 
electronic map files, which were all kindly supplied by Dr. Dominic Mellor. 
2.6.2.1 The test of independence 
The McNemar sign test was used to determine the independence of antibiotic 
resistances. It is usually used for testing prior and post dichotomous results in the 
same sample. However, it can be used to test the response for a related pair of 
variables, e.g. antibiotic resistance patterns. If the null hypothesis is true, it is 
expected that the frequency table for 'yes, no' and 'no, yes' will be equal. If the p-
value is less than 0.05, it means the pair show significantly different responses (SPSS 
Inc. 2006; Dohoo et al. 2003). 
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2.6.2.2 Hierarchical cluster analysis 
In hierarchical cluster analysis, clusters are not formed in one simple step. It is a long 
procedure involving many calculations. The results are derived and presented 
according to the linkage and measure methods chosen by the researcher. Square 
Euclidean Distance (SED) is the most common means of measuring the distance 
between a pair of observations. Euclidean distance (ED) and simple matching are both 
used for calculating the distance between data in binary format (SPSS Inc. 2006). The 
difference among the measure methods lies in the description of the positions of 
outliers. Outliers are those results very dissimilar to the major patterns. In the 
clustering study, SED was chosen as the standard measure method. Simple matching 
and ED were also used in order to check the positions of outliers. 
There are 7 different linkage methods supported by SPSS (SPSS Inc. 2006). However, 
for binary data, e.g., antibiotic resistant patterns, "between-group-linkage" is a more 
suitable method. The methods differ in the selection of the first observation (target) in 
the algorithm. Normally, if the dataset is big enough, different distance measurement 
or linkage methods will usually generate the same or very similar results. The 
"between-group-linkage" calculates the distance according to the average of distances 
between all pairs of objects (isolates). In the "between-group-linkage", D(r,s) is 
computed as 
D(r,s) = Trsl (NI' * Ns) 
Where Trs is the sum of all pairwise distances between cluster r and cluster s. Nr and 
Ns are the sizes of the clusters rand s respectively 
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At each stage of hierarchical clustering, the clusters rand s, for which D(r,s) is the 
minimum, are merged. 
The first step in the algorithm is to separate all cases into different clusters containing 
one case only. Then, the two closest observations are joined. In the next step, a third 
observation can either join the cluster to form one group or joins another observation 
to create two different clusters. Each step results in one less cluster than in the 
previous step. This calculation continues until all cases are combined in one cluster. In 
this algorithm, missing values are not allowed, and so missing data were removed for 
the purposes of this particular analysis. 
The final results of clustering are usually shown as a dendrogram. The decision maker 
needs to determine what degree (level) can be thought of as a group. This is known as 
'cutting the dendrogram'. This answer can be got from checking the dendrogram or 
the score in the calculation. The pattern of how these scores change with the 
clustering steps can help the user to find the final grouping. 
The main disadvantage of this type of analysis is that there are no exact rules about 
which distance measures and linkage methods to use. A sensible approach is to try 
different linkage methods and use different distance measures to assess the robustness 
of output; "K-means" analysis can be undertaken to validate conclusions. 
2.6.2.3 K-meal1s cluster analysis 
Data can be classified by a method with no pre-assumptions, such as hierarchical 
clustering analysis, or classified by a pre-determined clustering method, such as K-
CHAPTER II 65 
means clustering. K-means clustering analysis is another classifying package 
available in SPSS (SPSS Inc. 2006). This method can assist decision-makers III 
choosing the most appropriate cutting line in hierarchical clustering analysis. 
In simple terms, K-means clustering analysis is an algorithm which may be used to 
classify or to group observations based on a given K number of groups, where K is a 
positive integer number. The result is given by minimizing the sum of squares of 
distances between data and the corresponding cluster centroid. The advantages of this 
method are that it helps users identify homogeneous groups of cases; it can handle 
large numbers of cases; the centres can be assigned a priori, if they are known; and 
users can select a method for classifying cases. In this method, analysis of variance F 
statistics will be generated. The weakness of this method is it is not robust with 
respect to outliers. The centroid may be influenced away from the true centre when 
some cases are very far from the centroid. 
2.6.3 Spatial analysis methods 
Spatial analysis is a method used for understanding relationships in a certain time 
and/or certain zone. It is a powerful, meaningful and useful tool in understanding and 
predicting the relationships between cases and space. There are many software 
packages with capabilities in this field, such as MapInfo and SaTScan. In this thesis, 
MapInfo was used for presenting the clusters on the electronic map. In the thesis, the 
cumulative incidence in NHS board level and post district level were shown in the 
thematic map format. 
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The main analyses were implemented in SaTScan. SaTScan was developed by 
Kulldorff and colleagues (Kulldorff, 1997). It is able to detect clusters of cases in time, 
space, and time-space using a random circling scanning method. In the Poisson-based 
model, the criterion is that the data must follow a Poisson distribution. The model can 
help users to detect clusters of any size anywhere in the study region. SaTScan uses 
the random circling method to identify the highest possible cluster(s) in time, space or 
time-space. The alternative hypothesis is that there is an increased risk of disease in 
the focused area; the null hypothesis is that the risk is not increased. For each random 
circle, a likelihood ratio is calculated until the system finds the most likely cluster, 
which has the largest likelihood ratio. The other possible clusters are listed and the p-
value shown under each possible cluster. All random circle finding is obtained by 
Monte Carlo simulation. 
In the Poisson model, census population data over time are necessary. In the thesis, 
the 200 1 Scottish census population data were used. The census data in 1981, 1991, 
and 200 1, did not show a dramatic changes and it was assumed that the population did 
not change dramatically over the study years. In the animal dataset, this underlying 
assumption could not be upheld and so the Poisson model was not used. 
The second model used in the thesis was a Bernoulli model. It is suitable for binary 
data and is used as a case-control study model. The null hypothesis is the risk in the 
case group is the same as that in the control group. This model was more suitable for 
the animal data. The positions of laboratories were used as specific coordinative 
position and the assumption was that the proportion of cases at each laboratory was 
the same under a Poisson distribution. 
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SaTScan also supports three additional models but they were not used: 1) a space-time 
permutation model; 2) an ordinal model; or 3) an exponential model. 
2.6.4 Time series method 
Time series study is a technique used to identify the nature of the phenomenon in a 
series of observations in a fixed time interval. It was first developed by Yule and 
Slutsky in the 1920s and used to develop a comprehensive model called 
autoregressive integrated moving average model (ARIMA) by Box and Jenkins in the 
1970s (Box and Jenkins 1976). It has four main purposes: modelling, forecasting, 
characterisation and classification (Borovkova 1998). The aim of modelling is to build 
a model which can describe historic data. Then, the generated model can be used for 
forecasting, providing basic estimates about the future. The fundamental characters of 
a model can be identified and models can be classified into groups according to the 
level of similarities (Borovkova 1998). It can focus on the series itself as a uni-variate 
time series study or take into account other factors as a multivariate study. There are 
linear and non-linear time series approaches. For example, the ARIMA model is a 
linear model and the self-threshold auto-regressive model is a nonlinear model 
(Watier 1995). 
The most basic time series model is the simple additive regression form: 
Zt= b + St + Tt + Et 
Where b is the constant. Et is the white noise, which explains the background 
information, St is the seasonal component and Tt is the trend (level) component. 
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There is another multiplicative form (Zt=b+Et*St*Tt) which, for disease researchers, 
is attractive given epidemic increases from one time point to the next. The trend 
package in SPSS 14 supports two models: the exponential smoothing model and the 
ARIMA model. The ARIMA model is a group of different forms. It contains: auto-
regressive (AR), moving average (MA), auto-regressive and moving average (ARMA) 
and auto-regressive integrated moving average (ARIMA) models. 
The AR model needs a time series in stationary form. In contrast, the MA model can 
deal with infinite time series. The ARIMA model combines the advantages of both 
processes and minimises the disadvantages. The general programmatic form is 
ARIMA(p,d,q), where p is the AR parameters, d is the differencing passes and q is the 
MA parameters. This thesis focuses on the ARIMA model because it also addresses 
some of the issues of exponential smoothing models. The ARIMA model is also 
advantageous because it has a low cost of development and maintenance and finally, 
it can generate lower root-mean-square-error (RMSE) compared with other models. 
This means that it has a better descriptive ability and in turn provides a good 
predictive ability (Abeku et al. 2002; Smelser and Baltes 2001). These issues are 
discussed further in later chapters. 
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3.1. INTRODUCTION 
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As outlined in the opening review, salmonellosis is well recognised as a zoonosis associated 
with symptoms such as diarrhoea and fever in infected animals and humans. Usually, the 
pathogen spreads by the faecal-oral route via contaminated water, food or direct contact with 
infected animals. Each year in the USA, 400 to 600 people die as a result of infection and 
between one and three million people are infected by one of the Salmonella spp. (Humphreyet 
al. 2000). In Scotland, most Salmonella cases are associated with two main serotypes: 
Salmonella Enteritidis is responsible for about 70% of reported cases and Salmonella 
Typhimurium (ST) is responsible for about 30% of cases (Browning et al. 2003; Browning et al. 
1999; Browning et al. 2001a; Browning et al. 2001b). S. Typhimurium definitive type 104 (ST 
DT104) was first isolated in the 1960s. It was not a major concern at that time due to the small 
number of isolates but concerns grew in 1988 after a cassette of resistant genes was found in its 
genome. The aims of this study outlined in this chapter were to describe the trends of 
Salmonella, ST and ST DT1 04 infections in Scotland, based on human isolates between 1988 
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and 2004. 
3.2 MATERIAL AND METHODS 
The surveillance of Salmonella infections in Scotland is based on cooperation between SSRL 
and HPS as outlined in Chapter 2. Based on these data and using the Scottish 2001 Census data, 
proportions, period prevalences and cumulative incidences were calculated for each of the 
categories described, stratifying by year, location and age of patient. 
3.3 RESULTS 
3.3.1. The trends of Salmonella spp., S. Typhimurium, and S. Typhimurium DTI04 
Figure 3.1 shows the numbers of total Salmonella, S. Enteritidis, S. Typhimurium, ST DTI04 
isolates including Home Cases and Imported Cases. Figure 3.2 shows the proportion in each 
year. A total of 32,582 isolates were collected from humans between 1988 and 2004. The 
majority of isolates were S. Enteritidis, with the next most common serotype being S. 
Typhimurium. Third position was occupied by four different serotypes over the sixteen years of 
the study, or five if imported cases are excluded: S. Virchow (1988-1996, 2000-2002); S. Hadar 
(1997-1999); S. Bareilly (2003 - following a major outbreak); and S. Newport (2004). When 
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Figure 3.1 The numbers of the Salmonella Enteritidis and Typhimurium and its phage type 
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ST DT104 from the Scottish human isolates, 1988-2004. Y: Home Cases; N: Imported Cases. 
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Figure 3.2 The proportion of different Salmonella serotypes from Scottish human isolates, 
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CHAPTER III 73 
imported cases are excluded, S. Wangata took third place in 1992. Based on these data the 
salmonellosis figures could be roughly divided into three periods: 1988-91, 1992-97, and 
1998-2004. Case numbers increased gradually to 3,349 by 1997, and then dropped quickly to 
1,143 by 2004. 
S. Typhimurium isolates totalled 8,067 over the whole period ofthe study - 3,941 classified as 
female, 4,175 as male, and the remainder unclassified by gender. Home Cases made up 7,212 of 
the total (3,414 female, 3,751 male), with some imported cases being recorded every year. The 
S. Typhimurium trend line rose gradually from about 500 isolates to. a peak of 744 in 1996. 
Recorded isolations then fell steeply, almost mirroring the trend line for salmonellosis. The 
proportion of S. Typhimurium of all cases of salmonellosis remained stable at about 20%. 
S. Typhimurium DTI04 isolates totalled 2,955, including 1,442 female and 1,494 male. Home 
Cases made up 2,798 of these (1,358 female and 1,422 male). S. Typhimurium DTI04 case 
numbers increased gradually to 511 in 1996 before falling, but even in the last year of the study 
ST DTI04 accounted for about 50% of all ST isolates. The isolates of ST DTI04 could also 
roughly be divided into three periods: before 1991, when there were very few isolates; 
1991-1998, the main infection period; and after 1998, when the figures began to decline, with 
just 73 cases recorded in the final year of the study in 2004. After 1991, ST DTI04 began to 
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account for an increasing and significant proportion of total ST cases. While total ST cases were 
declining, the ST DT1 04 total increased sharply in both number and proportion of the ST total, 
reaching its highest number (520) and highest proportion (69.9%) in 1996. After 1996, even 
though both ST and ST DT104 declined somewhat, ST DT104 still accounted for a significant 
percentage of ST. 
Figure 3.1 also shows that the isolate numbers of Salmonella and S. Typhimurium were quite 
stable and did not change dramatically before 1997. However, the trend line for isolates of ST 
DTI04 shows a very traditional epidemic curve, rising from 20 to 511 in nine years. In 1997 
the numbers began to drop, and remained below 100 from 2001 onwards. Imported cases of 
ST DT 104 were more stable than Home Cases, usually totalling less than ten per year (Figure 
3.2). 
3.3.2 Cumulative incidence of Home Cases in NHS Health Boards 
The cumulative incidence of salmonellosis was 6.44 per thousand persons from 1988 to 2004 in 
Scotland. Table 3.2 shows the number of submitted isolates in the GG, GR, and LO Health 
Boards were the three highest. Two islands had the lowest isolates. The AA, WI, and SH Health 
Boards had the lowest cumulative incidence but the DG, BR, LN, LO, and GR Health Boards 
had higher cumulative incidences (Table 3.1, Figure 3.3). Every board had a similar trend; 
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initially rising and then falling roughly speaking at the same time. Generally, the southern 
and eastern parts of Scotland had higher rates and the middle and northern parts of 
Scotland lower rates. 
The cumulative incidence of S. Typhimurium was 1.42 per 10 thousand persons. The DG, 
SH, and GG Health Boards had higher cumulative incidences than other Health Boards. In 
contrast, the TY, WI and AC Health Boards were the lower rate regions. The results are 
slightly different from salmonellosis (Table 3.2). 
Table 3.3 shows the cumulative incidence of ST DT104 was 6.05 per 10 thousand 
persons. Although the GG Health Board had the highest submissions, the DG and OR 
Health Boards had very high rates. The cumulative incidence of the BR Health Board 
was as high as 7.21 per 10 thousand persons. The SH, AA and HG Health Boards had 
lower cumulative incidences. In addition, the SH Health Board only had 4 isolates in 14 
years. In summary, the results showed the DG Health Board had higher cumulative 
incidence in salmonellosis, S. Typhimurium and ST DT1 04 infections. 
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3.3.3. The distribution of ST phage types 
The most common phage type was phage type 49 from 1988 to 1990 (Table 3.4). From 
1991, the most common phage type was then DTI04. The proportion of ST DTI04 
increased up to 70% in 1996. From 1996, the submissions of ST DTI 04 declined but still 
were more than 30% of all ST isolates. The second common type was usually RDNC 
(nonrecognised phage lysis pattern). The phage types 66, 204c, 170 and 104 were the 
second most common phage types in 1988, 1990, 1992 and 1996, respectively. ST DTI 04 
was mainly of Scottish original except in 1992, when 17 ST DTI04 isolates were 
recorded as being imported from other countries (Table 3.5, Figures 3.4 and 3.5) 
Table 3.4 S. Typhimurium phage types isolated from humans in Scotland. 
Year Most No. of No. of Second most No. of No. of 
common isolates Home common phage isolates Home 
phage type Cases type Cases 
1988 49 173 173 66 91 86 
1989 49 110 99 RDNC* 77 57 
1990 49 148 147 204c 148 147 
1991 104 95 95 RDNC 78 59 
1992 104 170* 161 150 170 104* 152 144 
1993 104 242 234 RDNC 62 47 
1994 104 292 265 RDNC 96 63 
1995 104 409 397 RDNC 104b* 78 63 
1996 104 520 511 104b 53 48 
1997 104 317 308 RDNC 67 58 
1998 104 230 219 RDNC 47 37 
1999 104 155 150 RDNC 39 27 
2000 104 152 145 RDNC 39 27 
2001 104 96 85 RDNC 35 26 
2002 104 85 91 U302 23 22 
2003 104 51 49 RDNC 36 29 
2004 104 79 73 RDNC 33 28 
Total 104 2955 2798 RDNC 987 768 
- .... - _. __ .. _-
The column 'All' is the total number of the named type; the number in 'Home' only 
includes the 'Home Cases'. 
* means when only 'Home cases' were counted. 
*RDNC: nonrecognised phage lysis pattern 
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Figure 3.4 The numbers of different ST phage types from the Scottish human isolates, 
1988-2004. Y: Home Cases; N: Imported Cases. 
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Figure 3.5 The proportion of different ST phage types from the Scottish human isolates, 
1988-2004. Y: Home Cases; N: Imported Cases. 
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3.3.4 Seasonal effects 
Figures 3.6 and 3.7 show the seasonal effects, classifying the number of isolates into 13 
four-weekly months. Most human isolates were reported in the summer months (August 
to October) and the numbers of Salmonella, ST, and ST DTI04 isolates all went up to 
their peak in the 9th period and then declined. There were also secondary peaks in the first 
and the 13th periods. The cases numbers of ST in all periods were between 20 and 150, 
except associated with an outbreak of phage type 49 in October 1990; When the data for 
ST DTI04 were updated to 2004, the pattern was maintained (Figure 3.8). The results 
showed a strong seasonal change in the ST time series. These aspects will be explored 
further in later chapters. 
6000 
Salmonella 
5000 ST 
4000 
3000 
2000 
1000 
a 
2 3 4 5 6 7 8 9 10 11 12 13 
Figure 3.6 The numbers of the Salmonella spp. isolates in each four-weekly month, 
Scotland, 1988-2002 
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Figure 3.8 The numbers of the ST DT1 04 submissions in each calendar month, Scotland, 
1988-2004 
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3.3.5. Age 
Figure 3.9 shows the distribution of ST DT104 isolates from the different age groups of 
patients. Children younger than 10 years had significantly more ST DT104 reports than 
other age groups. Although the age group 65+ had 194 isolates, the cumulative incidence 
was only 2.4 per thousand persons due to the large population denominator in this group. 
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Figure 3.9 The numbers of reported isolations of ST DT1 04 from different age groups, 
Scotland, 1988-2004 
3.4 DISCUSSION 
The purpose ofthis chapter was to describe the trends in Salmonella, ST, and ST DT104 
infections in Scotland. Although there are some minor difference between Scotland 
and other European countries, the trends are broadly similar (Helms et al. 2005). In 
~ 
z 
~ 
z 
::> 
CHAPTER III 85 
and other European countries, the trends are broadly similar (Helms et al. 2005). In 
England and Wales, The trend of Salmonella spp. infection rose until 1998 and then 
declined in 1999 (Threlfall et al. 2000). In the rest of Europe, the proportion of ST of all 
Salmonella spp. cases declined in line with observations in this study but the proportions 
of ST DT104 and MR ST DT104 infections all increased particularly in 1996 (Helms et al. 
2005). 
There would appear to be good grounds for concluding that there has been something of 
an epidemic but whether the reported isolations are a true reflection of infections is a 
matter for debate. Diagnostic kits and methodology development is directly related to the 
ability to detect and report and in the early rise, the increased case numbers may reflect 
a detection bias (Humphrey et al. 2000). Add to this awareness (Humphrey et al. 2000) 
and planned surveillance and the rate of increase is likely to be exaggerated. 
In Scotland, several factors might be associated with the decline of Salmonella isolate 
numbers from 1998. These would include improved biosecurity following BSE and the 
banning of bone meal in livestock feed in 1996; vaccination against S. Enteritidis PT4 in 
1994; vaccination against S. Enteritidis in egg-laying flocks in 1997 (Defra 2003; 
Threlfall 2000; Helms et al. 2005). All of them might cause the total Salmonella cases to 
decline (Helms et al. 2005; Threlfall 2000). ST DT1 04 reflected the same general trends 
and the reasons for this are less clear although biosecurity and changes in farming practice 
are likely factors. For example The Over Thirty Month Scheme (OTMS), which was 
introduced in May 1996, forces cattle older than 30 months to go directly from farms to 
slaughter and incineration (Ternent 2002). 
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The seasonal trends are well-established and are related to increased temperature and 
summer related behaviours (Browning et al. 2003). Indeed these trends are in agreement 
with the situation for E. coli 0157, which also has the highest incidence in June- August 
(Ternent 2002), as well as other food borne organisms. The age profile of cases is again 
well established and relates to immune status and exposure (Browning et al. 2003). 
As regards spatial effects, the difference in the cumulative incidences in the different 
health boards is worthy of further investigation. Whether these relate to exposure or 
detection biases is difficult to establish. Certainly, it will interesting to relate these 
figures to livestock distribution and infection rates in livestock as suggest by Calvert et 
all (Calvert et al. 1998). Before exploring the situation in animals, the next chapter will 
address the resistant ST DTI 04 in more detail. 
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DESCRIPTIVE EPIDEMIOLOGY OF ANTIMICROBIAL RESISTANCE 
IN S. TYPHIMURIUM TYPE DT104 IN SCOTLAND (1988 -2004) 
4.1 INTRODUCTION 
88 
A multi-resistant ST DT104 clone resistant to ampicillin, chloramphenicol, streptomycin, 
sulphonamides and tetracycline, viz., ACSSuT R-type, became a major cause of ST DT104 
infection in humans in the UK from the late 1980s. It appeared in several European countries, 
USA, Canada, Israel, Turkey and Japan during the 1990s (Threlfall 2002). Chapter 3-1 
showed that in Scotland, ST DT104 isolates accounted for 38.8% of ST isolates and caused 
8.6% of Salmonella infections from 1988 to 2004. Nalidixic acid and trimethoprim resistances 
were identified from ST DT104 strains in England and Wales (Threlfall et al. 1996) and there 
has been a worrying in increase in ST DT104 isolates with trimethoprim and low-level 
ciprofloxacin resistance in many industrialised countries (Parry 2003). 
One aim of Enter-Net, funded by the EU, is to investigate and evaluate Salmonella infections 
(Fisher 1999). The purposes of the surveillance system are to collect isolates and share 
information among participants to control salmonellosis. Many different resistance types 
(R-types) have been identified. This chapter describes the changes in ST DT104 resistances in 
Scotland from 1988 to 2004. It will be used as the initial information for the following 
hierarchical cluster and geographical cluster analyses. 
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4.2 MATERIAL AND METHODS 
Isolates were routinely tested by the Kirby-Bauer disk diffusion method for sensitivity to a 
panel of 14 antibiotics (15 treatments) in the SSRL (Browning et al. 2001a). The 15 
treatments used in the SSRL were described in Chapter 2. A total of 2,798 isolates of ST 
DTI04 defined as Home Cases were examined. 
Scores were assigned based on the numbers of antibiotics to which an isolate was resistant. 
Low level ciprofloxacin and cefotaxime resistances were excluded because they were added 
into the panel from 1999. Thus, the highest R-type scores were 13. 
When the HPS publications were reviewed, 'multi-resistant type' before 2001 were defined as 
an isolate resistant to 3 or more antibiotics. After that year, the definition was changed. 
'Multi-resistant type' was then defined as an isolate resistant to 4 or more antibiotics in the 
panel (Browning et al. 2001 b; Browning et al. 1999; Browning et al. 2004; Browning et al. 
2001a; Browning et al. 2005; Browning et al. 2003; Helms et al. 2002). In this Chapter, the 
latter definition was adopted i.e., resistant to 4 or more antibiotics. 
Basic descriptive epidemiological analyses were performed as in Chapter 3. 
4.3 RESULTS 
Table 4.1 shows the changes of the R-type scores in each year. The proportions of different 
R-type scores are shown in Figure 4.1. The fully sensitive type (FS) remained present in 
high proportions from1988 to 1990 but numbers dropped sharply thereafter. In contrast, the 
percentage and number of resistant types increased rapidly, especially those R-types isolates 
with score 6. The ratio of the sensitive to the resistant type dropped from 80% to 14% after 
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1991. Sensitive isolates (R-type scores less than 4) almost disappeared after 1992. During the 
study period, the overall ratio of the R-score more than 4 against the R-score less than 4 was 
89%. 
Table 4.1 Numbers of isolates by their R-type scores using 13 antibiotics (Scottish human 
isolates, 1988-2004) 
R scores 
YEAR 0 1 2 3 4 5 6 7 8 9 Total 
1988 16 1 2 1 20 
1989 6 3 1 7 17 
1990 8 1 1 10 
1991 9 1 3 2 1 69 5 90 
1992 24 1 1 115 3 144 
1993 6 1 6 1 1 217 2 234 
1994 12 7 6 221 18 1 265 
1995 8 2 11 9 2 286 78 1 397 
1996 4 1 4 31 2 329 137 3 511 
1997 7 1 4 2 213 61 20 308 
1998 3 1 7 1 158 38 10 1 219 
1999 9 1 2 3 110 25 150 
2000 2 3 5 3 107 25 145 
2001 2 4 2 1 1 30 45 85 
2002 1 1 10 3 1 31 31 3 81 
2003 1 2 1 29 16 49 
2004 3 25 25 20 73 
Total 117 7 57 99 17 101948 504 38 1 2798 
Figure 4.1 shows that the proportion of MR ST DTI04 was always higher than that of R-type 
score less than 4 from 1991. Although the case numbers declined from 1997, the percentage 
ofMR ST DTI04 remained high. From 2001, the proportion ofMR ST DTI04 went down. In 
2004, the percentages ofMR ST DTI04 fell further and only 25 out of73 isolates had R-type 
scores of 3. 
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Figure 4.1 Changes in the R-type score proportions of human ST DTI04 isolates, Scotland, 
1988-2004. The numbers in the legend are the R-type scores. 
Table 4.2 shows the R-types identified from 1988 to 2004. A total of 52 R-types were 
identified throughout the study period. The percentage of the fully sensitive type was 4%. The 
most common R-type score was 6 (69.6%). The ApCISpStSuTe R-type contained 1,941 
isolates. It constituted 99.6% of all isolates with a R-type scores of 6. There were 17 and 10 
isolates in the R-type score 4 and 5 group, respectively. 504 isolates were present in the 
R-type score 7 group. The first R-type score 7 isolate was identified in 1991. In this group, the 
most common R-type was the ApClSpStSuTeTm R-type (325 isolates). The second most 
common R-type was the ApClNaSpStSuTe R-type (169 isolates). A total of 38 isolates 
belonged to R-type score 8, in 6 different R-types. The first R-type score 8 isolate 
(ApCIKaNaSpStSuTe R-type) was identified in 1994. The most common R-type in the R-type 
score 8 group was the ApCINaSpStSuTeTm R-type (10 isolates). Only 1 isolate was R-type 
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score 9. 
Table 4.2 The ST DT104 resistance types from human isolates, Scotland, 1988-2004. 
R-types 
Na Te Ap 
2 ApSu SpSt StSu SuTm 
3 SpStSu ApClSu ApKaSu ApNaSu 
ApStSu ApSuTe ApSuTm StSuTe 
SuTeTm 
4 ApClSpSt ApClSpSu ApClSuTe ApSpStSu 
ApStSuTe NaSpStSu SpStSuTe SpStSuTm 
5 ApClSpSuTe ApClStSuTe ApClSuTeTm ApSpStSuTe 
ClFzSuTeTm SpStSuTeTm 
6 ApClKaStSuTe ApClNaStSuTe ApClSpStSuTe ApClSpStSuTm 
ApClStSuTeTm ApCpSpStSuTe KaNaSpStSuTm 
7 ApClFzSpStSuTe ApClGmSpStSuTe ApClKaSpStSuTe ApClNaSpStSuTe 
ApClSpStSuTeTm ApCpNaSpStSuTe ApCpNaSpStSuTm 
8 ApClCpNaSpStSuTe ApClFzNaSpStSuTe ApClGmNeSpStSuTe 
ApClNaSpStSuTeTm ApClKaSpStSuTeTm(Lc) ApClKaNaSpStSuTe(Lc) 
9 ApClKaNaSpStSuTeTmLc 
R-types are sorted according to their R-type scores, which are listed in the left hand column. 
Table 4.3 shows the numbers of each R-type from 1988 to 2004. Each year, the numbers of 
R-types which appeared were slightly different. In 1988, there were 4 R-types and the fully 
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sensitive type. It was reported that R-types ACSSuT (ApClStSuTe) were most common in 
England and Wales (Threlfall et al. 1994). However, in the Scottish data, only three isolates 
belonging to the ApClStSuTe R-type were reported in three different years. In 1990, only 3 
different R-types were reported. After 1990, the phenotype diversities increased. The highest 
diversity was recorded in 1996; 17 R-types were reported. There was no correlation between 
type numbers and case numbers every year (Spearman's rank test, p=0.003). 
Table 4.4 shows the numbers of Imported cases from 1988 to 2004. 14 R-types and 157 
isolates were recorded. The most common imported R-type was the ApClSpStSuTe R-type 
(112 isolates). The trend for the fully sensitive type was the same as for 'Home cases' and 
were only present in the earlier years if the study. The ApClKaNaSpStSuTeTmLc R-type 
(from Spain) and theFzTe R-type (from Majorca) are the two R-types which have not been 
found in Home Cases. The three most common places of origin of Imported Cases were Malta, 
Majorca, and Spain. 
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Table 4.5 shows the resistance to each single antibiotic each year. According to the resistance 
percentage (R%) of each antibiotic, the 15 antibiotics can be roughly divided into three groups. 
The first group (Group 1) coutained Ap, CI, Sp, St, Su, and Te. The second group (Group 2) 
contained Tm, Lc and Na. The other drugs, Ka, Fz, Cp, Gm, Ne and Cfwere allocated into the 
third group (Group 3). The temporal distribution of resistance to each in each group is very 
similar. Group 1 were antibiotics to which resistance was common. Case numbers all went up 
sharply from 1991 and reached a peak in 1996. In contrast, 13.2%, 7.6% and 6.7% of 
isolates were resistant to Tm, Na and Lc, respectively. Na resistance was first discovered in 
1991. The percentages resistant in Group 3 antibiotics were lower than 1 %. 
Figure 4.2 shows the cumulative percentage for each antibiotic resistance throughout the 
study period. The resistances of Ap, CI, Sp, St, Su and Te had very similar trends. The 
cumulative numbers all rose sharply from 1991. From 1990 to 1999, the cumulative numbers 
for the isolates resistant to Group 1 antibiotics increased four fold. From 1992 to 1993, there 
was a two-fold increase. The cumulative trend of the increase in Tm and Na resistances 
increased after 1994, reducing again after 1998. 
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Table 4.5 The numbers of ST DTI04 isolates resistant to each antibiotic in each year, 
Scotland, 1988-2004 
Year Ap CI Sp St Su Te Tm Na Lc Ka Fz 
1988 4 3 N 2430 NN 0 
1989 8 7 7 11 11 8 0 0 N 0 
1990 2 2 1 2 2 2 0 0 N 0 
1991 80 79 81 80 83 80 5 1 N 0 
1992 120 118 118 119 120 119 2 0 N 0 
1993 228 220 221 222 228 221 2 0 N 0 
1994 249 242 246 248 256 242 14 6 N 2 
1995 393 382 392 391 402 385 66 23 N 0 
1996 467 462 489 490 497 464 77 67 N 3 
1997 288 287 292 292 293 287 45 37 14a 
1998 204 203 211 211 212 203 30 28 15 
1999 135 131 139 139 139 132 17 13 11 
2000 135 132 140 140 143 132 18 10 6 
2001 81 76 81 82 85 78 40 8 8 
2002 79 68 64 69 78 68 35 4 4 
2003 44 41 42 43 44 42 11 1 1 
2004 48 45 70 70 73 45 8 12 12 
TotalR 2565 249825942611 26702511 370 210 71 
9 
3 
1 
o 
o 
5 
o 
o 
23 
Cp Gm Ne Cf Total 
N NON N 20 
N N 0 0 N 17 
o 0 0 0 N 10 
1 0 0 0 N 93 
1 0 0 0 N 144 
o 0 
1 0 
1 0 
1 0 
o 
o 
o 
o 
o 
1 
o 
o 
6 
1 
o 
3 
o 
o 
o 
o 
o 
4 
o 0 N 235 
ION 268 
o 0 N 412 
o 0 N 503 
1 
o 
o 
o 
o 
o 
o 
o 
2 
1 N 300 
o Ob 215 
o 0 149 
o 0 145 
o 0 89 
o 0 80 
o 0 45 
o 0 73 
1 0 2798 
TotalS 233 300 184 287 128 287 24282568 995 2775 2755 2757 2796 2777 687 
R% 91.7 89.3 93.4 90.1 95.4 89.7 13.2 7.6 6.660.82 0.22 0.14 0.07 0.04 0 
N: not done. 
a: 30 isolates were not tested. 
b: 109 isolates were not tested. 
Total R: The numbers of all resistant isolates 
Total S: The numbers of all sensitive isolates 
R%: resistance percentage 
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Figure 4.2 The cumulative percentages of ST DT 1 04 isolates resistant to each antibiotic every 
year, Scotland, 1988-2004 
4.4 DISCUSSION 
The aim of this chapter was to set the emergence of resistance in the context of the 
epidemiological trends described in the last chapter, as well as highlighting that when 
considered as a whole, the resistant population itself is heterogenous. The factors related to 
the expression of antibiotic resistance patterns are complex. The phenotype diversities in a 
Salmonella serotype under the same antibiotic exposure experience have been documented 
(Davison et al. 2005). Nosocomial Salmonella outbreaks related to antibiotic treatment have 
also been reported (Olsen et al. 2001; Stephen et al. 2003). The fitness of the selected 
, 
, 
I 
I 
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population of micro-organisms in competition with others enhances the survival ability of 
multi-resistance strains (Dick 2003). External factors are therefore well recognised as playing 
an important role in the evolution of antibiotic resistance patterns in different regions. It is 
apparent that two neighbouring countries may present different distribution of MR ST DT104 
(Helms et al. 2005). In England and Wales, 95% of ST DT104 were resistant to 
ApCISpStSuTe in 1996 (Helms et al. 2005), but in Scotland, it was 72% only. In other 
European countries the percentage of MR ST DT104 increased from 1994 to 2001 (Helms et 
al. 2005), a trend not reflected in Scotland. Nevertheless, for the fully sensitive R-type, the 
numbers reported have fallen everywhere (Helms et al. 2005). 
In England and Wales, the most common R-type of ST DT104 historically has been the 
penta-form ApClStSuTe R-type, which was first reported in 1988 (Threlfall 2000). It is 
worthy of note that spectinomycin was not present in the test panel at that time. The present 
study has shown that the hex a-form, ApCISpStSuTe R-type, was the most common R-type in 
Scotland. In the following chapters the label ApClStSuTe, will be used. It is commonly 
abbreviated to ACSSuT because there was another ApClSpStSuTe R-type in the Scottish 
dataset. The first imported ApClSpStSuTe R-type was isolated in 1991 from a traveller who 
went to Spain but it is believed that the hexa-form R-type might be Scottish in origin and that 
this clone has then spread to other countries (Threlfall 2000). 
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Isolates were tested for sensitivity to a panel of 15 treatments. The combination of R-types 
may therefore be up to 215 in number. Only 52 R-types were identified. This may the case for 
two reasons. Firstly, the database may not have captured all R-types. Only one-third of 
salmonellosis in humans is reported officially (Wheeler et ai. 1999). Secondly, the appearance 
of selected antibiotic resistances is highly related, such as the ACSSuT R-type (Threlfall 
2000). The results suggested that the 15 antibitotics could be classified into 3 groups. This 
assumption will be analysed by hierarchical cluster analysis in Chapter 5. 
There were two core resistance patterns - the SpStSu or ApCISpStSuTe - with one or other 
identified in almost all isolates. However there is a significant diversity and for all the 
predominance of the clone resistant to Ap, CI, Sp, St, Su, and Te (Threlfall 2000), the current 
study suggests that the contention of Lawson et aI., (2004) that is that earlier MR DTI04 
strains were more heterogeneous than those of today based on genotype (Lawson et ai. 2004). 
This study was, however, based on phenotypic observations. 
There are issues of concern: In 2002, of 1,168 isolates of MR ST DTI04, 11 % had 
trimethoprim resistance, 10% low-level ciprofloxacin resistance and 1 % both, in the England 
and Wales data (Parry 2003). Similar patterns are seen among animal isolates in England and 
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Wales (Jones et al. 2002). In contrast, in the Scottish data, 35 out of 80 isolates in 2002 (44%) 
had trimethoprim resistance and, 4 (5%) isolates were resistant to low level ciprofloxacin. 
In summary, there has been an increase in MR DTI04 throughout the study period. The nature 
of the resistance is varied and it is clear that besides the emergence of resistance to individual 
antibiotics, there are permutations and combinations of these resistance types. Of significant 
note is the decline of the fully sensitive isolate. The following chapters will examine these 
phenotypes in more detail, will explore the broad "three group" categorisation of this chapter 
and attempt to relate the patterns here with animal isolate data, as well examining the 
distribution of key R-types in time and space. In particular, the timing of emergence of 
individual resistance will be commented on in Chapter 10. 
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5.1 INTRODUCTION 
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Salmonella Typhimurium definitive type 104 (ST DTI04) infection was first identified in 
1952 but it became of major concern after the chromosomal encoded antibiotic resistant strain 
was identified by Threlfall (Threlfall 2000). After the discovery, there were significant 
increases in numbers of ST DTI 04 isolates as a proportion of Salmonella spp. It was believed 
that the phenomenon was directly related to the spread of this strain (Threlfall 2000; Threlfall 
et al. 1994; Malorny et al. 2001; Prager et al. 1999); however, many different resistant 
phenotypes were identified by the Scottish Salmonella Reference Laboratory (SSRL). 
Recently, more and more different genotypes with similar resistance phenotypes have been 
identified (Yang et al. 2002; Threlfall et al. 2005). To date, 15 antibiotics have been used to 
identify the antibiotic resistant properties of each isolate in the SSRL (Browning et al. 2003). 
As mentioned in Chapter 4, 52 R-types were found in 2,798 isolates from the human 
submissions. 
The expression of antibiotic resistance relates to many factors. The presence/absence of genes, 
the qualitative and quantitative level of expression (Palzkill 2001), and the level of gene 
mutations all influence the responses in the antibiotic resistance tests. When a cassette of 
genes are operated by one initial gene (IN!), the genes in the cassette will be translated and 
transcribed together. For example, the SGIl cassette identified in the genome of ST DTI04 
contains 5 antibiotic resistance genes which translated together. In these circumstances, 
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although one antibiotic was used for treatment, the bacteria will translate all the potential 
relative functional genes in this cassette. 
The expression of antibiotic resistance relates to the previous antibiotic exposure experience 
of a clone of bacteria (Sanchez et al. 1997; Levy 1994). This experience relates to treatments 
and the usage of growth promoters. There are many different kinds of multi-drug efflux 
pumps, which can actively and non-specifically move antibiotics out from bacteria (Gillespie 
and Bamford 2003). If a bacterium has a previous antibiotic exposure experience, it may 
respond faster when a drug is used. again 
In Chapter 4, similar R-types were grouped according to the patterns identified. From the 
previous results, responses to 13 antibiotics were allocated to three groups: high, medium and 
low resistant sub-groups. The low resistance drugs have not been reported as being integrated 
into the ST DT104 genome. The results in Chapter 4 showed that R-types may share basic 
resistance cores, e.g., the SpStSu or the ApCISpStSuTe resistance pattern. 
Hierarchical cluster analysis is a useful tool for classifying cases of interest into groups 
according to the user's enquiry. It is a non-parameter method free from a priori assumptions 
that links samples into suitable groups according to the link method and the measured 
distance. K-means cluster analysis is effective in dealing with a very large datasets and can be 
used to validate hierarchical cluster analysis. 
The aims of the study in this chapter were to use cluster analyses to identify the relationship 
among antibiotic resistant patterns in the human isolate R-types from 1990 to 2004. 
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5.2 MATERIAL AND METHODS 
There are 15 treatments used in SSRL to identify ST DTI04. However, the treatments were 
introduced in different years (Chapter 2). Hierarchical cluster analysis does not allow for any 
missing information in a case. Thus, to obtain a better profile of the relationships, it was 
necessary to maximise the case and variable numbers. Of the 15 treatments used, only 796 
isolates collected from 1998 to 2004 were included. In contrast, there were 2,761 isolates 
collected from 1990 to 2004 available for analyses when 13 drugs were used (Table 4.3). 
Only 37 isolates recorded in 1988 and 1989 were excluded with R-types ApClSuTe and 
ApClStSuTe (Table 4.2). The 9 and 15 treatment hierarchical cluster analyses were also 
performed but were used for reference only. The cluster analysis, linkage methods, distance 
measurements, data presentation and K-means cluster analysis were all carried out as 
described in Chapter 2. The McNemar test was used to analyse whether the antibiotic 
resistance patterns are matched (SPSS Inc. 2006; Dohoo et al. 2003). 
5.3 RESULTS 
5.3.1 The relationships among the antibiotic resistance patterns 
The 13 drugs were allocated into 2 distinct groups (Figure 5.1). The upper group was called 
Group H-A and the bottom group was called Group H-B. Group H-A was highly homogenous 
but had some minor diversities. Na and Tm are less similar to other Group H-A drugs. When 
the second line was set at cutting line 3/25, Group H-A was divided into group H-Al, H-A2, 
and group H-A2. Group H-Al contained Gm, Ne, Cp, Fz and Ka. Group H-A2 contained Na 
and Group H-A3 contained Tm. In Group H-B, it was divided into 2 sub-groups: 1) Group H-
BI contained Ap, Cl and Te; 2) Group H-B2 contained Su, Sp and St. When 15 antibiotics 
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were put in the model, Cf was located in Group H-Al. Lc were located in Group H-A2 with 
Na. Tm was located in Group H-A3 but could be considered as part of group H-B. 
Rescaled Distance Cluster Combination 
CAS E o 5 10 15 20 25 
Label Num +- - - - - - - - -+- - - - - - - - -+- - - - - - - - -+- - - - - - - - -+- - - - - - - --+ 
GM 5 
NE 8 
CP :, 
FZ 4 
KA 6 
NA 7 
TIl 13 
CL 2 
TE 12 
AP 
SP 9 
ST 10 
SU 11 
Abbreviation: OM: Gentamicin, NE: Netilmicin, CP: Ciprofloxacin, FZ: Furazolidine, Ka: Kanamycin, Na: Nalidixic acid, TM: 
Trimethoprim, CL: Chloramphenicol, TE: Tetracycline, AP: Ampicillin, SP: Spectinomycin, ST: Streptomycin, SU: Sulphonamide. 
Figure 5.1 Dendrogram constructed from the 13 antibiotic hierarchical cluster analysis using 
the 'between group' linkage method and the binary square Euclidean distance measurement. 
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In the K-means cluster analysis, with K set at 2, group 1 had Ap, CI, Sp, St, Su and Te and 
the group 2 contained Cf, Cp, Fz, Gm, Ne, Ka, Na and Tm (with Lc). The result suggested 
that the cutting line used in the hierarchical analysis was suitable. 
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The dependence of variables was checked by the McNemar test (Dohoo 2003). The result 
showed that only six pairs of antibiotic resistances had similar responses. All of the drugs 
belonged to Group H-A and the drugs were not found to be highly resistant. There were 70, 1, 
35, and 960 for Na + and Lc +, Na - and Lc +, Na + and Lc -, and Na - and Lc - isolates, 
respectively and as a consequence, the two were considered to be independent. 
5.3.2 The relationships among R-types 
Figure 5.2 shows 50 R-types aggregated into many groups. Three cutting sites were chosen 
based on the dendrogram. The first cutting site was chosen at the distance of 20/25. Thus, 
three groups were formed. They were named as Group A, Band C. The numbers and the 
resistance patterns are shown in Table 5.1. The name of each cluster was usually given 
according to the reference number of the first isolate in this R-type. Group A, Band C 
contained 29, 21 and 1 R-types, respectively. With only one isolate in Group C it could be 
assumed for practical purposes that there were 2 groups. This was confirmed by the K-means 
cluster analysis. The second cutting site was chosen at 15/25. Six clusters formed as follow: 
Group a, b, c, d, e, and f. Group a and b were listed in Group A and named as Group Aa and 
Ab. The third cutting site was chosen at 10115 and then 10 groups were formed; 3 were in 
Group Aa, 2 were identified in Group Ab and 3 were found in Group B, respectively. Only 
Group B was divided to 2 clusters. The sub-groups were named from 1 to 8. Group Conly 
had one isolate and did not contain any sub-group. 
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Group A contained 29 R-types and 2,506 isolates. Group B contained 20 R-types and 
288 isolates. There were 3 sub-groups containing most of submissions and the 3 
main groups were all located in Group A. They were Group No 45, No 52 and No 605. 
Basically, they share the same ApClSpStSuTe R-type structure. Group No 52 had an 
additional Tm resistance and Group 605 had an additional nalidixic acid resistance. 
There were 3 main sub-groups found in Group B as well. The cases in Group No 38 
were sensitive to all treatments. Group No 268 was the ApSu R-type. Group No 85 
was the SpStSu R-type. Basically, the isolates in Group Bd were all ampicillin 
sensitive. All isolates in Group 2 were resistant to Sp and St. Group Bc was sensitive 
to non-chromosomal related antibiotics. There were some differences between Group 
A and B. The main difference between Group A and B was the chloramphenicol 
resistance. Also, in Group B, the R-types were less resistant to Sp/St and 
Cp/Fz/Gm/Ka/Na. Many of the R-types in this group were sensitive to Ap. The 
dendrograms constructed from the 9 and 15 treatment hierarchical cluster analyses 
were similar. 
Figure 5.3 shows the general trend was dominated by Group Aa, Ba, Bb, and Bc and 
their subordinate 6 R-types. Group No 45, the ApClSpStSuTe R-type, had the highest 
percentage from 1992. This R-type showed a very similar pattern corresponding to the 
pattern of all isolates throughout the study period. In contrast, the percentage of Group 
38, the FS R-type, declined gradually. Group No 52, the ApClSpStTeTm R-type 
became a concern after 1991 and contributed about 40 per cent in 2001. Group 605, 
the ApClSpStSuTeNa R-type, became a concern after 1994 and had a surge in 2004. 
The major R-type in Group B was Group No 38, the FS R-type. Group No 268, the 
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ApSu R-type and Group No 85, the ApStSu R-type had significant increases in 2003 
and 2004, respectively. 
5.4 DISCUSSION 
This chapter has investigated the way in which the phenotypic expression of 
resistance occurs in ST DT104. In common with previous chapters the diversity and 
dynamic nature of resistance is evident, albeit that there are predominant R-types. 
There were 50 R-types identified in the current study. The diversity of the R-types 
among ST DT104 isolates from the human dataset is high. However, they were also 
similarities and they can be grouped into two major distinct groups. Many R-types 
appeared and then disappeared. Threlfall reported they could be considered as variant 
forms caused by the mutation of the genome (Threlfall et al. 2003). Gene fragments 
lost or repeated may be caused by transposons during evolution, especially of those 
genes located on plasmids. Gene mapping of those few phenotypes would help to 
understand the relationship among phenotypes in each group. 
The appearance of the additional Tm resistant isolates has been associated with the 
treatment of the ApCISpStSuTe R-type isolate infection in cattle by Tm (Threlfall et 
al. 1996) although it is not clear how much trimethoprim was prescribed for human 
treatments over the study period. 
The emergence of quinolone resistance is an issue of concern. It is believed that the 
emergence of quinolone resistance is associated with use of enrofloxacin, a kind of 
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fluoroquinolone, for veterinary use from November 1993 in the UK (Threlfall et al. 
1997). From this dataset, the first nalidixic acid resistant isolate identified in SSRL 
was in 1991, which was aNa R-type. Na resistance isolates were identified every year 
from 1994. There were 4 isolates identified as Cp resistant. All of them had the 
ApClSpStSu R-type. There were also 71 isolates identified as Lc resistant from 1997, 
when the test was introduced. The quinolone resistant mechanism is associated with 
the mutation(s) in gyrA and with the mutation in gyrB to get the full resistance to 
fluroquinolone (Aarestrup et al. 2003). In order to investigate further the 
ciprofloxacin resistance, there have been suggestions that the breakpoint of 
ciprofloxacin resistance should be reduced from 4 mg/L to 0.125 mg/L (Aarestrup et 
al. 2003; Threlfall et al. 1997). The low concentration ciprofloxacin (0.125mg/L) is 
used to compare with the MIC level of nalidixic acid (Aarestrup et al. 2003). There 
were 4 out of 2,761 Cp resistant isolates but 71 out of 1,066 isolates were resistant to 
low level ciprofloxacin. From the current data, the dependent relationship between the 
two drugs could not be established. 
In summary the cluster analysis suggests that there are a number of phenotypes that 
are worthy of consideration when investigating the emergence of resistance. How 
these phenotypes relate to each other at the molecular level is a matter for speculation 
and how they relate to isolates from veterinary sources is an important next step in the 
investigation. 
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The ApClSpStSuTe ST DT104 R-type is the main antibiotic resistance phenotype identified 
world-wide since it was first described (Threlfall 2000). However, the distributions of other 
variants have not been similarly addressed. The different ST DT104 R-types were 
investigated in Chapter 5 and the results suggested that the R-types could be allocated into 
two main groups. Group A contained many multi-resistant R-types. Group B contained those 
R-types which were more sensitive to the 13 antibiotics used at the SSRL. However, the 
distributions of these different groups in time, space and time and space have not been 
determined. 
SaTScan is a program developed by Kulldorff in 1996 (Kulldorff 1997). It detects the most 
likely clusters in time, space and time-space by a method that compares the likelihood of 
circles chosen randomly and then lists the highest possible circle by order (Kulldorff 2006; 
Kulldorff 1997). It is a powerful tool that can be directed at identifying the most likely 
distributions of two groups and their subgroups. The program uses two models to approach 
the issue. Firstly, adopting assumptions associated with the Poisson distribution, the relative 
risk of a target group in time, space, or time-space can be compared with the general 
population in the same zone. Secondly, adopting a Bernoulli approach, a case-control analysis 
can be performed. The model compares the distributions of 'case' and the 'control' groups 
and then the results are presented as the location of the most likely high/low cluster of the 
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'case' group. The aim of this study was to discover the most-likely temporal, spatial, and 
spatio-temporal clusters for: 1) Salmonella submissions 2) S. Typhimurium submissions, 3) 
ST DT104 submissions, 2) Group A submissions, 3) Group B submissions, 4) Group Hex 
submissions and 5) Group FS submissions. The Group A, Group B, Group Hex and Group FS 
were as defined in Chapter 5. 
6.2 MATERIAL AND METHODS 
In this study, retrospective analyses based on Poisson and Bernoulli distributions were used to 
investigate the temporal, spatial, and spatio-temporal clusters in the population. The study 
was implemented at two different geographical levels: the NHS board and the postal district 
levels. The assumption was that the expected clusters would have the same or similar 
positions if the variance within each Health Board was low, i.e., were occurring randomly in 
each board. According to the requirements of SaTScan, three different datasets, in text format, 
were used. They were: 1) the population dataset, which supplied the population in space over 
time; 2) the co-ordinate dataset, which supplied the information about the grid position of the 
locations; 3) the case and control dataset, which included when, where and how many cases 
occurred. A duration of 1 year was used as the basic unit of analysis. In the Poisson model, 
only case, co-ordinate, and population datasets were required. In the Bernoulli model, a 
control rather than the population dataset was required. 
The popUlation data were originally from the 2001 Scottish census data. Comparison of the 
1991 and 2001 censuses showed that the Scottish population was relatively stable (General 
Register Office (Scotland) 2002; General Register Office (Scotland) 1991), and for the 
purposes of this study, it was assumed that the population in each study zone did not change 
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between 1988 and 2004. The population dataset was presented in a x, y, z format, in which x 
was location, y was the corresponding population and z was the time when the cases occurred. 
The original dataset provided the population in 15 NHS boards (Chapter 2). In contrast, the 
population in each postal district needed further calculation. The basic unit in a census is 
called a 'census tract'. Generally, a unit is the same as a postal district; however, because of 
the limitation of natural borders, some postal districts are divided into two census tracts. 
Twenty-six such census tracts were merged into 13 postal districts using MapInfo. 
SaTScan does not use the area of each zone in calculating clusters; instead, it uses the centroid 
of each zone. The latitude and longitude coordinate system was used in this study. The format 
of the coordinate dataset is also a (x, y, z) system, in which x is the name of the place, y is 
latitude, and z is longitude. MapInfo was used to calculate the centroid of each NHS board 
and then the locations were exported to a text format file. All names and locations of the NHS 
boards were described in Chapter 2. 
The study subject was the Home Cases, which was defined as cases reported as occurring in 
the UK without a history of travelling abroad in the previous three months (Chapter 2). The 
cases were sorted, matched, and stacked according to their corresponding time and locations 
in Excel 2000. Each submission contained the Health Board of the case reported, i.e., the 
place of the case. In the case and the control datasets, the case numbers in each postal district 
were counted. Four isolates were recorded as being in England and 127 of 2,798 had no 
location recorded and were defined as "missing". 
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All Salmonella, ST, ST DT104, the ST DT104 ApClSpSStuTe R-type (named as Group Hex), 
ST DT104 FS type (named as Group FS), the ST DT104 Group A (named as Group A), and 
ST DT104 Group B (named as Group B) isolates were analysed separately. 
Clusters identified in the Bernoulli model at the postal district level were listed according to 
the rank given from the model. 
6.3 RESULTS 
6.3.1 ST DT104 infections in Scotland from 1988 to 2004 
Figure 6.1 shows all the cases with their corresponding postal districts in Scotland. The 
central belt of the Scotland is shown enlarged in Figure 6.2. 
Figure 6.3 shows the cumulative incidences in each postal district. Generally, the cumulative 
incidences were higher in the southern and eastern parts of Scotland. The cumulative 
incidences in the outer islands and the central belts were also high. 
! -: 
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15 to 29 (24 ) 
~ .. 
8 to 15 (74) 
-D 5 to 8 (148) q 
D 4 to 5 (83) 
- 3 to 4 (132) 
11 D 2 to 3 (141 ) ~ 4' 
(189) ~~ D 1 to 2 ii~ 
Figure 6.1 The case numbers of ST DT1 04 in each postal district in Scotland (1988 to 2004); 
blanks spaces are areas with no cases. The numbers of postal districts belonging to the group 
were shown in the brackets. The central belt of Scotland in the box is enlarged in Figure 6.2 
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15 to 29 
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3 to 4 
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D 2 to 3 
D 1 to 2 
Figure 6.2 The case numbers of ST DTI04 in each postal district in the central belt of 
Scotland (1988 to 2004) shown in detail. The blank areas do not have any case. 
-~ 
CHAPTER VI 125 
10.2 to 80.8 (134) 
7.4 to 10.2 (112) 
D 5.8 to 7.4 (102) 
4.4 to 5.8 (112) Q 
D 3.2 to 4.4 (109) 
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Figure 6.3 The cumulative incidence in each postal district in Scotland from 1988 to 2004; 
the blanks are the areas no any case. The numbers of postal districts belonging to the group 
were shown in the brackets. 
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6.3.2 Results of temporal analysis based on the Poisson model 
The purely temporal cluster analysis was performed to detect the temporal clusters from the 
study groups. Table 2.2 shows the results from each group in the purely temporal study. In the 
period from 1998 to 2004, Group Salmonella and Group ST had a temporal lower risk cluster 
(TLRC). Group ST DT104 and Group A had a temporal higher risk cluster (THRC) in the 
period from 1993 to 1998. Group B had a THRC in the period 1994 to 1996. Group Hex had a 
THRC during the period from 1992 to 1999. The TLRC from Group FS was during 2000 to 
2004. 
Table 6.1 The most likely temporal clusters from Group Salmonella, Group ST, and its 
subgroups from 1988 to 2004. 
Groups Relative Risk ,e-value Period 
Salmonella 0.411 0.001 1998-2004 
S. Typhimurium 0.431 0.001 1998-2004 
ST DT104 4.106 0.001 1993-98 
Group A 4.639 0.001 1993-98 
Group B 2.261 0.001 1994-96 
Group Hex 6.275 0.001 1992-1999 
Group FS 0.107 0.001 2060-04 
6.3.3 Results of the spatial cluster analysis based on the Poisson model at the NHS board 
level 
The purely spatial cluster analysis was performed to detect the spatial clusters from each 
study group. Table 6.2 shows the most-likely clusters in each study group. 
Three spatial higher risk clusters (SHRCs) for Group Salmonella were identified in DG, GR, 
and LN. Two SHRCs were located in the southern part of Scotland and other SHRC was 
located in the East. Only two SHRCs were identified in Group ST. These clusters covered the 
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DG and GR Health Boards, respectively. The STRC from Group Salmonella and Group ST 
were the same. Two spatial lower risk clusters (SLRCs) were identified in LO and FF and AC, 
GG, FV and AA. The two circles were located in the eastern and western sides of the central 
belt. 
Three SHRCs were identified for Group ST DTI04. They were located in the DG, the GR, 
and the LN Health Boards. The locations were the same as the SHRCs identified from Group 
Salmonella. Three SLRCs from Group ST DTI04 were found in the FF, LO and TY, the AC, 
GG, FV and AA, and the HG Health Boards. The first two circles were the same as those 
identified in Group Salmonella and Group ST. 
The isolates in Group A, Group B, Group Hex and Group FS were allocated as described in 
Chapter 5. Three SHRCs were identified for Group A. The clusters were located in the DG; 
the SH, OR, and GR; and the LN Health Boards. The first circle was in the southern part of 
Scotland and the second circle, which included the outside islands, was located in the western 
part of Scotland. The third circle was located in the middle of the southern part of Scotland. 
Group A also had 3 SLRCs located around the AC, GG, FV, and AA Health Boards; around 
the FF, LO and TY Health Boards; and in the HG Health Board. The three SLRCs covered 
the northern part of Scotland. No SHRC for Group B were found but an SLRC was located in 
the circle of the WI, HG, OR, GR, TY, and AC Health Boards. The circle covered the 
northern part of Scotland. The most-likely clusters for Group Hex showed four SHRCs 
located in the DG; the LN; the OR; and the GR Health Boards. In addition, two SLRCs were 
located in the AC, GG, FV, and AA; and the LO Health Boards. There was also a higher rank 
SLRC identified in the HG Health Board with a p-value of 0.059. However, no significant 
SHRC or SLRC was identified for Group FS. 
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Table 6.2 The most likely spatial clusters from the Group Salmonella Group ST, and its 
subgroups, Scotland, 1988 - 2004. 
Grou~s Relative Risk P-value 
Salmonella 
DG 1.963 0.001 
GR 1.552 0.001 
LN 1.272 0.001 
LO, and FF 0.885 0.002 
AC, GG, FV, andAA 0.740 0.001 
Salmonella Typhimurium 
DG 1.850 0.001 
GR 1.601 0.001 
AC, GG, FV, and AA 0.728 0.001 
LO and FF 0.924 0.1 
ST DT104 
DG 2.560 0.001 
LN 1.274 0.001 
GR 1.257 0.003 
FF, LO and TY 0.842 0.003 
AC, GG, FV, and AA 0.810 0.001 
HG 0.596 0.001 
GroupA 
DG 2.725 0.001 
SH, OR, and GR 1.323 0.001 
LN 1.298 0.002 
FF, LO, and TY 0.814 0.001 
AC, GG, FV, andAA 0.785 0.001 
HG 0.618 0.004 
GroupB 
WI, HG, OR, GR, TY, and AC 0.621 0.017 
Group Hex 
DG 3.256 0.001 
OR 2.592 0.023 
LN 1.331 0.003 
GR 1.264 0.038 
LO 0.740 0.002 
AC, GG, FV, and AA 0.736 0.001 
HG 0.665 0.059 
Group FS 
Purely Spatial NONE 
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6.3.4 Spatio-temporal cluster analysis based on the Poisson model at the NHS board 
level 
Spatio-temporal cluster analysis based on a Poisson model was performed to detect possible 
clusters from the study groups relating to the corresponding areas over time. Table 6.3 shows 
the spatio-temporal clusters (STCs) from the study groups. The identified STCs were the 
same in both Group Salmonella and Group ST. The spatio-temporal higher risk cluster 
(STHRC) was found in the circle including the SH, OR and GR Health Boards in the period 
from 1990 to 1997. The spatio-temporallower risk cluster (STLRC) was found in the circle of 
the AC, GG, FV, AA and LN Health Boards between 1999 and 2004. No STHRC was 
identified from Group ST, but a STLRC was located in the circle of the AC, GG, FV, AA, 
and LN Health Boards in the period 1991 to 2004. When the study focused on mainland 
Scotland only, Group Salmonella and Group ST generated different clusters. The two 
STLRCs for Group Salmonella were located in the HG, GR, TY, FV, FF and AC Health 
Boards between 1999 and 2004; and the DG, AA, LN, BR, and GG Health Boards between 
2001 and 04. 
There was one STHRC for Group ST DT10410cated in the circle of the WI, HG, OR, GR, TY, 
AC, and FV Health Boards in the period from 1995 to 97. The circle covered the northern part 
of Scotland. The other STHRC from Group ST DT104 was located in the circle of the BR, 
LO, LN, FF, and DG Health Boards in the period from 1993 to 98. The circle covered the 
middle and southern parts of Scotland. 
The spatio-temporal cluster analysis for Group A showed the same clusters as those identified 
in Group ST DT104. There were two STHRCs for Group Hex. The first STHRC covered the 
DG, AA, LN, BR, and GG Health Boards between 1993 and 98. The cluster covered the 
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Table 6.3 The most likely spatio-temporal clusters from Group Salmonella, Group ST, and its 
subgroups, Scotland, 1988 - 2004. 
Grou~s Relative Risk P-value Period 
Salmonella 
SH, OR, and GR 2.039 0.001 1990-97 
AC, GG, FV, AA, and LN 0.432 0.001 1991-2004 
Excluding Islands-temporal-spatial 
HG, GR, TY, FV, FF, and AC 0.497 0.001 1999-2004 
DG, AA, LN, BR, and GG 0.484 0.001 2001-04 
Salmonella Typhimurium 
SH, OR, and GR 2.069 0.001 1990-97 
AC, GG, FV, AA and LN 0.444 0.001 1999-2004 
Excluding Islands-temporal-spatial 
AC, GG, FV, AA, LN 0.431 0.001 1991-2004 
ST DT104 
WI, HG, OR, GR, TY, AC, FV 3.043 0.001 1995-97 
BR, LO, LN, FF and DG 2.691 0.001 1993-98 
GroupA 
BR, LO, LN, FF, and DG 2.841 0.001 1993-98 
WI, HG, OR, GR, TY, AC, FV 3.210 0.001 1995-97 
GroupB 
AA, LN, DG, GG, and AC 3.969 0.001 1996 
GR, TY, FF, HO, and FV 0.258 0.001 1998-2003 
Group Hex 
DG, AA, LN, BR, and GG 3.202 0.001 1993-98 
HG, GR, WI, TY, FV, FF, OR, AC 2.797 0.001 1994-97 
Group FS 
LO, FF, and BR 4.870 0.001 1988-92 
GG, FV, LN, and AA 2.695 0.086 1991-94 
WI, HG, OR, GR, TY, AC 0.069 0.016 1999-2004 
middle and the southern part of Scotland. The second STHRC was located in the northern part 
of Scotland and covered the HG, GR, WI, TY, FV, FF, OR, and AC Health Boards between 
1994 and 1997. 
There was one identified STHRC for Group B which included AA, LN, DG, GG, and AC 
Health Boards in 1996. The circle covered the centre-western and the southern parts of 
Scotland. In contrast, a STLRC including the GR, TY, FF, HG, and FV Health Boards in the 
period from 1998 to 2003 was identified. The area covered the eastern and the northern parts 
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of Scotland. There was one STHRC and one STLRC identified for Group FS. The STHRC 
covered the LO, FF, and BR Health Boards between 1988 and 1992 and the STLRC WI, HG, 
OR, GR, TY, and AC Health Boards in the period 1999 to 2004. 
6.3.5 Clusters from spatial cluster analysis based on the Poisson model at the postal 
district level 
Table 6.4 shows the clusters from the different study groups. Clusters were named according 
to their group name and ranked order from the Bernoulli model. The SHRCs and the SLRCs 
in both Group ST DTI04 and Group A had the same locations and radii. Three SHRCs and 
three SLRCs were identified from Group ST DTI04 and Group A (Figure 6.4 and 6.5). The 
first SHRC, DTI04all-lIGroup A-I, had a centre located in the north-western side of Annan, 
DG, within a radius of approximately 93 km. The second SHRC, DTI04all-2/GroupA-2/Hex-
2, had a centre in Aberdeenshire, GR, with a radius of approximately 20 km. The third SHRC, 
DTI04all-3/groupA-4, had a centre located in Lothian, with a radius of approximately 4.6 km. 
The first SLRC, DTI04all-4/GroupA-3, had a centre located in the Western Isles (Figure 6.4) 
with a very large radius of approximately 245 km. The second SLRC, DTI04all-5/GroupA-5, 
had a centre located in Fife, with a radius of approximately 48 km. The third SLRC, 
DTI04all-6/GroupA-6, had a centre located in Greater Glasgow, with a radius of 
approximately 3 km. 
There were three identified SHRCs and one SLRC for Group Hex. The first HRC identified 
from Group Hex was named Hex-I, whose centre was located in Dumfries and Galloway, and 
had a radius of 95 km. The centre and the radius were almost the same as those of DTI 04-1. 
The coverage area was in the southern part of Scotland. The second HRC from Group Hex, 
Hex-2, 
CHAPTER VI 132 
Table 6.4 The most likely spatial clusters from Group ST DT104, and its subgroups, Scotland, 
1988 - 2004; ordered in rank. The study was implemented at the postal district level. 
Name P-value Location Radius (km) RR 
Clusters from Group ST DT104 
DT104 all-1 0.001 55.004581 N, 3.319748 W 93.13 1.933 
DT104 all-2 0.001 57.396759 N, 2.861479 W 20.28 4.917 
DT104 all-3 0.001 56.002213 N, 3.895982 W 4.58 3.219 
DT104 all-4 0.001 57.247871 N, 7.320584 W 244.82 0.759 
DT104 all-5 0.001 56.217957 N, 2.913362 W 47.79 0.747 
DT104 all-6 0.005 55.866852 N, 4.092675 W 2.82 0.061 
Clusters from Group A 
Group A-I 0.001 55.004581 N, 3.319748 W 93.13 2.035 
Group A-2 0.001 57.396759 N, 2.861479 W 20.28 5.338 
Group A-5 0.001 56.002213 N, 3.895982 W 4.58 3.189 
Group A-3 0.001 57.247871 N, 7.320584 W 244.82 0.682 
Group A-4 0.001 56.217957 N, 2.913362 W 47.79 0.700 
Group A-6 0.037 55.866852 N, 4.092675 W 2.82 0.068 
Clusters from Group B 
Group B-1 0.001 57.267067 N, 3.414077 W 77.3 0.176 
Group B-2 0.015 56.073265 N, 4.030589 W 15.76 2.860 
Group B-3 0.027 55.880638 N, 3.159124 W 2.35 8.388 
Group B-4 0.109 55.859253 N, 4.475159 W 0 11.518 
Clusters from Group Hex 
Hex-1 0.001 55.001743 N, 3.195488 W 95.23 2.488 
Hex-2 0.001 57.396759 N, 2.861479 W 20.28 6.15 
Hex-4 0.039 59.069847 N, 3.177505 W 0 4.782 
Hex-3 0.001 56.791744 N, 4.955959 W 125.57 0.656 
Clusters from Group FS 
FS-1 0.003 55.832664 N, 4.348066 W 1.65 14.945 
FS-2 0.003 55.900124 N, 3.144440 W 0 27.319 
FS-3 0.069 55.265659 N, 2.816563 W 16.46 17.516 
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Figure 6.4 Spatial distribution of identified significant SHRCs of study groups using the 
maximum cluster size < 50% of the total population in Scotland, 1988-2004. 
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.oT104 all-4 
Figure 6.5 Spatial distribution of identified significant SLRCs of study groups using the 
maximum cluster size < 50% of the total population in Scotland, 1988 - 2004. 
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had the same position and radius as those of STDTI04-2. The third HRC from Group Hex 
was called Hex-4 . Its centre was located in the Orkneys. 
There were two SHRCs and one SLRC for Group B (Figure 6.4). The first SHRC from Group 
B was called Group B-2. The centre was close to Shielbrea, FV within a radius of 
approximately 16 km. The second SHRC from Group B was called Group B-3. The centre 
was in Lothian. The two SHRCs had small radii, about 2 km, which means that the clusters 
were highly aggregated. The SLRC from Group B was called GroupB-l. The centre was 
located in Grampian, within a radius of approximately 77 km. 
There were two SHRCs identified from Group FS. The first one was FS-l and had the same 
centre as FST -1 and Group BT -2. The point was located in the G53 postal district, south-east 
of Paisley, GG, within a radius of approximately 1.7 km. The centre of the second SHRC, FS-
2/FST-2/Group BT-4, was located in the EH17 postal district, LO. There was one case 
submitted in 1989 and five cases were isolated in 1990. 
6.3.6 Clusters from spatio-temporal cluster analysis based on the Poisson model at the 
postal district level 
Table 6.5 shows the identified spatio-temporal clusters (STCs) from all study groups. There 
was only one STHRC identified from Group ST DTI04 (DTI04all-l). The location of the 
STHRC was centred around Hawick, Borders, from 1993 - 98 (Figure 6.6). The radius of this 
cluster is approximately 96 km. The centre of the identified STHRC from Group A (Group 
AT-I) was located between Edingham and Southwick, DG from 1993 to 98. Its subgroup, 
Group Hex, had two STHRCs identified. The first one was called HexT -1, with a 
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Table 6.5 The most likely temporal-spatial clusters from Group STI04 and its sub-groups 
from 1988 to 2004 at the postal district level; clusters in rank. The study was based on a 
Poisson model. 
Name P-value Location Radius RR Period 
DTI04 allT-l 0.001 55.510201 N, 95.95 2.732 1993-98 2.839513 W 
Group AT-l 0.001 54.923302 N, 116.87 2.897 1993-98 3.769124 W 
Group BT-l 0.001 55.859253 N, 0.00 195.772 1996 4.475159 W 
Group BT-2 0.001 55.832664 N, 1.65 87.115 1999 4.348066 W 
Group BT-3 0.001 56.144978 N, 43.04 2.778 1992-96 3.849847 W 
Group BT-4 0.001 55.900124 N, 0.00 152.965 1990 3.144440 W 
HexT-l 0.001 55.061913 N, 99.59 3.290 1992-98 3.617562 W 
HexT-2 0.001 57.684399 N, 197.99 2.815 1993-97 4.723242 W 
HexTI00-l 0.001 55.503174N, 99.71 3.270 1993-98 4.123856W 
HexTI00-2 0.001 57.089546N, 75.14 4.020 1995-97 2.410524W 
HexTI00-3 0.001 58.602936N, 52.83 9.450 1994-97 3.350581W 
HexTI00-4 0.001 58.212681N, 23.51 27.706 1999 6.378440W 
FST-l 0.001 55.832664 N, 1.65 221.450 1999 4.348066 W 
FST-2 0.001 55.900124 N, 0.00 384.518 1990 3.144440 W 
FST-3 0.005 55.265659 N, 16.46 59.647 1988-92 2.816563 W 
FST-4 0.020 56.257370 N, 47.97 7.775 1992 3.911094 W 
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Figure 6.6 Spatio-temporal distribution of significant STHRCs and STLRCs of study groups 
using the maximum cluster size < 50% of the total population in Scotland, 1988 - 2004. 
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centre was located in Maxwelltown, DG in the period 1992-98. The radius of HexT-l was 
approximately 99.6 km. The centre of this STHRC was very close to the centre of Group A-I 
but the cluster was smaller. The second circle was called HexT-2. Its centre was located in the 
IV23 postal district, Lubfearn, HG, from 1993-97. The radius of HexT-2 was as large as 
197.99 km. As a consequence of the radius being larger than 100 km, it was required to limit 
the maximum radius to 100 km. Thereafter, four identified STHRCs were identified instead of 
the original two STHRCs (Figure 6.7). The four clusters were called HexTI 00-1, HexTI00-2, 
HexTI00-3, and HexTI00-4. HexTI00-2, HexTI00-3 and HexTI00-4 were located in the 
margin of HexT-2. HexTI00-1 was moved to the northern site of HexT-l to fill the space 
where HexT-2 was original occupied. The point ofHexTl00-l was centred on Smallburn, LN. 
The area also covered the southern part of Scotland. The other two circles were located in the 
northern part of Scotland. The point of HexTI00-2 was located in Myrebird, GR within a 
radius of approximately 75 km. HexTI00-3 were centred on Castletown, HG, within a radius 
of approximately 53 km. The centre of Hexl00T-4 was located in Stornoway, Isle of Lewis. 
There were four identified STHRCs from Group B. They were located in Group BT -1, Group 
BT-2 Group BT-3 and Group BT-4/FST-2. The centre of Group BT-l was located in the PA3 
postal district, the north-western area of Paisley in 1996. The data showed that although all 
isolates in this area were from 1995- 97, 14 out of the 21 isolates were reported in 1996 and 
10 out of those 14 were isolated in June and July. The centre Group BT-2 (FST-l) was 
located at G53, the south-eastern area of Paisley in 1999. Seven out of 18 cases were 
submitted in 1999 and all the cases occurred in October, with four cases were marked as 
family contact (FC). Two cases were reported from the same address but were not marked as 
FC. It would be an outbreak centre. The centre of Group BT-3 was located near Menstrie, 
Stirling, FY, and the period was from 1992 to 1996. The circle covered the northern part of 
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Figure 6.7 Spatio-temporal distribution of identified significant STHRCs and STLRCs of 
study groups using the limitation of 100 km and the maximum cluster size < 50% of the total 
population in Scotland, 1988 - 2004. 
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Edinburgh, Perth, and the north of Glasgow. The centre of Group BT-4/FST-2 was at EHI7, 
LO and the circle contained 5 isolates from June to September in 1990. The 5 cases were 
isolated from children and were identified as FS type. 
Two STHRCs from Group FS were the same as those from Group B. FST-l had the same 
location and radius as in Group BT-2 and FS-1. FST-2 was the same as Group BT-4 and FS-2. 
The third cluster called FST-3 was located in the TD9 postal district, near Hermitage, Hawick, 
DG, from 1988 to 1992. Five out of 15 isolates occurred from 1988 to 1992 in this area. The 
fourth STHRC from Group FS was called FST-4. The centre of FST-4 was located in the 
FV15 postal district, near Greenloaning, FV. The radius of FST-4 was approximately 48 km. 
The circle covered the east-northern part of Glasgow, Stirling, Perth, and Falkirk, that is, 
located around the middle part of the central belt. 
6.3.7 Temporal cluster analysis based on the Bernoulli model at the NHS board level 
The most-likely clusters from the comparisons between Group ST, Group A, Group Hex, 
Group FS and their corresponding control groups: non Group ST, non Group A, non Group 
Hex, and non Group FS were identified. A temporal higher risk cluster (THRC) for Group ST 
was identified in the period 1997 to 2001. The HRTC for ST DTI04 was identified between 
1988 and 1992 (Table 6.6). The temporal lower risk cluster (TLRC) for Group A was 
identified between 1988 and 1990. There was a THRC for Group B inthe same period. Group 
Hex had a TLRC from 2001 to 2004. Group FS had a THRC in the period from 1988 to 1992, 
when compared with other ST DTI 04 isolates (Table 6.6). 
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Table 6.6 The most likely temporal clusters from study groups based on Bernoulli 
distribution at the NHS board level. 
Compared groups 
Group ST and non Group ST 
Group ST104 and Non-Group ST104 
Group A and Non-Group A 
Group Hex and Non-Group Hex 
Group FS and Non-Group FS 
Relative rate 
0.775 
0.181 
0.328 
0.529 
10.450 
P-value Duration 
0.001 1997-01 
0.001 1988-92 
0.001 1988-90 
0.001 2001-04 
0.001 1988-92 
6.3.8 The most likely clusters from spatial cluster analysis based on the Bernoulli model 
at the NHS board level 
The results from the comparison between Group ST and Non-Group ST showed that there 
were three SHRCs and two SLRCs. The centres of the SHRCs were located in the DG, LN 
and OR Health Board while the centres of the two SLRCs were located in the LO and AC 
Health Board (Table 6.7). There were two SHRCs from Group ST DT104 located in the 
eastern and the southern parts of Scotland. The SLRC from Group ST DT1 04 covered the HG 
and GR Health Boards (Table 6.7). 
Table 6.7 The purely spatial clusters from study groups based on Bernoulli distribution at the 
NHS board level. 
NHS Health Boards Relative rate P-value Radius (km) 
Group ST and Non-Group ST 
DG 1.557 0.001 0 
LO 0.781 0.001 0 
AC 0.823 0.001 0 
LN 1.126 0.005 0 
OR 1.625 0.013 0 
Group ST104 and Non-Group ST104 
HG,GR 0.788 0.001 118.3 
DG,AA 1.266 0.001 54.18 
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6.3.9 The most likely clusters from spatio-temporal cluster analysis based on the 
Bernoulli model at the NHS Health Board level 
Table 6.8 shows the most-likely spatio-temporal clusters from the comparisons between pairs. 
In the period from 1988 to 95, there were two identified STHRCs from the Group ST and 
Non-Group ST comparison. The first STHRC covered the DG, AA, LN, BR, and GG Health 
Boards within a radius of approximately 97 km. The second STHRC covered large areas, 
including the northern part of Scotland and the Outer Islands, within a radius of 
approximately 183 km in 1988. After limiting the maximum radius to 100 km, four new 
STHRCs and one new STLRC were generated from the second STHRC. The HG Health 
Boards were identified as STLRCs from 1997 to 2001. The Health Boards of TY and FF 
(1988), GR (1988 - 1990), WI (1999), and OR (1996 - 2002) were identified as STHRCs. 
Following the comparison of the rate of Group ST DT104 with that of Non-Group ST DT104, 
two STLRCs were identified. In the period from 1988 to 90, the first STLRC covered the 
northern part of Scotland within a radius of approximately183 km. The second STLRC was 
identified in the circle of the LN, GG, AA and LO Health Boards within a radius of 
approximately 52 km, in the southern part of Scotland between 1988 and 90. After breakdown, 
the first STLRC generated two STHRCs and one STLRC. The STLRC was located in the HG 
Health Board, 1988 - 1990. A STHRC covered the southern part of Scotland in the period 
1993 to 2000. The two STHRCs were located in the Outer Islands - one STHRC was located 
in the WI Health Board (1999 - 2002) and the other high rank STHRC was located in the OR 
Health Board from 1994 to 96 (p=0.059). 
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Table 6.8 The most-likely cluster from spatio-temporal cluster analysis based on Bernoulli 
distribution at the NHS board level. 
Health Board Relative P Radius Duration 
rate (km) 
------
Group ST and Non-Group ST 
DG, AA, LN, BR, GG 1.367 0.001 97.61 1988-95 
HG, GR, WI, TY, FV, FF, OR, AC 1.963 0.001 183.84 1988 
Radius < less than 100km 
DG, AA, LN, BR, GG 1.367 0.001 97.61 1988-95 
TY,FF 2.242 0.001 43.98 1988 
GR 1.528 0.001 0.00 1988-90 
WI 3.726 0.002 0.00 1999 
HG 0.580 0.020 0.00 1997-01 
OR 2.183 0.043 0.00 1996-02 
Group ST104 and Non-Group ST104 
HG, GR, WI, TY, FV, FF, OR, AC 0.044 0.001 183.84 1988-90 
LN, GG, AA, LO 0.075 0.001 52.45 1988-90 
Radius < less than 100km 
GG, FV, LN, AA, AC, LO, FF, TY, DG 2.600 0.001 97.61 1993-00 
HG 0.000 0.001 0.00 1988-90 
WI 2.586 0.001 0.00 1999-02 
OR 2.281 0.059 0.00 1994-96 
6.3.10 The most likely clusters from spatial cluster analysis based on Bernoulli 
distribution at the postal district level 
Table 6.9 shows the spatial clusters from the different comparisons. Figure 6.8 shows the 
SHRCs and Figure 6.9 shows the SLRCs from the comparison between different pairs. After 
Group A and Non-Group A were compared, the centre of the first SHRC, A-B-S-01, was 
located near Tomintoul, GR with a radius of approximately 77 km. There was an SLRC, A-B-
S-02, located in Lothian with a radius of approximately 2 km. The third SHRC, A-B-S-03, 
had a centre located south of Hamilton, GG with a radius of approximately 20 km. The circle 
covered Wi shaw, ML2 and Lanark, ML 11. 
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Table 6.9 The most-likely spatial clusters from the comparison between different pairs; order 
in rank. The study was based on Bernoulli model at the NHS Health Board level. 
Names P-value 
Group A and Non-Group A 
A-B-S-01 0.001 
A-B-S-02 0.013 
A-B-S-03 0.056 
Location 
57.267067 N, 3.414077 W 
55.880638 N, 3.159124 W 
55.638416 N, 3.812780 W 
Group Hex and Non-Group Hex 
Hex-N-01 0.001 54.939037N, 4.189730 W 
Hex-N-02 0.001 56.367844 N, 4.079036 W 
Group FS and Non-Group FS 
FS-N-01 0.001 55.900124 N, 3.144440 W 
FS-N-02 0.001 55.815506 N, 4.365403 W 
Radius (kIn) Relative risk 
77.3 1.106 
2.35 0.398 
20.66 1.103 
89.84 
70.11 
0.00 
2.19 
1.279 
0.841 
18.493 
11.124 
There were two THRCs and one TLRC identified in the comparison of Group Hex and Non-
Group Hex. The THRC Hex-N-01 was located in the DG7 postal district, the southern part of 
Galloway Park, DG, covering Stramaer and Dumfries. Hex-N-03 was located in the AB34 
postal district, with a radius of 46 km and covering the area from the western side of 
Aberdeen to Glenmore Forest Park. The centre of the single TLRC, Hex-N-02, was located in 
the PH6 2 postal district, near Comrie with a radius of 70 km. The circle covered the central 
belt of Scotland. 
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Figure 6.8 Spatial distribution of identified significant SHRCs of study groups based on 
Bernoulli model in Scotland, 1988 - 2004. 
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Figure 6.9 Spatial distribution of identified significant SLRCs of study groups based on 
Bernoulli model in Scotland, 1988 - 2004 
CHAPTER VI 147 
Comparing Group FS and non Group FS, there were two identified THRCs. The first, FS-N-
01, was located in the EH178 postal district, Edinburgh, LO, with six observed isolates, 
greater than the expected 0.34. The second THRC was centred near Nitshill within a radius of 
2 lan, an area which covered the G53 7, PA27, G53 5, and G78 1 postal districts. 
6.3.11 The most likely clusters from spatio-temporal cluster analysis based on the 
Bernoulli model at the postal district level 
Table 6.10 and Figure 6.10 show the spatio-temporal clusters from the different comparisons. 
The first, A-B-Ol, had a centre located in the DD8 postal district, near Glamis, Dundccn, TY 
with a radius of approximately 102 km in the period from 1988 to 1990. The circle covered 
Stirling, Perth, Dundee, the northern site of Edinburgh, and the southern side of Aberdeen. 
The second, A-B-02, was located in the G41 postal district, near Pollokshaws, Glasgow, GG, 
with a radius of approximately 4 km between 1999 and 2000. The north/south range of this 
area was from Kingston, G 1 to Giffnock, G46. The east/west range of this area was from G73 
to G52. In more general terms, the area was located in the marginal position of the Greater 
Glasgow Health Board. (Figure 6.10). 
There was one STLRC, Hex-N-Ol, identified in the comparison of Group Hex and others. The 
centre of the circle was located in the PH6 postal district, near Dunira, FV, within a radius of 
approximately 70 lan from 2001 to 2004. The area covered the central belt of Scotland, which 
was the same as the comparison between Group A and others. 
A STHRC, FS-N-Ol was identified in the comparison of Group FS and others. The centre of 
the STHRC was located in north-eastern Scotland (near Aberdeen) within a radius of 206 km 
in the period 1988 to 1992. After the maximum radius was limited to 100 km, one STHRC 
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was identified (FS-N-100-01). The centre of the circle was located near Edinburgh within a 
radius of approximately 99 km (Figure 6.10). The area covered the middle and the southern 
parts of Scotland. 
Table 6.10 The spatio-temporal clusters from study groups based on Bernoulli model at the 
postal district level. Clusters were listed according to the ranks from the model. 
Name P-value Location Radius Relative Period 
rate 
Group A and Non-Group 
A 
A-B-01 0.001 56.600147 N, 3.000730 W 101.92 0.221 1988-1990 
A-B-02 0.001 55.828152 N, 4.282462 W 4.13 0.101 1999-2000 
Group Hex and Non-Group Hex 
Hex-N-01 0.001 56.367844 N, 4.079036 W 69.81 0.378 2001-2004 
Group FS and Non-Group FS 
FS-N-01 0.001 57.675259 N, 2.960798 W 205.9 11.735 1988-1992 
Radius <100km 
FS-N-100-01 0.001 56.105236 N, 3.161780 W 99.10 10.307 1988-1992 
FS-N-100-02 0.063 57.166752 N, 2.153729 W 10.05 24.245 1988-1991 
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Figure 6.10 Spatio-temporal distribution of identified significant STHRCs and STLRCs from 
study groups using the maximum cluster size < 50% of the total population in Scotland, 
1988 - 2004. 
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6.4 DISCUSSION 
E. coli 0157 has been investigated with regard to the case distribution in space at both animal 
health district and postal district levels (Toft et al. 2005; Ternent 2002). These studies 
suggested that to use a spatial scale with more regions is more complex but can reveal 
aggregations which may be invisible at a higher level structure (Toft et al. 2005). On the other 
hand, a study at a higher level may avoid problems caused by small sample sizes and missing 
data (Toft et al. 2005); may be time-saving and may still provide the necessary 
epidemiological inference for intervention. The current study has supported these 
observations. It has shown that the results at both geographical levels were similar in the 
higher case area, where the cases aggregate together, but were heterogeneous and most likely 
misleading where there were smaller higher/lower risk clusters analysed at a higher level of 
resolution. 
Ideally, one would hope that the results at the two different geographical levels would be the 
similar. However, contrasting the NHS Health Board and the postal district levels, the results 
appear to be affected by variances within and between areas. There are several reasons; 
SaTScan tries to achieve as large a cluster as possible and maximises the circle that can fit the 
criteria given, such as 50% population. Thus, a most likely circle can be represented as a 
centre without any cases at the centre but with many smaller clusters at the margin of the 
circle (Kulldorff and Nagarwalla 1995). The problem arose particularly in the results from 
Highlands and the Island areas. The HG Health Board usually had fewer incidents, but the 
Outside Islands had more incidents. The results may then show an incorrect HRC/LRC 
including the HG, GR, OR, and SH Health Boards. with the centre located in the HG Health 
Board. The problem may be overcome by changing the criteria by limiting the radius or 
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reducing the percentage of the population covered, but this too presents problems as choosing 
these parameters is somewhat subjective. One benefit of using analysis at the NHS Health 
Board level is that it is less likely to compromise patient confidentiality; another is that 
missing addresses play less of a role as the case is assigned at NHS board level only. 
Implementing the study at the postal district level also has benefits - it limits clusters to a 
smaller zone, so, where a higher rate cluster is found, a small scale investigation could be 
carried out in a short time. Further advantages include easier identification of an outbreak and 
the avoidance of mis-understandings caused by geographical issues. For example, the 
Grampian Mountains are located in the middle of Scotland and not many people live in this 
area and so the incidence would be very small. The higher rate clusters at postal district level 
usually did not include the mountains. In contrast, the centres of the lower rate clusters were 
located around mountains. 
Mis-understandings usually occur where there is no prior knowledge of the study areas. 
However, in this study it was known a priori where topographical features were likely to 
affect population density and these influence the distribution of clusters. The results based on 
the Poisson model showed the LRCs were usually located in the Highlands or surrounding 
area and the HRCs were located in the southern and eastern parts of Scotland; this is of some 
comfort. 
From the cattle census at postal district level, a large number of cattle are found in Dumfries 
(DG8, 7, 2, 11 and ML17), Grampian (AB54, 53,41 and 51), and the Orkney Islands. The 
fact that the results in this study show higher rate clusters following a similar distribution to 
the cattle distribution rather than population density per se provides evidence similar to that 
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found in the case of E coli 0157 (Ternent 2002). Calvert concluded that 37.8 per cent of 
submissions from DG may have regular contact with cattle (Calvert et al. 1998). However, 
caution is required; cattle density is an index of rurality and it may be that it is this feature 
alone that is being identified. 
A virulence gene was identified from plasmids in multi-resistant types (Threlfall et al. 2005). 
The ApClSpStSuTe R-type was the main isolate from Scottish humans from 1991 to 2004. 
However, some scientists believe the general ApClSpStSuTe R-type is not a hyper-virulent 
strain, rather, it has a better ability to survive. The rpoS (Loewen and Hengge-Aronis 1994), 
qacEL1 (Cloeckaert et al. 2000), and marA (George and Levy 1983) all enhance its survival 
ability. High virulence also means that a strain can spread more widely and survive longer. 
From the comparison results in the Bernoulli study, Group A and its subgroups had a wider 
circle and the multi-antibiotic resistance phenotypes appear to have a greater possibility of 
occurring in livestock areas. The results also suggest that the survival ability in Group A may 
be better. The study overall also supports the suggestion that Group B was more associated 
with urban areas, transferred more slowly and tended to be self-limiting. Accordingly the radii 
were usually small and the relative risks were usually near 1. On the other hand, Group FS 
had higher relative risks in temporal and spatio-temporal studies. 
A disease can be epidemic or endemic. In an endemic disease, there are no higher/lower rate 
clusters in a purely temporal study. The results in this study showed that lower risk clusters 
were identified in the temporal cluster study of the Salmonella and ST groups. Control 
measures against salmonellosis, especially S. Enteritidis, were introduced from 1994. In 1994, 
S. Enteritidis PT 4 vaccine was introduced into broiler breeders. In 1997, live attenuated S. 
Enteritidis vaccine was allowed in egg-laying flocks (Defra 2003). Although vaccines were 
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used against S. Enteritidis, the purely temporal study for ST DT104 supports the argument 
that other factors could be responsible for the decline from 1998. For Groups Hex and FS, the 
purely temporal results support the contribution of other factors - improvement in catering 
practice, a cool summer, and lighter contamination of uncooked foods have all been suggested 
(Scottish Centre for Infection and Environmental Health 1999; Handysides 1999). 
The argument about the advantages and disadvantages of the Bernoulli and Poisson models is 
the same as for the cohort and the case-control study. Generally, the results of the two models 
should be very similar (Kulldorff and Nagarwalla 1995). The Poisson model is more suitable 
for dealing with a rare disease because, by using the whole population as the denominator, it 
has greater statistical power (Kulldorff 1997). The results showed that the two studies had 
similar results. However, the Poisson model was able to identify more clusters, especially 
those clusters in Group B and its subgroups. 
In summary and considering the results as whole, the dual approach of spatial resolution and 
adopting the two different modelling approaches, has permitted the identification of high and 
low risk clusters in space, time and space-time. The key issue is that there is some 
heterogeneity when one considers the groups of Salmonella as outlined in this and other 
chapters. It is vitally important not to over-interpret the individual results as issues of data 
quality, choice of time unit, data sparsity, statistical power and spatial resolution will prevent 
individual analyses from being particularly robust. Suffice to say, in this chapter, that there 
are differences, that these differences are consistent and will be interesting to revisit in the 
light of analyses based on the animal isolates. 
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Salmonella is an important pathogen associated with significant morbidity and mortality in 
livestock. In 2003, Salmonella Typhimurium (ST) was the second most common 
Salmonella serotype in England and Wales (Defra 2003). Economic loss caused by ST is 
considerable, consisting not only of animal mortality costs but also of disinfection costs, 
which, in a 400 sow farm with ST, may amount to £9,608 in a 3 week period (Anon 
2007d). Clearly, ST infection in livestock needs to be controlled by the most efficient 
means possible. 
Ever since antimicrobial drugs were first used to control bacterial infections in livestock, 
the development of antibiotic resistance has been inevitable (Henney 2007). Antibiotic 
resistance genes can be single gene segments or many genes located together, called gene 
cassettes, in a bacterial genome or in R-plasmids. The gene cassette can move among 
species via conjunction or simple direct intake from the environment (Tortora et al. 2001). 
A gene cassette called the Salmonella genomic island 1 containing 5 antibiotic resistance 
genes against ampicillin (Ap), chloramphenicol (Cl), spectinomycin (Sp), streptomycin 
(St), tetracycline (Te) and sulphonamide (Su) has been identified in a clone of S. 
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Typhimurium DT 104 (ST DT104), referred to as R-type ACSSuT (ThrelfaIl2000). When 
ST DT104 was identified in 1985, it was not a major concern because it did not contain 
any resistance genes. However, since the penta-resistant form of ST DT104 was discovered, 
the prevalence of multi-drug resistant ST DT104 in livestock has been increasing gradually 
(Browning et al. 2001 b; Browning et al. 2004; Browning et al. 2005; Browning et al. 2003; 
Browning et al. 1999). Antibiotic use has been shown to influence the increase of resistant 
strains ofST DT104 in humans (Threlfall et al. 1994); thus, it is essential to understand the 
ecological and epidemiological patterns of ST DT1 04 infection in animals. 
The aims of the study described in this chapter are to describe the epidemiology of 
Salmonella isolates from the animal population and veterinary sources in Scotland from 
1990 to 2004 and to describe the antibiotic resistance patterns of all Salmonella isolates 
collected from veterinary sources in Scotland from 1990 to 2004. 
7.2 MATERIAL AND METHODS 
Salmonella isolates come from widely differing veterinary sources, ranging from animals 
and foodstuffs to environmental samples, collected via a passive surveillance system. Since 
1993, Defra publications have separated Salmonella reports from livestock into isolations 
and incidents, as detailed in Chapter 2 (Defra 2003). 
All records were kindly supplied by HPS. Data were re-checked using EXCEL version 
2000. Table 7.1 lists the relevant variables used in this study. The original dataset did not 
contain the date the sample was received. The reference numbers included the year and 
week of submission. A new variable, week, was generated from the reference numbers. 
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The week ranged from 1 to 53 and the week number was used as the minimum time 
interval. Thus, a year was divided into 13 four-weekly months. The 53rd week was 
assigned to the 13th four-weekly month. 
The antibiotic resistance patterns were re-coded as 1/0 where 1 referred to resistant and 0 
referred to sensitive. R-type scores were used as described in Chapter 4. The calculation 
method for the resistance score was the same as described in Chapter 4. The variable 
"pathogen" was re-assigned into 3 categories: S. Typhimurium, S. Enteritidis, and others. 
Table 7.1 The description of variables used in the study 
Variables 
Pathogen 
Type 
Year 
NO 
Source 
Trues ource 
Lab source 
Resistant pattern 
Week 
Pathogen2 
Description 
Serotype of Salmonella 
Phage types of Salmonella Enteriditis and 
Typhimurium 
The year of collection 
The collection number - contains the reported week 
Which animal the case is from 
The categories of animal 
The veterinary laboratory of isolation 
The 15 antibiotic resistance patterns 
The week the case was reported to laboratory 
S. Typhimurium, S. Enteritidis, and Others 
In this study data quality and issues of confidentiality precluded using data at a fine level 
of spatial resolution. As a consequence, the Animal Health Divisions defined by the 
Scottish Agriculture College (SAC) were used as the unit of spatial aggregation (Ternent 
2002). Scotland is divided into six animal health divisions: Highland, North East, Central, 
South West, South East and Islands (Figure 7.1). Cases reported by laboratories were 
assumed to have occurred in the corresponding Animal Health Divisions and were 
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Figure 7.1 The regions of the Animal Health Divisions. 
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allocated accordingly. However, there is no laboratory in Islands and samples sent from the 
Islands were allocated into Highlands. 
All data manipulation and basic statistical analysis were carried out in Microsoft Excel 
version 2000. 
7.3 RESULTS 
7.3.1 The trend of Salmonella, Salmonella Typhimurium, and Salmonella 
Typhimurium DT 104 in Scotland between 1990 and 2004 
7.3.1.1 Sources of Salmonella cases 
There were 12,384 Salmonella spp isolations reported from 1990 to 2004. All isolates were 
sorted into 19 categories ascribed by HPS (Table 7.2). The avian category contained 38 
species of birds; the majority were caged birds and wild birds. In this category, 197 
samples were from pigeons, 337 from pheasants and 272 from wild birds. The 
miscellaneous animal category contained 21 species, but the samples were mainly from 
porpoises (1 09 samples). The zoo animal category had 10 species. The reptile category had 
19 species and cases were mainly from snakes (44). The feed category contained meal 
samples from three groups: poultry, fish and other animals, including samples from 
chicken products and mussels. The 'other water' category referred to water samples 
collected from reservoirs. The environment category contained 7 isolates from 
environments surrounding animals. 
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Table 7.2 The Salmonella spp. submissions to SSRL from each animal category during the 
study period. 
SOURCE Typhimurium Enteritidis Others Total 
BOVINE 2985 41 1932 4958 
POULTRY 194 878 3072 4144 
PORCINE 338 2 153 493 
OVINE 160 1 727 888 
CAPRINE 2 2 
EQUINE 83 5 10 98 
AVIAN 759 50 332 1141 
CANINE 94 12 95 201 
FELINE 84 16 13 113 
PHEASANT 1 1 
CERVINE 1 1 
ZOO ANIMAL 10 1 5 16 
REPTILE 1 3 115 119 
OTHER WATER 1 1 
MISC.ANIMAL 25 17 145 187 
ANIMAL 7 7 ENVIRONMENT 
FOOD 4 4 
FEED 8 8 
NOT STATED 1 1 2 
Total 4736 1026 6622 12384 
There were many Salmonella serotypes identified throughout the study period. More than 
one third of all Salmonella samples were from cattle samples. A further third of samples 
were from poultry (Table 7.2). Almost all S. Enteritidis isolates were obtained from poultry 
samples (878/1 026). In contrast, most cases of ST were from cattle (Table 7.2). Only 194 
samples of ST were of poultry origin. 
Table 7.2 shows that 94% of all Salmonellae cases (11,624 isolates) were from five main 
animal categories, bovine, poultry, avian, ovine and porcine; 4,736 samples were reported 
as ST, 2,985 of which were bovine related. The table also shows poultry isolates were 
mainly reported as non-ST. 
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The Salmonella spp. samples reported per year from the 5 animal categories are listed in 
Figure 7.2. It shows that there was an overall decline from 1993 to 1999, when only 284 
cases were recorded by HPS. Isolates related to bovine sources were low in 1993 and 1998, 
respectively. However, isolates from poultry sources increased between 1995 and 1998. 
After 2000, the total submissions declined. There were fewer isolates sent from poultry 
samples; only 31 and 39 samples from poultry sources were sent in 2000 and 2001, 
respectively. 
In 2002, there were 676 reports of Salmonella from different animal sources. This 
represents an increase of 30% compared with the previous years (Figure 7.2). The increase 
was due to isolates from cattle, which increased by almost 200% in 2002 (458) compared 
to 2001 (165) (Figure 7.2). There were only 3 poultry isolates sent to SSRL from 2003 to 
2004. 
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Figure 7.2 Chart showing the animal sources of Salmonella spp. submissions to SSRL 
from 1990 to 2004. 
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Figure 7.3 shows the number of submissions for Salmonella, ST and ST DT104, 
respectively. The Salmonella submissions declined in 1993, mainly caused by the decline 
in S. Enteritidis submissions. In 1997, the Salmonella submissions were the highest with 
1431 isolates recorded. After 1997, the submissions of Salmonella spp. declined again. The 
number of isolations dropped in years 1993 and 2000, increasing again the following year. 
The trend for ST DT104 was not similar to others. It had only 8 isolates in 1990, with 
numbers rising from 1991 , with 509 the highest recorded number of isolates in 1994. After 
1994, the submissions began decline with only 21 isolates in 2004. 
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Figure 7.3 The submissions of Salmonella, ST and S. Enteritidis to SSRL in Scotland, 
1990-2004 
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Figure 7.4 shows that trend of the proportion of ST DT104 in the isolates rose in 1991 and 
1994. In 1994, 509 isolations in ST (about 80%) were of ST DT1 04. The isolation numbers 
and proportion of ST DT1 04 declined gradually after 1994. 
There were 47 different phage types of S. Typhimurium isolated from Scotland throughout 
the study period and the proportions varied over time. However, there were 5 main phage 
types. In 1990, ST phage type 204c was the most common phage type. ST DT104 became 
predominant in 1992. The proportion of ST DT104 declined in 1994 and then ST Phage 
type 40 replaced it as the major type from 2000 (Figure 7.4). 
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Figure 7.4 The phage types ofST submissions to SSRL in Scotland, 1990-2004. 
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Figure 7.5 shows the submissions in every four-week month from 1990 to 2004. Generally, 
the figure shows that there were 2 peaks in each year, the first peak was recorded in the 5th 
or the 6th four-week month. The second peak OCCUlTed in the 11 th or 12th four-week month. 
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Figure 7.5 The submissions from S. Typhimurium in each four-weekly month period, 
Scotland, 1990-2004 
7.3.1.2 Salmonella Typhimurium DTI04 
Tables 7.3 and 7.4 show that ST DTI04 was isolated from 11 different categories and 38 
animal species. There were a total of 1,930 bovine submissions, with half of the isolations 
(1094) from the South West Division. The region includes Dumfries, Ayr, and Paisley, and 
is a traditional livestock area. The preponderance of submissions from cattle was reflected 
in the correlation of the total number of ST DTI04 with the number from bovine sources, 
whether analysing by Animal Health Division (p=0.001) or year. 
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Table 7.3 The ST DT104 submissions from cattle and total cattle numbers in each Animal 
Health Division, Scotland, 1990-2004. 
Animal Health Divisions Cattle Total Cattle population Cumulative % (2003) 
Highland 177 217 151,019 0.117 
North East 244 370 368,998 0.066 
Central 164 242 511,044 0.031 
South East 339 514 198.996 0.170 
South West 1006 1094 569,148 0.177 
Total 1930 2437 
*Islands has 106,115 cattle, the population were added into the Highland animal district 
Table 7.4 shows the ST DTI04 submissions from different sources in each year. ST DTI04 
isolations were mainly reported from bovine sources (80%); the second most common was 
from pigs. 
Table 7.4 Reported numbers of isolates of ST DT1 04 by species in the SSRL animal 
dataset, Scotland, 1990-2004 
Misc. Zoo 
YEAR Avian Bovine Canine Caprine Equine Feline Animal Ovine Porcine Poultry Animals Total 
1990 7 1 8 
1991 3 108 1 2 3 117 
1992 1 105 4 6 3 1 2 1 123 
1993 147 2 2 3 10 164 
1994 5 452 4 4 3 4 11 23 2 1 509 
1995 10 388 11 1 3 13 1 30 10 12 479 
1996 2 284 11 11 9 2 22 9 8 1 359 
1997 1 209 12 5 13 3 13 12 4 6 278 
1998 1 87 4 4 8 6 22 8 1 141 
1999 49 1 1 2 9 6 49 117 
2000 36 2 2 1 2 9 5 57 
2001 1 25 8 7 41 
2002 6 1 1 3 11 
2003 7 1 1 3 12 
2004 20 1 21 
Total 24 1930 53 1 38 53 15 102 117 95 9 2437 
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Table 7.5 describes the ST DTI04 submissions from veterinary sources in each of the 13 
four-week periods. The seasonal trend was not significant between 1994 and 1997 but 
there were usually smaller peaks in the 6th and the 10th period. The first peak usually 
occurred from the 2nd to the i h period. The second peak usually occurred from the 10th to 
the 13th period. 
Table 7.5 The ST DTI04 submissions reported in each four-weekly month from animal 
sources, Scotland, 1990-2004 
Four-
weekly 
period 1990 1991 1992 1993 1994 1995 1996 1997 1998 199920002001200220032004 Total 
1 2 4 2 12 19 35 11 6 4 1 11 1 1 1 110 
2 7 8 10 10 22 30 16 8 1 11 1 4 128 
3 11 8 10 25 25 26 17 12 12 1 1 1 149 
4 2 8 5 26 41 29 18 6 5 2 1 1 144 
5 4 9 18 33 38 42 35 12 13 3 1 4 212 
6 4 13 10 41 56 43 22 16 18 2 2 1 228 
7 5 4 13 36 50 17 26 19 3 2 3 2 3 1 184 
8 1 3 3 4 45 40 15 25 6 2 6 4 2 3 159 
9 5 8 20 32 26 9 13 12 7 4 9 1 1 147 
10 1 15 9 15 69 38 27 29 18 6 2 2 231 
11 4 27 12 10 54 47 30 18 11 34 3 3 2 2 257 
12 2 16 17 24 55 40 30 16 8 10 4 1 1 224 
13 16 20 23 71 37 26 32 7 14 11 3 1 3 264 
Total 8 117 123 164 509 479 359 278 141 117 57 41 11 12 21 2437 
7.3.2 Antibiotic resistance results 
Table 7.6 shows the R-type score of all ST DTI04 submissions in each year. The hex-
antibiotic resistant form was the most common and there were three R-types belonging to 
this form (Table 7.7), the majority (99.8%) being ApCISpStSuTe The R-type score 7 
contained 7 R-types and 148 samples; many isolates (88.5%) belonged to the 
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ApCINaSpStSuTe(Lc) and ApCISpStSuTeTm R-types i.e., basically, ApCISpStSuTe with 
extra Na or Tm resistances. R-type score 8 was mainly of ApCIGmNeSpStSuTe R-type (8 
samples). Throughout the study period, the number of the fully sensitive type, FS, was very 
small. Moreover, only 50 isolates had R-type scores of 0 - 3 and all other isolates were 
multi-resistant types. 
Table 7.6 The R-type score of the ST DT 104 submissions from animal sources, 13 
antibiotics were used but the resistance pattern of low level ciprofloxacin was excluded, 
Scotland, 1990-2004 
R -type score 
YEAR 0 1 2 3 4 5 6 7 8 9 10 Total 
1990 1 1 6 8 
1991 2 1 1 1 108 4 117 
1992 4 1 116 1 1 123 
1993 5 1 153 1 4 164 
1994 4 1 1 6 4 5 469 18 1 509 
1995 1 3 1 450 22 2 479 
1996 3 5 326 20 4 1 359 
1997 2 2 242 30 1 1 278 
1998 1 2 1 118 14 6 1 143 
1999 2 1 102 10 1 1 117 
2000 1 53 3 57 
2001 24 16 1 41 
2002 6 5 11 
2003 1 1 7 3 12 
2004 1 18 2 21 
Total 22 2 8 18 8 9 2198 148 17 7 2 2439 
Table 7.7 presents the resistance patterns identified throughout the study period. Isolates 
resistant to Lc were listed separately, although, they were grouped into one R-type. There 
were 25 R-types identified, despite the difference in Lc pattern. Most of the cases belong 
to the ApCISpStSuTe R-type. The second most common R-type was ApCISpStSuTeTm. It 
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Table 7.7 R-types ofST DT104 identified from animal sources, Scotland, 1990-2004 
Antimicrobial 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 Total 
FS 2 4 5 4 2 2 22 
Te 2 
SpSu 
SuTm 1 
ApSu 3 2 6 
SpStSu 4 3 5 2 16 
SuTeTm 2 2 
ApC1SpSt 1 1 
ApSpStSu 
ApStSuTe 3 6 
ApC1SpStSu 1 
ApSpStSuTe 2 
C1SpStSuTe 2 2 
ApC1SpStTe 1 
ApC1SpSuTe 
ApKaStSuTe 
KaSpStSuTe 
ApC1SpStSuTe 6 108 116 153469450323241 118 102 53 24 6 7 18 2194 
ApC1FzSpStSu 1 
ApNaSpStSuTe 3 3 
ApC1GmSpStSuTe 5 5 
ApC1KaSpStSuTe 3 7 
ApC1NaSpStSuTe 9 6 4 19 
ApC1NaSpStSuTeLc 2 2 4 12 2 22 
ApC1NeSpStSuTe 
ApC1SpStSuTeTm 16 18 10 16 8 5 3 4 5 3 90 
ApCIFzSpStSuTe 3 4 
ApC1NaSpStSuTeTm 4 4 
ApC1NaSpStSuTeTmLc 2 2 
ApC1KaSpStSuTeTm 
ApC1GmNaSpStSuTe 1 1 
ApC1GmNeSpStSuTe 2 3 8 
ApC1CpNaSpStSuTeLc 1 
ApC1GmKaNeSpStSuTe 4 5 
ApC1KaNaSpStSuTeTmLc 
ApC1GmKaNeSpStSuTeTm 2 
ApC1GmNaNeSpStSuTeLc 1 
Total 8 11712316450947935927814311757 41 11 12 21 2439 
Types 3 7 5 5 16 8 10 10 8 8 3 4 2 2 4 
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was first isolated in 1991 but high numbers (90) were recorded in 1994. The SpStSu 
R-type was isolated 16 times after 1994 and was in 4th position behind the fully 
sensitive type. Since 1996, nalidixic acid resistance has been found in three R-types, 
ApClNaSpStSuTe, ApClGmNaSpStSuTe, and ApClNaSpStSuTe (Table 7.7). Nine R-
types had Na resistance. Despite the resistances against Tm, Na, Ap, Cl, Sp, St, Su, 
and Te, other drugs were still effective against the ST DT104 isolates collected from 
the animal dataset. The number of R types found every year was different. From 1994 
to 1999, more than 8 R-types were reported every year. In 1994, there were 16 
R-types. Overall, two R-types, ApClSpStSuTe and ApCISpStSuTeTm, were usually 
identified every year. 
Figure 7.6 shows the numbers of isolates resistant to each antibiotic from the animal 
ST DT104 submissions. According to the results shown in Figure 7.6 and Table 7.8, 
antibiotics can be separated into two sub-groups; high and low antibiotic resistance 
groups. The first group included Ap, CI, Sp, St, Su and Te. The number of isolates 
resistant to those antibiotics sharply increased from 1991 and, from 1993 to 1994, the 
numbers more than doubled. The highest number was recorded in 1994. Thereafter, 
the numbers decreased, falling to less than 50 in 2004. The other antibiotics including 
Cp, Fz, Gm, Ka, Na, Ne, and Lc formed another group. The number of isolates 
resistant to single antibiotics in this group were usually few in each year. Generally, 
the two groups had very similar trends and patterns. 
169 
CHAPTER VII 170 
500 '~ 
450 
400 
350 
300 \ -+- AP --- CL CP ---><- FZ -+- GM 
tl -+- KA 
a 250 
:l -+-NA 
Z 
200 - NE_ 
- SP 
150 
100 
ST 
SU 
-- _/ 
50 l / 
0 
TE 
TM 
~'~~ ~~! ~ fa • --;;;;;-j. .':~~. iai -" , 
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 
Years 
Figure 7.6 Trends of samples resistant to 13 antimicrobial agents, Scotland, 1990-
2004 
170 
I, 
CHAPTER VII 171 
Table 7.8 The cumulative ST DT104 submissions from animal sources for each single 
antibiotic treatment, Scotland, 1990-2004 
YEARAp CI Sp St Su Te Tm Gm Ka Na Ne Fz Cp Lc Total 
1990 7 6 6 7 7 7 0 0 0 0 0 0 0- 8 
1991 121 119 119 120 121 122 1 0 0 0 0 3 0- 125 
1992 240 237 237 239 240 241 2 1 0 0 1 3 0- 248 
1993 399 395 395 398 399 400 2 6 5 0 6 3 0- 412 
1994 894 888 893 899 901 898 21 7 8 0 7 4 0- 921 
1995 1369 1362 l371 1377 1380 l373 40 9 11 0 10 4 0- 1400 
19961723 171017271733 17391724 51 14 l3 l3 14 4 0- 1759 
1997 1997 1984 2003 2009 2015 1997 67 21 14 22 16 5 0 3 2037 
1998 2137 21212141 21472155 2134 81 22 15 34 17 5 0 7 2178 
19992251 22352256226222702248 88 22 18 39 17 5 0 12 2295 
200023072291 2313 231923272304 91 22 18 39 17 5 0 12 2352 
2001 234823322354236023682345 95 22 18 52 17 5 1 25 2393 
20022359234323652371 23792356 100 22 18 52 17 5 1 25 2404 
20032369235323762381 23902366 103 22 18 52 17 5 1 25 2416 
2004239023732397240224112387 103 22 18 54 17 5 1 27 2437 
% 98.0 97.3 98.3 99.0 99.0 98.0 4.2 0.9 0.7 2.2 0.7 0.2 0.04 4.2 
7.4 Discussion 
The trend in Salmonella isolations set out in this chapter could be influenced by many 
factors: the number of Salmonella isolates from veterinary sources sent to laboratories; 
changes in serotypes of Salmonella in a year; changes in the recording system; 
changes in the animal population and changes in the Food Hygiene legislation and its 
implementation. 
Samples of Salmonella infection were sent from a wide range of veterinary sources, 
including foodstuffs, animals, and environment. Clearly, if more samples from one 
group were sent, the major serotype in that group would occupy a larger proportion of 
the total population of isolates. For example, poultry constituted the main contributors 
to S. Enteritidis but S. Typhimurium was mainly from bovine sources. Thus, when 
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isolates from poultry in a year were higher than the isolates sent from cattle, the 
isolates from S. Enteritidis were predominant. Submissions could also be affected by 
non cyclical or unexpected seasonal factors. For example, the submissions from sheep 
fell because of the dry summer between 2003 and 2004 (Browning et al. 2005). 
As the ST submissions were mainly from bovine sources, the decline or increase in 
the number of samples from cattle also modified the trend. Cattle isolates fell 
considerably between 1998 and 2003, a drop which may have been related to 
movement restrictions put in place due to an outbreak of Food and Mouth Disease 
(FMD). 
In addition, many poultry submissions were from the poultry surveillance system and, 
as such, the submissions were not clinical cases. Any change in this system would 
affect the number of isolates sent to laboratories. After 1993, laws were modified. 
Before 1993, under the Zoonoses Order 1989, Poultry Laying Flocks Order 1989 and 
Poultry Breeding Flocks and Hatcheries Order 1989, owners of poultry farms were 
forced to test for Salmonella. At the end of 1993, a decline in reported S. Enteritidis 
from the poultry industry resulted in the removal of this requirement (Defra 1999; 
O'Brien and de Valk 2003). In 1994, a S. Enteritidis PT 4 vaccine was introduced into 
broiler breeders. In 1997, live attenuated S. Enteritidis vaccine was allowed for egg-
laying flocks and then in 2000, the Lion Quality Stamp was introduced as well (Defra 
2003). All of these interventions will have reduced submissions from poultry 
livestock (Browning et al. 2001a). From 1993 to 1999, poultry isolates from the non-
statutory surveillance system were high. However, since 2000, the proportion of 
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incidents resulting from non-statutory surveillance has decreased (Defra 2003), thus 
modifying the trend from 1993 to 2000. 
The decline of submissions from animals may be a consequence of a reduction of 
disease in animals or a lack of case submissions because of economic pressures; for 
example, one impact may have been BSE (Browning et al. 1999). A slaughter order 
for cattle in 1997 was implemented against BSE. The order is likely to have directly 
reduced the number of samples sent to laboratories. The results in this chapter show a 
decrease in submissions from bovine sources in 1998 and 1999. Another example is 
the reduction of isolates from cattle in 2001, possibly due to the Foot and Mouth 
Disease outbreak (Browning et al. 2003). 
The introduction of a ban on feeding mammalian meat and bone meal to livestock in 
March 1996 may be another factor in reducing Salmonella infections. The rate of 
contamination of domestic processed animal proteins with samonella has decreased 
from 25% in 1993 to 2.1 % in 2000 (Defra 2003). This would appear to parallel the 
decline of Salmonella infections reported here. 
Changes in the record structure used in this study are documented (Defra 2003) and 
the effect of this is difficult to assess. 
The trend of ST 
Factors which may influence the trend in Salmonella submission rate may also affect 
the trend in ST. ST was mainly isolated from cattle so the decrease in bovine 
submissions would result in a decline in the number of ST. The bovine submissions 
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were affected by BSE and FMD during the study period. The cattle population in 
Scotland remained stable from 1990 to 2004 according to the SERAD census records, 
except for a small drop in 2002; it is therefore more likely that submission rates were 
affected by economic pressures or possibly, in the case of FMD, movement 
restrictions rather than either numbers of cattle or fundamental changes in the 
prevalence of infection. However, again, this will remain a moot point. 
Phage type change may be related to the antibiotic usage 
ST DT104 replaced phage type 204c as the major ST phage type from 1992 to 2001; 
subsequently phage type 40 emerged. Although it is difficult to ascertain why the 
major phage type changed, the historic data suggested that antibiotic usage may be a 
possible reason. The most common phage types have changed many times since 1969 
(Anon 1998). In 1969, ST DT 29 was the most common multi-resistant type in 
humans and cattle. It was related to the use of apramycin, which is a similar 
compound to gentamicin (Anon 1998). Then, the third wave was caused by ST DT1 04 
and is presented in the current study. Its replacement by DT 40 would be another 
interesting topic for future research. 
Seasonal effects were not very significant in the submissions from animal sources 
Throughout the study period, two seasonal peaks were identified. However, a 
significant pattern was not observed in every year. From 1994 to 1998, the time series 
showed that the ST DT104 isolations were similar in every four-week period. The 
observation is similar to a publication in 1999, which mentioned that there was no 
significant seasonal effect for the samples from veterinary sources (Browning et al. 
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2001 b). There were a lot of ST DT 104 isolations from 1994 to 1998; a seasonal effect 
may have been masked by a larger "epidemic" of submissions. 
The south of Scotland had higher prevalence 
Although it is impossible to trace the original location of submissions, the data 
showed that there was higher prevalence in the south east and the south west animal 
health districts. The results in Chapter 3 also showed that the same areas had a higher 
prevalence of human submissions. From 1993 to 1996, 37.8 % of human ST DT104 
cases reported in the areas were from the people who had regular contact with cattle 
(Calvert et al. 1998). Cattle are the major ST DT104 reservoir and direct transmission 
of ST DT104 from cattle to human has been demonstrated (Calvert et al. 1998; Wall 
et al. 1995). The transmission in rural areas can occur not only by foodborne spread 
but also by direct contact (Calvert et al. 1998). The cluster statistical methods 
employed in the following chapters will test the hypothesis. 
R-score 6 and 7 were the most common R-types 
In total, 2,346 out of 2,439 isolates belonged to R-score 6 and 7 and 2,325 out of 
2,346 isolates were ApCISpStSuTe (2,194), ApCISpStSuTeTm (l09) and 
ApCISpStSuTeNa (22) R-types. The main clone ApCISpStSuTe R-type is 
disseminated across the EU (Threlfa1l2000) and the main reason the R-type score 6 is 
the most common form in this study. The emergence of Tm resistance is believed to 
be associated with the treatment against the ApCISpStSuTe R-type (Threlfall 2000), 
which was the second most common R-type throughout the study period. The third 
most common R-type was the ApCINaSpStSuTe with or without the additional Lc 
resistance. Fluoroquinolones were licensed for therapeutic use in the 1990s and 
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resistant strains found in 1996; enrofloxacin was licensed for veterinary used in the 
UK in 1993 (Threlfall et al. 1996). An increase in fluoroquinolone resistance in ST 
has been described, which parallels the time for which fluoroquinolone has been used 
in veterinary medicine (Threlfall et al. 1996). However, the fact that human usage 
parallels this period is often ignored. 
Aminoglycoside resistance is another important issue. The R-type score 7 had 2 R-
types which had the additional Gm and Ka resistances with the ApCISpStSuTe 
resistance. The active efflux pumps may playa role in moving aminoglycosides out, 
non-specifically. The ApCIGmNeSpStSuTe R-type was found in bovine and ovine 
isolations reported from laboratories located in Thurso, Perth, and Ayr. 
Regardless of the antibiotic in question, the epidemiology of antibiotic resistance 
varies according to three main factors: the size of the population of micro-organisms; 
the pre-exposure prevalence of resistance genes; and the fitness of the selected 
population of micro-organisms in competition with other micro-organisms present in 
the environment which have not been exposed to antibiotics (Georgala et al. 1999). 
These reasons explain why the main R-types would have a better chance of survival. 
The higher the R-type score a strain has, the higher the chance of survival. All the 
above assumptions were based on antibiotics being used constantly in a limited 
population in a limited area and this has almost certainly not been the case in the 
study period or study region. The high number of confounding factors described in 
this chapter make definitive explanations elusive as to why numbers have risen and 
fallen; one would expect the proportion of resistant organisms to increase over time in 
the face of selection pressures. 
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Conclusion 
Although the trends of Salmonella and ST infections from veterinary sources were 
masked by many factors, they showed declines after 1998. The trend of ST DTI04 
was highly related to the isolations of ST DTI04 from bovine sources and may have 
been influenced by other diseases such as BSE and FMD. The surveillance system 
and vaccine programme instigated in poultry livestock have been successful In 
controlling Salmonella infections, at least at the reporting level. The changes of 
resistance patterns remains more elusive and there are many assumptions that must be 
made, even at the most basic level. The relationships among R-types will be the focus 
of study in the following chapters. 
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CHAPTER VIII 
HIERARCHICAL CLUSTER ANALYSIS 
OF ANTIBIOTIC RESISTANCE PATTERNS IN 
SALMONELLA TYPHIMURIUM DTI04 
8.1 INTRODUCTION 
179 
The specific strain S. Typhimurium definitive type DT 04 (ST DTI04) has been isolated 
widely from humans, cattle, goats, sheep, fish, pets and wild animals (Browning et al. 2005; 
Threlfall 2000). The phage type is well known for its genome containing a cassette containing 
multi-antibiotic resistant genes (Threlfall 2000). After the penta-antibiotic resistant strain was 
first isolated, it was to be expected that resistance against ampicillin, chloramphenicol, 
streptomycin/spectinomycin, sulphonamide, and tetracycline would occur together (Threlfall 
2000). The relationships among different antibiotic resistant patterns from the human ST 
DTI04 submissions have been identified in Chapters 5 and 6. It was hypothesised that similar 
relationships would be identified in the animal submissions. 
Hierarchical cluster analysis is a powerful tool for exploring and sorting data into a number of 
groups, as has been mentioned in Chapter 2 and Chapter 3. The aims of this Chapter were: 1) 
to understand the resistance patterns of antibiotics in isolates from animals, 2) to understand 
the relationship of phenotypes isolated from animal sources, and 3) to discuss the similarity 
and dissimilarity between the human and the animal results. The following Chapter 9 uses 
these results to identify the relationships in time, space and space-time. 
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8.2 MATERIAL AND METHODS 
The dataset is the same as that used in Chapter 7. The study method was the same as 
described in Chapter 5 and relationships among thirteen antibiotic resistance patterns were 
investigated. Low level ciprofloxacin and cefotaxime were introduced to test for resistance in 
the Scottish Salmonella Reference Laboratory from 1997 and 1998, respectively. However, 
only 311 isolates could be included for analysis when all 15 antibiotic treatments were used 
and so the two antibiotic resistance patterns were excluded in the major study. When 13 
antibiotics were used, there were 2,439 isolates included and so the dendrogram constructed 
from 13 antibiotic resistance patterns was the focus of the analysis. The dendrogram 
constructed from 15 antibiotic resistance patterns was used as the reference to understand the 
whole set of relationships. A K -means cluster analysis was executed to check the results. The 
procedure of executing the K-means cluster analysis and the hierarchical cluster analysis were 
introduced in Chapter 5. The different distance calculating methods, the square Euclidean 
distance (SED), the Euclidean distance (ED), and the simple matching (SM), which were 
introduced in Chapter 5, were also used to explore the distances amongst outliers. 
8.3 RESULTS 
8.3.1 Relationships among antibiotic resistance pattern 
The three distance measurement methods generated similar results but a minor difference was 
observed. The dendrograms were the same when SM and SED were used (Figure 8.1). When 
13 antibiotics were used, Cp, Fz, Ka, Gm, Ne, Na, and Tm were in the upper group, which 
was referred to Group A-A. Tm is located in the position nearest the lower group (Group A-
B), in which Sp, St, Su, Ap, Te, and Cllie (Figure 8.1). Figure 8.2 shows the dendrogram to 
be a little different from Figure 8.1. When ED was used to calculate the distance, the basic 
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shape was still the same but the distances between pairs were greater (Figure 8.2). In addition, 
Sp, St, and Su were closer to each other and Ap, Cl, and Te were closer to each other. 
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Figure 8.1 The dendrogram constructed from the 13 antibiotic hierarchical cluster analysis 
using the square Euclidean distance or the simple matching measurements, and the between 
group linkage method. 
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Rescaled Distance Cluster Combination 
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CP 3 
FZ 4 
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1M 13 
SP 9 
ST 10 
SU 11 
AP 1 
TE 12 
CL 2 
Figure 8.2 The dendrogram constructed from the 13 antibiotic hierarchical cluster analysis 
using Euclidean distance measurement, the between group link method. 
8.3.2 The R-type relationships 
Figure 8.3 shows the dendrogram of all clustered R-types. The figure shows there are two 
distinct groups, Group A and B. The distance between Group A and Group B is considerable. 
Thus, the first line to separate the two groups could be chosen from 15/25 to 20/25. The first 
line was set at 15/25 in the figure. The second line was set at the distance of 12/15. Thus, the 
line separated Group A into 4 subgroups, Group Aa, Ab, Ac, and Ad and Group B into two 
subgroups, Group Ba and Bb. The third line to separate the tree into 9 subgroups was set at 
10/25. All the R-types in each different group are listed in Table 8.1. The results were 
checked by K-means cluster analysis. 
When K =2, the results suggested that some subgroups in Group A were better classified in 
Group B. The second group contained 58 cases, which belonged to Group Ad without the 
subordinate Group No. 639, Group No. 217, Group No.1 (from group Ab2), and Group 462. 
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Basically, the result was still similar to that in the hierarchical cluster analysis. When 
K=3, Group Ac and Ad were reallocated from Group A. Group Ac then formed the 
second group, and Group Ad together with Group B formed the third group. The 
results in the K-mean cluster analysis led to the conclusion that the first cutting site 
was suitable. 
It is of note that Group A is much bigger than Group B and contains many different 
multi-resistant types. In total, 35 R-types were found but many R-types did not occur 
in large numbers during the study period. Only 5 R-types were present in numbers 
higher than 10, Group No. 14 (ApCISpStSuTe R-type), Group No. 3 
(ApCISpStSuTeTm R-type), Group No. 1452 (ApCINaSpStSuTe(Lc) R-type), Group 
No. 653 (SpStSu R-type) and Group No.2 (Fully sensitive type). Three main R-types, 
Group No. 14, Group No.3, and Group No. 1452 were located in Group Aa. They are 
highly related and the distances between them are less than 5/25. Group No. 653 was 
located in Group Ad1 and Group No.2 was located in Group Ba3 (Table 8.1). The 
other groups contained very few cases and represented less than 5% of the total per 
year. Figure 8.4 shows the patterns of each group by years. Group A, its subordinate 
group Group Aa1, and its grouped R-type Group No.3 dominated the general pattern 
throughout the study period. From 2001, the proportions of another two R-types, 
Group No 14 (ApCISpStSuTeTm R-type) and Group No 1452 (ApCISpStSuTeNa R-
type) in Group Aa1 became more significant. The Group No. 14 formed 45% and 
25% of cases in 2002 and 2003, respectively. In 2001, there were 21 % (14/57) of 
cases from Group No. 1452. All other groups, their sub-groups and related R-types 
formed a low proportion of cases and did not play significant roles throughout the 
study period. 
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Figure 8.4 The proportions per year for each group, subgroups and R-types; Y-axis is 
the percentage; X-axis was the year from 1990 to 2004. 
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8.3.3. The comparison of the clustering results between human and animal 
datasets 
188 
The antibiotic and the R-type relationships from the human dataset have been 
identified in Chapter 5. The antibiotic relationships in the human submissions were 
the same as those in the animals (Figures 5.1, 5.2, 8.1, 8.2, and 8.3). Generally 
speaking, the pattern was the same in both the human and the animal datasets. Ap, Cl, 
Sp, St, Su, and Te were in the same group and the Cp, Cf, Fz, Ka, Gm, Ne, Na, Lc and 
Tm were located in the other group. 
There were some differences in the R-type relationship although the main structure 
remained the same. There were 22 R-types found in both human and animal datasets 
despite the diversity in the Lc resistance pattern (Table 8.2). The SpStSu R-type was 
located in the animal Group A but it was located in the human Group B. It is the only 
R-type, which was located in a different group. All major patterns, the ApClSpStSuTe, 
ApClSpStSuTeTm, SpStSu, and FS R-types were identified in both human and 
animal databases. Although the orders of some R-types were a little different, the R-
types still remained in the two distinct first order groups. 
However, there were unmatched R-types; 29 in the human dataset and 13 in the 
animal dataset. Although the numbers of those unmatched R-types were few, the 
human R-types show higher diversity and the animal R-types show higher multi-
resistance patterns (Table 8.3). 
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Table 8.2 The R-types found in both animal and human datasets. The R-types are 
sorted according to the sequence in the results of the human hierarchical cluster study. 
Human NO 
Group A 
Animal No IHuman NO 
Group B 
Animal No 
45 ApClSpStSuTe(LC) 
915 ApSpStSuTe 
1987 ApCIKaSpStSuTeTm 
52 ApClSpStSuTeTm 
2050 ApCIKaNaSpStSuTeTmLc 
1708 ApCINaSpStSuTeTm(Lc*) 
605 ApCINaSpStSuTe(Lc) 
1827 ApCICpNaSpStSuTe(Lc*) 
146 ApCIFzSpStSuTe 
622 ApCIKaSpStSuTe 
114 ApClSpSuTe 
574 ApCIGmSpStSuTe 
1826 ApCIGmNeSpStSuTe 
2168 ApCISpSt 
11 ApStSuTe 
337 ApSpStSu 
31 306 Te 
1136 38 FS 
2236 268 ApSu 
14 642 SuTm 
2227 58 SuTeTm 
2099 85 SpStSu 
1452 
2388 
64 
637 
51 
1780 
217 
462 
1 
2173 
*: The animal type has Lc form but the human type does not 
88 
2 
835 
1261 
816 
653 
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Table 8.3 Un-matched R-types in the animal and human datasets. 
Human N Human Animal N Animal No. No. 
2395 1 ApCISpStSuTm ApNaSpStSuTe 3 1473 
531 9 ApCIKaNaSpStSuTe(Lc) ApCISpStTe 1 461 
711 1 ApCINaStSuTe ApCIFzSpStSu 1 1840 
146 4 ApCIFzNaSpStSuTe CISpStSuTe 2 433 
935 1 ApCIFzNaSpStSuTe ApCINeSpStSuTe 1 969 
2506 1 ApCIKaStSuTe ApCIGmNaSpStSuTe 1 1587 
135 1 ApClSpSu ApKaStSuTe 1 304 
2548 2 ApCIStSuTeTm ApCIGmN aN eSpStSuTeLc 1 1803 
1211 1 ApCISuTeTm ApCIGmKaNeSpStSuTeTm 2 669 
1299 2 StSuTe ApCIGmKaN eSpStSuTe 5 353 
2400 1 ApSuTe SpSu 1 2411 
2158 1 ApCpNaSpStSuTeLc ApCISpStSu 1 617 
2519 1 ApCpSpStSuTe KaSpStSuTe 1 639 
2102 1 ApCpNaSpStSuTmLc 
53 2 Na 
2497 2 Ap 
442 3 ApStSu 
337 1 ApSpStSu 
1439 1 ApKaSu 
1210 1 ApNaSu 
1238 2 ApSuTm 
1593 1 SpStSuTe 
2446 1 SpStSuTeTm 
1534 3 SpSt 
1632 5 SpStSuTm 
2148 3 NaSpStSu(Lc) 
22 4 StSu 
2123 1 KaN aSpStSuTmLc 
1334 1 CIFzSuTeTm 
Total 29 13 
N: the numbers in the group 
8.3.4 The independent test between the resistance patterns of nalidixic acid and 
low level ciprofloxacin 
There were 27 isolates resistant to Na and Lc, 9 isolates resistant to Na but sensitive to 
Lc, no isolate resistant to Na and Lc, and 604 isolates sensitive to Na and Lc. The 
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McNemar test for independence showed that the responses were significantly 
different, (p = 0.007) 
8.4 DISCUSSION 
191 
The relationships among the different antibiotic resistant patterns from human isolates 
have been discussed in Chapter 5. They supported the assumption that the high levels 
of resistance of the Group B antibiotics are highly related to the emergence of 
chromosomally encoded antibiotic resistant ST DTI04. The results in Chapter 5 also 
supported the assumption that the high levels of sensitivity of the Group A antibiotics 
was probably attributable to the genes in R-plasmids. From the results in Chapter 5 
and the current study, the relationships among antibiotics in humans and animal 
isolates would appear to be similar. It suggested that some factors influencing the 
development of antibiotic resistant strains in humans could be the same as those in 
animals. 
Whilst it is not possible from this study to confirm or refute a definitive relationship 
between the two populations of bacteria, what is clear is that there are many 
similarities when one clusters the different R-types. Speculation on why this might be 
the case requires more careful consideration of the relationships in time and space, as 
in particular, the temporal relationship between emergence in the human and 
emergence in the animal popUlation may give some indication as to the direction of 
the spread of resistance types. 
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As outlined previously, It is suggested that the high usage of growth promoters in 
livestock, mutation and treatment are related to the development of antibiotic resistant 
strains (Threlfall et al. 2003). It would be a fair assumption that in the case of animal 
treatment, one might see emergence first in the animal population and then in the 
human. For example, Threlfall suggests that the emergence of the trimethoprim 
resistant ST DTI04 strain was related to the treatment of ApClSpSuTe R-type 
(Threlfall et al. 1996). Although the Tm resistance was first identified in other phage 
types of S. Typhimurium, the trimethoprim resistance in ST DTI04 was first recorded 
in 1991 in Scotland in the year of the increase of the ApClSpStSuTe R-type. The Tm 
resistance was recorded in the Scottish dataset one year earlier than that in England 
and Wales (Threlfall et al. 2005). There is as yet no any evidence to prove that the 
Tm resistance is associated with any chromosomally-encoded antibiotic resistance 
gene. Instead, evidence supports the association of the resistance with plasmids and 
Tm resistance associated with plasmids was reported as early as 1981 in California 
(Ikeda and Hirsh 1985). This study has shown a decline in the percentage of the 
ApClSpStSuTe R-type from 2001 and an increase in the percentage of the 
ApClSpStSuTeTm R-type. This may be due to competition and displacement. 
However, the decline of the percentages of ApClSpStSuTeTm R-type after 2002 may 
relate to the reduction in trimethoprim/sulphonamide use for therapeutic purposes in 
animals as the sales oftrimethoprimlsulphonamide for therapy fell from 103 tonnes in 
2001 to 77 tonnes active ingredient in 2004 (Anon 2007). 
There is considerable evidence that the ST DTI04 infections in humans relate to 
direct contact with animals and animal products (Threlfall et al. 1994; Wall et al. 1994; 
Threlfall et al. 2000). Thus, it is to be expected that 22 out of 35 R-types in the animal 
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dataset were found in the human dataset. In contrast, only 22 out of 50 human R-types 
were found in the animal dataset. What one cannot conclude, however, is where the 
resistance emerged first. Evidence of transfer of the organism does not necessarily 
imply origin of the resistance. For this temporal studies will be useful. 
Hierarchical cluster analysis was a helpful tool for exploring a dataset and providing 
information about the structure of the dataset. The results identified the possible 
relationships among antibiotics and the R-types. The next chapters extend this using 
temporal, spatial, and spatio-temporal analyses. 
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9.1 INTRODUCTION 
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As outlined in earlier chapters in Scotland, samples from suspected cases of S. Typhimurium 
infection are analysed and then the confirmed results are stored at SSRL and HPS. According 
to the findings from the human dataset, the ST DT104 epidemic occurred from 1993 to 98. In 
addition, higher risk areas were found in the southern and eastern parts of Scotland. Higher 
risk areas were also identified in the outer islands. In contrast, Highlands and the central belt 
of Scotland were relatively lower risk areas. The previous results showed that the higher risk 
clusters in humans might be associated with the location of the cattle population. It is believed 
that 37.8 per cent ST DT104 cases which occurred in Dumfries and Galloway (DG) from 
1993 to 96 may have regular contact with cattle (Calvert et al. 1998). In addition, for ST 
DT104, DG had the highest prevalence in both cattle and human (Calvert et al. 1998) and the 
assertion, though unsupported, was that the clustering of cases was related in the two species. 
The aim of this study was to use SaTScan to identify the most-likely clusters from the animal 
isolations in time, space, and time-space. 
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9.2 MATERIAL AND METHODS 
Chapter 2 described the structure of the animal dataset. Chapter 6 described the general 
SaTScan methods that were used in both the animal and the human datasets. The main 
difference between the human and the animal datasets was the recording system. Each animal 
record contained the year and the week number when the isolation was sent. The basic time 
interval in this study was the year. In this study, it was assumed that clients usually sent 
samples to the laboratories near their work place. In addition, the study assumed that the 
locations of the laboratories, which identified the cases, were the locations where the cases 
occurred. The implications of these assumptions are discussed later 
There are 17 veterinary laboratories involved in identifying animal Salmonlella spp. 
infections. The laboratories are scattered in 5 animal health districts (Table 9.1 and Figure 
9.1). Because the true population of all animals was unknown, only a Bernoulli model was 
implemented to find the most likely clusters in time, space, and time and space. The study 
groups were previously generated as described in Chapter 8: Group ST, Group A ST DT104 
isolations, Group Hex ST DT104 isolations, and Group FS ST DT 104 isolations were used as 
the 'case groups'. The corresponding 'control groups' were Non-Group ST, Group B ST 
DT104 isolations, Non-Group Hex ST DT104 isolations, and Non-Group FS ST DT104 
isolations .. 
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Table 9.1 The ST DTI04 submissions from animal sources in 17 different laboratories, 
Scotland, 1990 - 2004. 
Laboratories Total 
ABD:PHL 15 
ABD:ROY 27 
ABD:VET 328 
AYR:ARL 1 
AYR:VET 514 
DMF:VET 580 
DUN:ARL 1 
EDI:AGR 235 
EDI:VET 35 
FIF:ARL 1 
GLA:VET 36 
INV:VET 65 
MID:VET 73 
OBA:LAB 1 
PER:VET 203 
ROX:VET 171 
THU:VET 251 
TOTAL 2,439 
CHAPTER IX 
~ 
,,-== 
/ 
~ 
Jv 
ASOrET 
IFARL 
rDVE~ 
eEOIAGR ~~t~ EDIVET 
eRO VET 
eOMFV 
SOPHL 
Figure 9.1 The positions of the 17 veterinary laboratories and the borders of the Animal 
Health Divisions 
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9.3 RESULTS 
9.3.1 The comparison between Group Salmonella Typhimurium and Non-Group ST 
The purely temporal study showed that Group ST had a lower relative risk cluster (LLRC) 
between 1997 and 2003 (p=0.001, RR=0.658): ST infections declined from 1997. 
The results showed the centres of the circles from the comparison between Group ST and 
others were the same in the purely spatial and the spatio-temporal analyses. There was one 
SLRRC/STLLRC located at MIDVET. However, because there were very few ST isolates 
recorded in MID VET this circle could be misleading. The SHRRC and the STHRC were 
identified as the same in both studies. They were located in the west-south part of Scotland 
(1990-96) and the east part of Scotland (1991-97) (Table 9.2). 
Table 9.2 The radii of the identified circles from the comparison between Group ST and Non-
Group ST based on Bernoulli model. 
Radius (km) RR P-value Duration 
Purely spatial 
MIDVET 0 0.107 0.001 
A YRVET, A YRARL, GLA VET, 81.30 1.859 0.001 
DUNARL, DMFVET 
ABDPHL, ABDROY, ABDVET, 159.76 1.712 0.001 
PERVET, INVVET, FIF ARL, 
EDIVET, EDIAGR 
Spatia-temporal 
MIDVET 0 0.052 0.001 1992-98 
A YRVET, A YRARL, GLA VET, 81.3 2.526 0.001 1990-96 
DUNARL, DMFVET 
ABDPHL, ABDROY, ABDVET, 159.76 1.834 0.001 1991-97 
PERVET, INVVET, FIF ARL, 
EDIVET, EDIAGR 
- .. _- .. _- -- .. - -- _ .. -
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9.3.2 The comparison between Group ST DTI04 and Non-Group ST DTI04 
The purely temporal study showed a higher relative risk cluster from Group ST DT104 in the 
period 1992 to 1999 (p=0.001, RR=4.33). Thus, the study period was separated into 1990-91, 
1992-99, and 2000-04. Table 9.3 shows the spatial and the spatio-temporal clusters from the 
comparison. There were 2 SLRRCs and 3 SHRRCs. The first most-likely SLRRC was in the 
southwest part of Scotland. The other SLRRC was in INVVET. The two SHRRCs were 
located in: 1) the central and the south west parts of Scotland and 2) in the south-east part of 
Scotland. The third SHRRC was located in the east part of Scotland (Aberdeen). The spatio-
temporal analysis showed that only one STHRC was identified. The area covered the central 
belt and the south-east part of Scotland between 1994 and 98. 
Table 9.3 The radii of the identified circles from the comparison between Group ST DT104 
and Non-Group ST DT 104. 
Radius (km) RR P-value Duration 
Purely spatial 
A YRARL, A YRVET, GLA VET, 88.91 0.598 0.001 
DUNARL, MIDVET 
DMFVET, ROXVET 67.07 1.436 0.001 
THUVET 0 1.618 0.001 
INVVET o 0.656 0.002 
ABDVET, ABDROY 3.79 1.162 0.010 
Spatia-temporal 
EDIAGR, MIDVET, EDIVET, 89.04 1.888 0.001 1994-98 
FIFARL, ROXVET, PERVET, 
GLAVET, DMFVET, DUNARL 
9.3.3 The comparison between Group A and Group B 
The purely temporal study showed that Group A had a THRRC in the period from 1995 to 
1997 (p=0.032, RR=1.015). Table 9.4 shows the most likely spatial and spatio-temporal 
clusters identified in the comparison. The SHRRC was located in the southwest part of 
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Scotland. The SLRRC was located at INVVET. There were 3 STLRCs identified in the 
spatio-temporal analysis. The first STLRC was located in the southeast part of Scotland 
between 1990 and 93. The second STLRC was located at INVVET from 1995 to 2001. The 
third STLRC was identified at THUVET in the period from 1990 to 92. In contrast, the 
STHRC was located in the west-south part of Scotland between 1995 and 2001. 
Table 9.4 The radii of the identified circles from the comparison between Group A and Group 
B. 
Radius (km) RR P-value Duration 
Purely spatial 
A YRVET, A YRARL, GLA VET, 8l.30 1.019 0.001 
DUNARL, DMFVET 
INVVET 0.00 0.918 0.007 
Spatia-temporal 
ROXVET, EDIAGR, MIDVET, 46.88 0.841 0.001 1990-93 
EDIVET 
INVVET 0 0.562 0.001 1994 
AYRVET, AYRARL, GLAVET, 81.3 1.018 0.003 1995-
DUNARL, DMFVET 2001 
THUVET 0 0 0 1990-92 
9.3.4 The comparison between Group Hex and Non-Group Hex 
In the period 2001 to 03, there was an identified TLRRC in the purely temporal cluster 
analysis (RR=0.637, p=O.OOl). Table 9.5 shows the identified spatial and spatio-temporal 
clusters from the comparisons. There was one identified SLRRC in the central belt of 
Scotland. The identified SHRRC was located in the southeast part of Scotland. The STLRC 
was identified in the circle composed by Glasgow, Dundee, Lothian, Oban, Perth, and Ayr 
within a radius of approximately 89 km from 1996 to 2002 in the spatio-temporal cluster 
analysis. The STHRC was found at DMFVET between 1994 and 96. It means a Group Hex 
higher risk cluster was located in the south part of Scotland. 
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Table 9.5 The radii of the identified circles from the comparison between Group Hex and 
Non-Group Hex. 
Radius (km) RR P-value Duration 
Purely spatial 
PERVET, FIFARL, EDIVET, 78.11 0.895 0.001 
MIDVET,EDIAGR, GLA VET, 
DUNARL 
DMFVET 0 1.078 0.001 
Spatia-temporal 
DUNARL, GLA VET, A YRARL, 89.04 0.854 0.001 1996-2002 
A YRVET, OBALAB, PERVET, 
MIDVET, EDIVET, EDIAGR 
DMFVET 0_ 1.107 0.001 1994-96 
_ .. _ .. _ .. _ .. _ .. _._._._----
9.3.5 The comparison between Group FS and Non-Group FS 
The purely temporal study showed that Group FS had a TLRRC between 1995 and 96. Thus, 
the study period could be separated into three periods: 1990 to 94, 1995 to 96, and 1997 to 
2004. Table 9.6 shows the identified spatial and spatio-temporal clusters from the comparison. 
There were 2 SHRRCs identified: 1) at INVVET, and 2) in the southeast part of Scotland in 
the purely spatial cluster analysis. In addition, a SLRRC was located in the southwest part of 
Scotland. The spatio-temporal analysis showed that there were 3 identified STHRCs and 1 
identified STLRC. The three STHRCs were located in 1) in the southeast part of Scotland 
(1990 - 93), 2) at INVVET in the period (1994 - 99), and 3) at THUVET (1990 - 92). The 
STLRC was located in the southwest part of Scotland in the period from 1991 to 97. 
CHAPTER IX 203 
Table 9.6 The radii ofthe identified circles from the comparison between Group FS and Non-
Group FS based on Bernoulli model. 
Radius (lan) RR P-value Duration 
Purely spatial 
A YRVET, A YRARL, GLA VET, 81.30 0.115 0.004 
DUNARL, DMFVET 
INVVET 0 10.742 0.008 
ROXVET, EDIAGR, MIDVET, 46.88 3.745 0.068 
EDIVET 
Spatia-temporal 
ROXVET, EDIAGR, MIDVET, 46.88 27.45 0.001 1990-93 
EDIVET 
INVVET 0 21.444 0.003 1994-99 
THUVET 0 121.850 0.012 1990-92 
AYRVET, AYRARL, GLAVET, 81.30 0.069 0.036 1991-97 
DUNARL, DMFVET 
9.4 DISCUSSION 
Although the original intention at the outset of the study was to investigate the animal cases at 
the same resolution as the human cases, this was not possible because of the form in which 
the data were collected and maintained. The approach adopted in this chapter has many short 
comings but was an attempt to address the problems associated with the structure of the 
animal data. 
One disadvantage of the Bernoulli model is that it only presents relative risk clusters not the 
true epidemic curve. Generally speaking, the results of the Bernoulli and Poisson model 
should be very similar (Kulldorff and Nagarwalla 1995). However, the Bernoulli model study 
is like a case control study and has all of the disadvantages of a case-control study. The results 
are affected by control groups and show the relative risk clusters. Thus, it should not be 
considered the same as showing a epidemic curve as might be identified using other 
techniques. However, the study can present possible relative higher/lower risk clusters over 
time, in space or in time-space. 
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The quality and quantity of outcomes highly depend on the original data. The main errors can 
be identified into two categories. Firstly, from the spatial perspective, precision of case 
location affects the results. In this study, the locations of laboratories were used instead of the 
true locations of cases. Secondly, in this study, the cases were assumed to have occurred in 
the district around the laboratories. This was for two reasons: the location of cases was 
inconsistently recorded and the underlying population denominator was not available. In 
effect what was being examined was the features of the populations of isolates at each 
laboratory. It was an attempt to understand the distribution of higher/lower risk clusters with 
the laboratory as the unit of interest. Ideally, a study should be based on actual location of 
infected farms in Scotland and on bovine farms only. If that is not possible, using the location 
of farms and the average ST DTI04 infection rate or individual infection rate for each farm 
(similar to how the laboratories have been treated here) would be a sensible approach. 
The statistical power is different in each comparison because the denominator is different 
(Kulldorff, 1997), although the statistical power for each result is always satisfied in each test. 
Thus, fewer cases in the control group will dramatically affect the results and it will bring 
some bias to the results. For example, control data containing 1 case in each area was used 
(Group fake 1). When Group Hex was compared with Group fake 1, it showed a lower risk 
cluster from 2001 to 2004 (p=0.001, RR=0.760). When 100 cases were used in each area in 
the control group, the result showed that the higher risk cluster was from 1993 to 1997. When 
200 cases were put in each area in the control group, the result showed that no HRC or LRC 
was found. The Bernoulli model is not suitable for the comparison between groups, when one 
group does not have enough cases (the statistical power is not sufficient). In SaTScan, the 
case and the control group can be reversible (Kulldorff 1997). Group FS did not contain any 
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cases in 1995 and 1996. Thus, the comparison between Group Hex and Group FS was not 
able to show any meaningful results and the results were not shown .. 
Fewer cases in some laboratories may result in misleading clusters. Two LRRCs were 
identified at INVVET and MIDVET, with radii of 0 lan. The two identified LRC laboratories 
have a common feature, which is that they are farther from other laboratories. The size of an 
area/location and the numbers in an area/location are factors which influence the results 
(Kulldorff and Nagarwalla 1995). This means the distance between locations and the numbers 
compared with other locations will have an effect. Thus, the MID VET , identified as a LRC 
because it had very few cases, could be misleading. The cluster at INVVET could also be 
misleading. When the dataset was checked, 6 out of 65 cases belong to Non-Group Hex and 5 
out of 6 cases belonged to Group FS. Thus, it appears that the LRC located at INVVET might 
relate to the large distance from others. 
ST DT104 has replaced phage type 204c as the major type in the UK (Anon 1998). Both the 
human and the animal datasets showed that the proportion of ST DT104 surged from 1991 
(Chapters 3 and 7). However, the epidemic duration appears to be different. The identified 
epidemic duration from the animal dataset (Bernoulli model) was from 1992 to 99 but that 
from the human dataset (Poisson model) was between 1993 and 98. From the human dataset 
based on the Bernoulli model, the temporal lower risk cluster was range from 1988 to 1992. 
Whether one year constitutes sufficient difference to be biologically meaningful (animal 
predating human) is doubtful but the co-occurrence at least suggests that there were similar 
factors influencing the spread of ST DT1 04 in both humans and animals. 
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The decline from 1997 in ST submission might relate to the restriction of movement in cattle. 
A decline from 1998 in humans was also identified (Chapter 6). A report suggests that the 
reasons for the fall in human cases in 1998 are still unclear but may be explained by improved 
catering practice, a cooler summer, and lighter contamination of uncooked foods (Scottish 
Centre for Infection and Environmental Health 1999; Handysides 1999). 
Higher risk clusters from Group A and its subgroup Group Hex were identified in the 
southern part of Scotland; in contrast, the higher risk clusters from Group B and its subgroup 
Group FS were usually identified in the middle and eastern part of Scotland and Highland, 
which is the northern part of Scotland. A report published by Calvert et al. (1998) on ST 
DT104 submissions from 1993 to 96 concluded that the Highland and the Dumfries and 
Galloway (DG) had a higher prevalence of infection in animals although the human 
prevalence was generally uniform across mainland Scotland excluding DG (Calvert et al. 
1998). The current study and the study described in Chapter 6 suggest that the southern area 
of Scotland, which covers the DG Health Board contained the higher risk clusters from mult-
resistant ST DT104 (Group A and Group Hex). The two results in Chapters 6 and 9 also 
identified higher risk clusters from low resistant ST DT104 (Group B and its subgroup Group 
FS) in the northern part of Scotland. 
In conclusion, not withstanding the short comings of the data available for study in this 
chapter, the analysis presents the first description of regional variarion in resistant ST DT1 04 
and sub-groups. The results suggest that the animals in the southern parts of Scotland had 
more chance to become infected with multi-resistant STDT104 strains, especially in the 
epidemic period from 1992 to 99. It is worth remembering that very few FS strains would be 
submitted to veterinary laboratories because of low morbidity or mortality caused by the 
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strain due to successful therapeutic intervention. Further studies locating isolates to farm are 
clearly necessary. 
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CHAPTER X 
TIME SERIES ANALYSIS OF HUMAN AND ANIMAL DATA 
RELATING TO S. TYPHIMURIUM PHAGE TYPE DT 104 
10.1 INTRODUCTION 
In Chapters 3 and 7, significant seasonal patterns in occurrence were observed in humans but 
were not observed in animals. Although the three stage time series lines were identified in 
Chapter 5, there currently is no tool to describe the general patterns of ST DT104 infection in 
Scotland. This Chapter describes the development of time series models, which can identify 
the seasonal effects and describe the general patterns. Thus, the generated model can be used 
to detect unusual increases in reported cases as rapidly as possible. 
Time series analysis is a method used to: 1) identifying the characteristics represented by the 
series of observations, and 2) forecasting future values of a data stream (Pankratz 1983). The 
auto-regressive integrated moving average model (ARIMA) was set up by Box and Jenkins in 
the 1970s (Box and Jenkins 1976). The ARIMA model combines the benefits of auto-
regressive and moving-average models and minimises the disadvantages of both. It describes 
the historic data well and can use the results generated to get a reasonable prediction ability 
(Pankratz 1983; Box and Jenkins 1976). In addition, it has two advantages: 1) low 
development and maintenance costs, and 2) it provides a baseline for prediction (Smelser and 
Baltes 2001). 
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Time series study has been used widely, especially in economic activities, such as setting 
policies and financial management (Smelser and Baltes 2001); however, it is still rarely used 
in understanding salmonellosis. Waltier and his colleagues attempted to develop time series 
models for non-typhoid Salmonella infections in France, S. Bovismorbificans infection, and S. 
Typhimurium infection, respectively (Watier et al. 1991; Watier et al. 1993; Watier 1995). 
The models are more complex but are based on an understanding of the ARIMA models. No 
time series model has yet been built for the Scottish Salmonella submissions. The ARIMA 
model is a good choice for building up the essential knowledge. 
The aims of this study were to use the univariate Box-Jenkins time series model to find the 
best models for both human and animal data streams, to evaluate the good and bad points of 
the models and to assess them in an epidemiological context. Ideally, the aim was to compare 
the series and establish whether there was a direct relationship between the animal and human 
trends. The results were also expected to be a base for further time series studies. 
10.2 MATERIAL AND METHODS 
The SPSS 14.0 trend package was used in this study. It has two model builders: 1) the 
exponential smoothing model and 2) the ARIMA model, which were used to find the best 
models. Only the ARIMA models were used in this study. 
Seasonal patterns can be detected using the auto-correlation function (ACF) and the partial 
auto-correlation function (P ACF). ACF was used to investigate how the correlation between 
any two data points of the series changes as their separation changes. It shows two outcomes: 
whether the time series is stationary and whether a seasonal pattern is present. The ACF value 
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at lag 1 means the value of the correlation between an observation at the time t with the 
observation at the time t-l. The PACF removes the requirement for stationary in the ACF and 
shows clearer seasonal patterns in a fixed interval time period (Box and Jenkins 1976; SPSS 
Inc. 2006). When seasonal patterns are present, the graphs will show periodic peaks in fixed 
interval lags (months). The strength of peaks will decrease gradually to zero because the data 
points are not infinite. In this study, 36 lags (36 months) were used to understand the periodic 
cycle. 
Data were cleaned and coded in Excel 2000 according to the requirements of time series 
study, which required cases at a fixed time interval. The month was the minimum time 
interval in this study and cases submitted in the same month were grouped together. The 
submissions from humans (1988 to 2004) and animals (1990/7 to 2004) were used, 
respectively. For model comparison, a second human model was generated using data from 
1990/7 to 2004/12. 
The human and animal record systems were different. Each record in the human dataset 
contained the date of submission, and so this submission date was used directly. In contrast, 
each animal submission only contained the week number (1 to 53) when it was submitted. 
Every animal case was assumed to be submitted on Monday. The date corresponding with the 
Monday was used to as the date of submission. Hence, cases were re-grouped into different 
months according to the newly recreated dates. A new time series containing the total cases in 
each month was formed and it was used in this study. 
The expert modeller pack in the SPSS 14.0 trend package was used to select the best models 
automatically. The selected models were assessed by customer models again according to the 
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good model criteria described by Box and Jenkins: the lowest root-mean-squared error 
(RMSE), the lowest mean absolute percent error (MAP E) , and the lowest normalized 
Bayesian index criteria (BIC) (Pankratz 1983; Box and Jenkins 1976; SPSS Inc. 2006). The 
independence of residuals of each model was measured according to the ACF and P ACF of 
residuals. The residuals were graphed in Q-Q plots to ascertain if they were random. If many 
points in the tails in the Q-Q plots are far from the central line, it means the data stream may 
not be from a normal distribution (SPSS Inc. 2006). 
The stationary R-square was used to assess the goodness-of-fit. When a model contains a 
trend or a seasonal pattern, the value is a suitable estimate of the proportion of the total 
variation in the series that is explained by the model (SPSS Inc. 2006). However, ifthere is no 
trend of seasonal pattern in the model, the R-square can be used directly. The higher the 
stationary R-square or R-square, the better the model. 
A good time series model should have an acceptable quality in forecasting. In order to be 
able to assess a model's ability to forecast accurately, a function called 'holdouts' was used. 
In this study, new predictive values for 2004 were generated using data points from 1988 to 
2003 in the human dataset. For the animal dataset, the same method was adopted for data 
from 199017 to 2003. The observations in 2004 were compared to understand the predictive 
ability for each group. 
It became apparent that the quality of the animal related data was not as robust as the human 
isolate data. In order to carry out a comparison based on the resistance to different 
antimicrobials, simple cumulative plots of isolates over time were generated and the dates of 
emergence compared. 
CHAPTER X 213 
10.3 RESULTS 
10.3.1 The model for the human dataset from 1988 to 2004 
Figure 10.1 shows that there is a strong seasonal pattern in human data from 1988 to 2004. 
The ACF graph shows peaks occurred in lag 1, 12, 24 and 36. Each data point is highly 
related to the previous data point, the 12, 24, and 36 month earlier data point. The relationship 
between a data point with its previous fixed interval period data point decreased to zero as 
time passed. The PACF graph shows one big peak in lag 1 and the peaks still occurred in a 12 
month interval. The pattern suggests that it might be a ARIMA(0,1,1)(0,D,Q)12. Also, when 
checked the seasonal peaks, it still shows a gradual decrease. Thus, the seasonal component 
could be (0,0,1)12 or (0,1,1)12' After careful selection by the criteria given above, the 
ARIMA(0,1,1)(0,1,1)12 is the best-fit (Table 10.1). The Q-Q plot shows that the residuals are 
from a normal distribution, although few data points are higher or lower than expected 
(Figure 10.2) and the residual ACF and PACF graphs show that there is no significant peak 
and periodic peak. It means all residuals are independent (Figure 10.3). 
Figure 10.4 shows that the model could catch the peaks very well in the epidemic period, 
mainly from 1993 to 2000. From 1988 to 1991/6, it was still good at identifying the trend but 
not very good at tracing the peaks. After 2001, the model can detect peaks but over-weights 
the seasonal component quite often. The prediction values fall faster than observations in the 
non-season period. 
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Figure 10.1 The ACF (above) and the PACF (below) graphs of human dataset from 1988 to 
2004. The X-axis is the month. 
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Table 10.1 The information of human model parameters and criteria index 
The ARIMA (0,1,1)(0,1,1)12 model 
From 1988/1 to 2004/12 
(0,1,1)(0,1,1) 
Human 
model 
Stationary 
R-square L- ________ 
Estimate SE 
Difference 1 
81 Lag 1 .744 .049 
Seasonal Difference 1 
812 
0.591 
,10 
g 10 
'; 
> 
1 z () 
1 
~ 
10 
r 
o 
Lag 1 .741 .060 
MAPE 65.12 RMSE 
Normal Q-Q Plot of Human0188 
0° 
t 
15.191 
12.457 
6.99 
o 
,10 -ll---,..--,----,r---,..---r-----,,.----,-...J 
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Obscrved Valuc 
Sig. 
.000 
.000 
Figure10.2 The Q-Q plot ofthe residuals from the human model (1988 -2004) 
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10.3.2. The model for the human dataset from 199017 to 2004 
This model using human data from 199017 to 2004 was similar to the model using the whole 
data stream (Table 10.2 and Figures 10.5 to 10.7). Figure 10.6 shows the distribution of the 
residuals is almost from a normal distribution, although few data points are still higher than 
expected. Figure 10.8 shows the predictive values in this model are almost the same as the 
predictive values in the model shown in Figure 10.4. They also show almost the same pattern. 
However, the higher MAPE and RMSE and the lower stationary R-square show that this 
model is a little worse than the model using the whole time series (Table 10.2). 
Table 10.2 The information of human model parameters and criteria index (199017 to 2004) 
The ARIMA (0,1,1)(0,1,1)12 model (199017 to 2004) 
From 199017 to 2004112 
(0,1,1)(0,1,1) Estimate SE t Sig. 
Human Difference 1 
model 
81 Lag 1 .737 .055 13.401 0.000 
Seasonal Difference 1 
812 Lag 1 .803 .073 11.058 0.000 I 
Stationary 0.588 MAPE 79.21 RMSE 9.25 
I 
R-square I I 
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Figure 10.5 The ACF (above) and the PACF (below) graphs of the human dataset from 
199017 to 2004. The X-axis is the month. 
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Figure 10.7 The residual ACF and PACF graphs from the human model (199017-2004) 
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10.3.3 The model for the animal dataset 
A different model type was selected for the animal dataset. The ACF graph shows a series of 
decreasing values but there are still many small peaks occurring in the lag 1, 12, 24, and 36 
(Figure 10.9). The PACF graph in the Figure 10.9 shows that there is a big peak in lag 1. It 
also shows that the values decrease slowly and very small peaks still appear in the 12-lag 
interval. All the information suggests that the time series is non-stationary and the model 
might be different from the human model. The model could be the ARIMA(O,l,l)(P,D,Q)12. 
The patterns suggest that the parameters P, D and Q should be 0 or 1. After due consideration 
it would appear that the ARIMA(0,1,1)(1,0,1)12 is the best,;fit (Table 10.3). The dependence 
and randomness of residuals are identified in Figure 10.1 0 and 10.11, respectively. From the 
residual ACF and P ACF graphs, the distribution of residuals are still from a normal 
distribution; however, many data points are higher and lower than expected. The stationary R-
square shows the fit ability is low. 
Figure 10.12 shows the model can trace the trends but does not fit the peaks before 2000 very 
well. After 2003, the model can still catch the trend but traces the peaks poorly. 
Table 10.3 The information of animal model parameters and criteria index. 
The ARIMA (0,1,1)(1,0,1)12 Model 
Estimate SE t Sig. 
Animal Difference 1 
model 
81 Lag 1 .612 .061 10.011 0.000 
<p12 Lag 1 .740 .155 4.771 0.000 
812 Lag 1 .545 .197 2.761 0.006 
Stationary 0.299 MAPE 65.565 RMSE 8.442 R-square .. __ . ____ ... ___ . __ 
_._ ... _-- ~---.--- .... - '------. __ ._ .... _- _ ... _ ... _ .. _ .. -
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Figure 10.9 The ACF and PACF graphs of animal dataset from 1990/7 to 2004. The X-axis is 
the month 
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43 
41 
39 
37 
35 
33 
31 
29 
27 
25 
g> 23 
...J 21 
19 
17 
15 
13 
11 
-1.0 -0.5 
Residual ACF 
[J 
[] 
0 
0 
[J 
Cl 
Cl 
I 
D 
CJ 
I 
CJ 
CJ 
0 
Cl 
CJ 
CJ 
CI [] 
Cl 
0 
CJ 
CJ 
CJ [] 
Cl 
0 
CJ 
D [] 
I 
0 
0 [J 
[J 
CJ [J 
D 
CJ 
0 [J 
[J 
0.0 
Residual PACF 
I 
CJ [J 
[J 
CJ 
Cl 
Cl 
D 
CJ 
D [J 
Cl 
CJ 
D 
Cl [J 
CJ 
CJ 
CJ 
CJ [J 
[J 
CJ [J 
[] 
CJ 
I 
Cl 
D 
D 
I 
D [J 
[J 
[] 
[J 
[J 
I 
CJ 
D [J 
[J 
0.5 1.0 -1.0 -0.5 0.0 0.5 
Figure 10.11 The residual ACF and PACF graphs from the animal model 
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Figure 10.12 The ARIMA(O,l,l)(1,O,l)12 model for the animal dataset 
10.3.4 The qualities of the predictive abilities of both human and animal models 
The holdout function was used to check the qualities of the models. Figure 10.13 and 10.14 
show that the two human models have a similar predictive ability. They show similar trace 
abilities and can predict the peaks in summer. However, the model in Figure 10.14 shows 
higher predictive values in summer and lower values in Febmary. The prediction abilities in 
both models are satisfactory. 
In the animal model, the predictive values were almost zero. It has two very small peaks in 
July and October, respectively. At the same time, the observations were between ° and 4. 
Generally speaking the quality of the predictive ability of this model is poor (Figure 10.15). 
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Figure 10.13 The predictive values and the human observations for the human model with 
data from 1988 to 2003 
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Figure 10.14 The predictive values and the human observations from the human model with 
data from 1990/7 to 2003/12 
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Figure 10.15 The predictive values and the animal observations from the animal model 
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10.3.5 Comparing the emergence of resistance in animal and human isolates 
Figures 10.16 to 10.23 show the simple plots comparing the cumulative totals of isolates 
considered resistant to the antimicrobials in this study. As can be seen, there is no consistent 
evidence of animal isolates predating human isolates in terms of resistance. Table 10.4 
summarises the timing of emergence in relation to each other. 
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Figure 10.16 Cumulative sum of the isolates resistant to ampicillin in humans (red) and 
animals (green) in Scotland from 1990 to 2004. The shape and number of the cumulative 
sums for chloramphenicol, spectinomycin, streptomycin, sulphonamide and tetracycline 
were nearly identical. 
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Figure 10.17 Cumulative sum of the isolates resistant to gentamicin in humans (red) and 
animals (green) in Scotland from 1990 to 2004. 
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Figure 10.18 Cumulative sum of the isolates resistant to kanamycin in humans (red) and 
animals (green) in Scotland from 1990 to 2004. 
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Figure 10.19 Cumulative sum of the isolates resistant to nalidixic acid in humans (red) and 
animals (green) in Scotland from 1990 to 2004. 
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Figure 10.20 Cumulative sum of the isolates resistant to netilmicin acid in humans (red) and 
animals (green) in Scotland from 1990 to 2004. 
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Figure 10.21 Cumulative sum of the isolates resistant to trimethoprim in humans (red) and 
animals (green) in Scotland from 1990 to 2004. 
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Figure 10.22 Cumulative sum of the isolates resistant to low level ciprofloxacin in humans 
(red) and animals (green) in Scotland from 1990 to 2004. 
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Figure 10.23 Cumulative sum of the isolates resistant to ciprofloxacin in humans (red) and 
animals (green) in Scotland from 1990 to 2004. 
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Table 10.4 The relationship between the emergence of resistance in human and animal 
isolates. Blank cells identify co-emergence; cells with figures identify the number of years 
between emergence in the two populations. The figure appears in the population of isolates 
where emergence occurring later. 
Antimicrobial 
Ap CI Sp St Su Te Tm Gm Ka Na Ne Cp Lc 
Human 2 1 5 
Animal 2 4 
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10.4 DISCUSSION 
This chapter set out to establish time series models for human and animal data of Salmonella 
data. To some extent this has been achieved, particularly in the case of the human data, but 
the ability to compare the time series meaningfully has been hindered by failure to establish a 
good animal data model. 
The different submission systems cause the models to present different ideas. In the human 
dataset, each case was from every patient whose samples were sent to SSRL and was 
identified as ST DT104 infection. The human model presented the numbers of isolates per 
month. In contrast, the animal model presented the numbers of incidents per month. Thus, 
cases in the animal system could be under-estimated and the two sets are not directly 
comparable The periodic patterns shown in ACF and P ACF were more significant in the 
human system, but less obvious in animals. There are a number of possible explanations for 
this. First, the submissions were from a number of different species and different species may 
peak at different times. The major source of cases was cattle, but the percentage of cattle 
cases did not remain the same throughout the study period, with the percentage of cattle cases 
dropping between 1998 and 2003. In addition, the total numbers ranged from hundreds before 
1997 to tens after 1998. Second, it is likely that farmers or veterinarians may treat a series of 
cases as one incident and therefore submit only one case. 
The structure of the data could directly impact the descriptive and predictive ability of the 
models (Smelser and Baltes 2001). As mentioned in previous studies, an increasing trend and 
a declining trend were identified in the animal and the human time series, respectively. It is 
believed that the sudden increase may be directly related to the surge of multi-resistant strains 
of ST DT1 04 (Threlfall et al. 1994) or phage type change (Anon 1988). Moreover, the decline 
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could be attributed to the introduction of the many Salmonella control orders, which have 
been mentioned in Chapter 3. The dramatic change in the submissions resulted in a lower 
descriptive ability. 
The different models lead to different inferences, Briefly, the human models weighted the 
earlier data and seasonal effect more heavily than did the animal models: the 
ARIMA(O,l,l)(O,l,l)12 model puts the same weight on the trend and the seasonal component. 
It means that the animal model relies more on the most recent observation. In addition, the 
animal model showed unmatched plots after 2000 because there were very few cases. There 
are some methods which use more factors to solve the problems and make better models. The 
self threshold auto-regressive model (SETAR) built by Watier and his colleagues for 
Salmonella Typhimurium infection used different equations when different conditions were 
observed (Watier et al. 1991). 
The ARIMA(O,l, 1 )(0,1,1)12 model was also adapted to the animal dataset to understand the 
difference. The model could identify the peaks during the epidemic period (1993 to 1999) 
very well but failed in describing data outside the epidemic period because of a stronger 
seasonal component. Thus, ARIMA(O,l,l)(l,O,l)12 is a better model to avoid over-weighting 
of the seasonal component. 
The prediction ability in the human models was good, but in the animal model comparatively 
poor. Again, the fewer case numbers and dramatic pattern changes affect the ability to predict. 
In addition, the few cases in the animal dataset, less than 5 and near to ° from 2001/9, also 
may affect forecasting. The prediction ability may be improved in two ways: extending the 
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time series to get a better mean; and choosing a more suitable range of time series. However, 
it is difficult to see how this might be achieved with the data collection systems in place. 
There are many ambitious models trying to get very good forecasting or description. 
However, the study attempted to build a reasonable model, which can present enough 
information for building a more complex model in the future. The univariate ARIMA model 
is easy to maintain, generates lower RMSE compared with other models (Smelser and Baltes 
2001; Abeku et al. 2002). Also, it can supply basic information for multivariate ARIMA 
studies. After the basic model structure has been built and more and more data points have 
been added, the model may present better results. 
There are often too many uncertainties to make a perfectly accurate prediction model possible 
(Smelser and Baltes 2001). However, the models based on the human data presented here 
satisfy the general basic principles of model building. They are parsimonious, the estimated 
alpha and theta are high quality, the RMSE and MAPE are acceptable, and the forecast ability 
is acceptable. Although a small part of this overall study, one might hope that these models 
might provide a starting point for other studies. 
In considering the failure of the data to allow direct comparison of the models, the simple 
plots used to identify the date of emergence in the human and animal populations provided 
some of the most telling evidence. Firstly, there was no consistent pattern as to where 
population resistance first appeared. Secondly, there some evidence that the chromosomally 
mediated resistances were more likely to co-emerge than the plasmid mediated. Thirdly, there 
were some differences in the rate at which the isolates then accrued, as evidenced by the slope 
of the cumulative plots. The cumulative plots were used to give some feel for total 
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environmental history but should be viewed with caution particularly given the caveats 
regarding the animal data. One might argue that these simple plots provide the strongest 
evidence in this thesis that the role of isolates in the veterinary sector, in terms of being the 
root cause of the problem, is not as clear as some would suggest. 
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CHAPTER XI 
GENERAL DISCUSSION 
The emergence of antibiotic-resistant ST DT104 infections in humans and animals has 
been a topic of research that has received a lot of attention. In terms of resistance, one of 
the first significant studies of Salmonella Typhimurium infections in the UK was carried 
out by Anderson, who recorded the antimicrobial resistance situation in England and 
Wales (Jones et al. 2002). Following this, the increasing concerns regarding the emergence 
of antimicrobial resistance led the UK government to survey the issue. The Scottish 
Salmonella antimicrobial resistance surveillance is managed by the HPS and the SSRL. 
The data from 1996 to 2003 were published in the HPS Weekly Report (SCIEH Weekly 
Report) (Browning et al. 2004; Browning et al. 2001a; Browning et al. 2001 b; Browning et 
al. 2005; Browning et al. 1999;Browning et al. 2003). To date no comprehensive 
systematic descriptive study focused on ST DT104 infections in Scotland has been 
undertaken. 
In outline, Chapters 3 and 4 described the epidemiological trends of the Salmonella, and 
ST DT104, highlighting that there were clear epidemic curves and although there was 
heterogeneity in the microbial population, certain clones predominated. Chapter 7 
confirmed that, broadly speaking, there were similar trends in isolates from animal sources. 
Chapters 5 and 8 described cluster analyses of human and animal isolates and, again, 
predominant types were similar and the clustering patterns suggestive of common 
ecological exposures and mechanisms. Although there were many similarities, there were 
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differences: fully resistant R-types were rarer in animals and multiple resistance more 
common. Chapters 6 and 9 then applied spatial and temporal analyses to the human and 
animal datasets, identifying in both populations, potential high and low risk clusters in time 
and space. With much less confidence in the inferences from the animal data, it would 
appear that MR isolates are more common in rural areas in both human and animals. 
Finally, in Chapter 10, in an attempt to apply time series approaches, robust models were 
achieved using the human data whilst, again, the animal data were of lesser quality. A 
simple plot of emerging resistance suggested that there was no clear uniform case to be 
made in support of resistance appearing first in animals and then in humans. 
The study has described changes in isolation rates for ST DT104 between 1988 and 2004. 
The emergence of the multi-resistant ST strains in England and Wales is highly related to 
the emergence of ST DT104 infections from 1992 (Jones et al. 2002). Since 1991, the 
Scottish ST DT104 infections have emerged in humans (rather than phage type 49), and in 
animals (rather than the phage type 204c). The reason for this is unclear but one possible 
explanation is due to the fitness selection related to the usage of antimicrobial agents and 
its ability to infect a wide range of hosts (Davison et al. 2005). It is suggested that the 
chromosomally-encoded resistance is stable but that plasmid-mediated resistance is not, 
even if selective pressure is withdrawn (Threlfall et al. 1994). Chapters 4, 5 and 8 showed 
that the proportion of human and animal isolates against chromosomally-encoded 
antibiotic resistances were both high and stable. In contrast, the proportion of isolates with 
plasmid-mediated resistances is low. Some of the plasmid-mediated resistances appeared 
only sporadically in the isolates. 
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This thesis used hierarchical cluster analysis to explore the diversities at the phenotype 
level. Chapters 5 and 8 showed that isolates from humans or animals can be allocated to 
two very similar groups. A total of 22 R-types, especially those multi-resistance types, are 
common in the human and animal isolates. Although there were 52 R-types in the human 
isolates and 35 R-types in the animal isolates, the unmatched R-types were a very low 
proportion of the whole, suggesting that there is commonality in the microbiological 
environment in which humans and animals exist. 
In addition, the clustering studies provided evidence of the disappearance of the R-types 
that are more susceptible. Although there may be a case to argue that the susceptible types 
are more likely to be successfully treated and less likely to be submitted, the trend is 
certainly downwards. 
The spatial and temporal studies were helpful in establishing areas of risk and identifying 
for the most part that the more resistant types were from rural areas. However, the 
ecosystem is dynamic and the site of a case occurring may not necessarily be the place of 
infection. There is also a dynamic situation in relation to the transfer of resistance 
determinants. It has been suggested that ST DT104 isolates acquired the chromosomally-
encoded resistance genes from fish (Doublet et al. 2003) or other species (Cloeckaert and 
Schwarz 2001). On the farm, an infected cow can shed 102 to 105 Salmonella Typhimrium 
organisms in a gram of faeces (Wray and Sojka 1978). The pathogen can transfer to other 
farms by trucks or even by dust (Woodhead et al. 2004) and can be found on most farms: 
Davison states that ST DT104 organisms could be identified on 63% of the dairy farms in 
England and Wales and that prevalence of ST DT104 infections are from 0.8 to 1.8. 
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(Davison et al. 2005). All this evidence suggests that there are other factors at play that 
lead to disease in animals, as well as exposure and disease in humans. 
The results presented in this thesis do not refute the assertion that human multi-resistance 
R-types might be of animal origin (Calvert et al. 1998), especially when the results of the 
purely temporal study are considered. This pathogen can transfer to humans via direct 
contact with infected animals (Calvert et al. 1998) or contaminated products. The temporal 
study pointed out the emergence of ST DT104 infections in humans and in animals are 
closely related in time: The most-likely epidemic period of ST DT104 infections in 
humans was from 1993 to 1998 and in animals it was from 1992 to 1999. Similarly, the 
spatial and spatio-temporal studies confirmed that rural areas are more likely to have 
resistant isolates in animals and humans supporting the observations of Calvert et al. 
(1998). However, what is not clear is the direction of this relationship. 
Working against the theory that there is a single explanation for the relationship between 
human and animal isolates are the differences in the time series models. Notwithstanding 
the deficiencies of the data, there were clear differences between the time series. When 
considering a simple time plot of when resistance to the individual antimicrobials emerged, 
there was no consistent temporal association between the emergence in humans and 
animals. This suggests that ecological and epidemiological drivers within the relationships 
are complex and not necessarily uni-directional. 
The aim of this work was to investigate the relationships between the human and the 
animal ST DT104 isolates resistant to a number of antimicrobials. To some extent the aim 
has been achieved. However, more importantly, while attempting to meet this objective 
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several methodologies have been explored and many important questions relevant to the 
relationship between the cases from the two sources have been highlighted. In order to 
improve the understanding of the relevance of resistance in ST DTI04 from humans and 
animals, there are several areas of work considered in this thesis that need to be expanded. 
Firstly, there is a strong link between the quality of data, the ability to use this data and the 
quality of outcomes. Because the animal data did not contain sufficient information, the 
quality of the outcomes in the SaTScan analysis from the animal dataset is marginal, as 
was the animal based time series. A few methods could be used to improve the quality. 
Locating the farms on electronic maps might improve the quality of the study. More 
precise animal numbers in each postal district would be helpful too. Both of these issues 
are being addressed in the wake of Foot and Mouth Disease. However, the limiting factor 
in this study was the quality of the information accompanying the samples. Data were 
inconsistent, often missing and there is a danger that incidents, outbreaks and individual 
cases are confused. Whilst these deficiencies detracted from the analysis of the animal 
isolates, it severely hampered any meaningful comparison of human and animal results at 
all levels of the thesis. The study has effectively been constrained to a number of 
quantitative studies in the two species leading to a qualitative comparison. 
Secondly, whilst useful at the level of phenotype, the cluster analysis could be expanded 
into a study at the level of genotype. A further study based on the heterogeneity of 
genotypes from the four main R-types: ApCISpStSuTe, ApCISpStSuTeTm, 
ApCISpStSuTeNa, and SpStSu, would provide important additional information. Threlfall 
reported the RFLP profile of the R-type ApCISpStSuTe (Threlfall et al. 2005) and this 
would lead to an ability to subdivide some of the more prevalent R-types. 
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In terms of geographical comparisons, it is important to recognise that Scotland is 
contiguous with the rest of the UK. Including England and Wales, UK based studies would 
be sensible but this would not be without problems. Surveillance techniques, data 
recording and laboratory methods would all need to be addressed in a standard fashion if 
the study was to address the spatial distribution of ST DTI04 infections in the mainland 
UK properly. In terms of temporal issues, the ARIMA model has provided an insight into 
the ability to forecast and this might also be extended should the data quality be sufficient. 
It is worth remphasising that sometimes simple epidemiological analyses and plots over 
time can provide more relevant insight than more complex approaches. 
The infections caused by ST DTI04 have been a concern for over 14 years and changes in 
the phage types are well documented (Anon 1998). Although the submissions from ST 
DT104 have declined, recently, the emergence of type DT 40 has replaced DT104 as a 
matter of concern. It may be that this study has been conducted as DT104 begins to 
decline as a threat. What is certain is that its ability to spread resistance determinants in the 
ecosystem will remain and, regardless of the organism, it is perhaps on these that future 
studies should be directed. 
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